Effect of a high fat diet on a mouse model of Alzheimer's disease by Lawrence, Catherine et al.
  
 
 
 
 
 
 
 
 
Effect of a high fat diet on a mouse model of Alzheimer’s 
disease 
  
  
  
  
 
 
A thesis submitted to the University of Manchester for the degree of  
Doctor of Philosophy  
in the Faculty of Life Sciences 
 
 
 
 
2010 
 
 
 
 
 
Elysse Knight 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 2 
 
List of contents 
 
List of contents................................................................................................................................... 2 
List of figures ..................................................................................................................................... 7 
List of tables..................................................................................................................................... 10 
Abstract of thesis ............................................................................................................................. 11 
Declaration....................................................................................................................................... 12 
Copyright statement......................................................................................................................... 12 
List of abbreviations......................................................................................................................... 13 
Acknowledgements.......................................................................................................................... 15 
Chapter 1 ......................................................................................................................................... 16 
1.0. Overview............................................................................................................................... 17 
1.1. Alzheimer’s disease (AD) ..................................................................................................... 17 
1.2. Behavioural and cognitive decline in AD patients................................................................. 17 
1.3. AD pathology ........................................................................................................................ 18 
1.4. Experimental models of AD .................................................................................................. 20 
1.4.1. 3xTgAD model of AD .................................................................................................... 21 
1.5. Risk factors for AD................................................................................................................ 23 
1.6. Obesity and energy balance................................................................................................. 23 
1.7. AD and energy balance ........................................................................................................ 24 
1.7.1. Mid-life obesity and risk of AD....................................................................................... 24 
1.7.2. Later-life obesity and risk of AD .................................................................................... 25 
1.7.3. Diet and risk of AD ........................................................................................................ 26 
1.7.4. Dietary modification in AD models ................................................................................ 27 
1.7.4.1. HF diets ................................................................................................................. 27 
1.7.4.2. Calorie restricted diets ........................................................................................... 28 
1.7.5. Weight loss and AD....................................................................................................... 28 
1.8. Summary and PhD hypothesis ............................................................................................. 31 
Chapter 2 ......................................................................................................................................... 32 
2.1. Animals................................................................................................................................. 33 
2.2. Examination of energy balance ............................................................................................ 33 
2.2.1. Diet................................................................................................................................ 33 
2.2.2. Longitudinal body weight and food intake analysis ....................................................... 34 
2.2.3. Indirect calorimetric measurement of metabolic rate .................................................... 34 
2.3. Assessment of behaviour and memory ................................................................................ 35 
 3 
 
2.3.1. Open-field (OF) behaviour test...................................................................................... 35 
2.3.2. Y-maze continous spontaneous alternation (SA) test ................................................... 36 
2.3.3. Odour recognition (OR) test .......................................................................................... 38 
2.3.4. Novel object recognition (NOR) test.............................................................................. 41 
2.3.5. Morris water maze (MWM) task .................................................................................... 43 
2.4. Culling................................................................................................................................... 49 
2.4.1. Perfusion ....................................................................................................................... 49 
2.4.2. Tissue extraction ........................................................................................................... 49 
2.5. Statistical analysis ................................................................................................................ 49 
Chapter 3 ......................................................................................................................................... 50 
3.1. Introduction and objectives................................................................................................... 51 
3.2. Materials and methods ......................................................................................................... 51 
3.2.1. Experimental design...................................................................................................... 51 
3.2.2. Statistical analysis......................................................................................................... 52 
3.3. Results.................................................................................................................................. 53 
3.3.1. Characterisation of the energy balance profile in 3xTgAD mice ................................... 53 
3.3.1.1. 2-month-old male 3xTgAD mice displayed increased body weight and food intake
............................................................................................................................................ 53 
3.3.1.2. 12- month -old 3xTgAD displayed altered body weight and food intake profiles ... 54 
3.3.1.3. Decreased survival in female 3xTgAD mice .......................................................... 55 
3.3.1.4. 2-month-old 3xTgAD mice displayed no difference in metabolic rate.................... 56 
3.3.1.5. 12-month-old 3xTgAD mice had a higher metabolic rate ...................................... 57 
3.3.1.6. 18-month-old 3xTgAD mice had a higher metabolic rate ...................................... 59 
3.3.2. Characterisation of the energy balance profile in 129SV and C57BL/J6 strains........... 61 
3.3.2.1. Male 129SV and C57BL/J6 mice displayed similar body weight and food intake 
profiles over 20 months ...................................................................................................... 61 
3.3.2.2. 20-month-old male 129SV and C57BL/J6 mice displayed similar body weight, food 
intake, water intake and metabolic rate .............................................................................. 62 
3.4. Discussion ................................................................................................................... 63 
3.4.1. Energy balance and survival in female 3xTgAD mice................................................... 63 
3.4.2. Altered energy balance in male 3xTgAD mice .............................................................. 63 
3.4.3. Energy balance in other mouse models of AD.............................................................. 65 
3.4.4. Why do aged male 3xTgAD mice have lower body weight? ......................................... 65 
3.4.5. Why do aged male 3xTgAD mice have higher metabolic rate?................................ 66 
3.4.6 Altered energy balance in AD patients?......................................................................... 67 
3.5. Conclusion............................................................................................................................ 68 
Chapter 4 ......................................................................................................................................... 69 
4.1. Introduction and objectives................................................................................................... 70 
4.2. Materials and methods ......................................................................................................... 70 
 4 
 
4.2.1. Experimental design...................................................................................................... 70 
4.2.1.1. OF test ................................................................................................................... 70 
4.2.1.2. SA test ................................................................................................................... 70 
4.2.1.3. MWM task .............................................................................................................. 70 
4.2.1.4. NOR test ................................................................................................................ 71 
4.2.1.4. OR test................................................................................................................... 71 
4.2.2. Statistical analysis......................................................................................................... 71 
4.3. Results.................................................................................................................................. 72 
4.3.1. Characterisation of behaviour and memory deficits in 3xTgAD mice............................ 72 
4.3.1.1. 3xTgAD mice displayed age-dependent changes in open-field (OF) behaviour ... 72 
4.3.1.2. 3xTgAD mice showed age-dependent memory deficits in the Y-maze spontaneous 
alternation (SA) test from 5 months of age ......................................................................... 73 
4.3.1.3. 3xTgAD mice had age-dependent memory deficits in the Morris water maze 
(MWM) task probe test from 5 months of age .................................................................... 74 
4.3.1.4. 3xTgAD mice displayed age-dependent memory deficits in the novel object 
recognition (NOR) test from 8 months of age ..................................................................... 76 
4.3.1.5. 3xTgAD mice showed memory deficits in odour recognition (OR) test at 3 months 
of age. ................................................................................................................................. 77 
4.3.2. Evaluation of behaviour and memory in 129SV and C57BL/J6 mouse strains............. 78 
4.3.2.1. 129SV and C57BL/J6 mice displayed no difference in open field (OF) behaviour at 
3, 8, 12 and 18 months of age ............................................................................................ 78 
4.3.2.2. 129SV and C57BL/J6 mice showed no difference in memory in the Y-maze 
spontaneous alternation (SA) test at 3, 8, 12 and 18 months of age.................................. 79 
4.4. Discussion ............................................................................................................................ 80 
4.4.1. Open-field (OF) behaviour test...................................................................................... 80 
4.4.1.1. OF behavioural test conclusions and future studies .............................................. 82 
4.4.2. Y-maze spontaneous alternation (SA) memory test ..................................................... 82 
4.4.2.1. Y-maze SA test conclusions and future studies .................................................... 83 
4.4.3. Morris water maze (MMW) memory task ...................................................................... 83 
4.4.3.1. MWM task conclusions and future studies ............................................................ 85 
4.4.4. Novel object recognition (NOR) memory test................................................................ 85 
4.4.4.1. NOR test conclusions and future studies............................................................... 86 
4.4.5. Odour recognition (OR) task ......................................................................................... 86 
4.4.5.1. OR test conclusions and future studies ................................................................. 87 
4.4.6. 129SV and C57BL/J6 strains ........................................................................................ 88 
4.5. Conclusion............................................................................................................................ 88 
Chapter 5 ......................................................................................................................................... 89 
5.1. Introduction and objectives................................................................................................... 90 
5.2. Materials and methods ......................................................................................................... 90 
5.2.1. Experimental design...................................................................................................... 90 
 5 
 
5.2.1.1. Energy balance...................................................................................................... 90 
5.2.1.2. Behaviour and memory.......................................................................................... 91 
5.2.2. Statistical analysis......................................................................................................... 91 
5.3. Results.................................................................................................................................. 92 
5.3.1. Effect of an HF diet on energy balance in 3xTgAD mice .............................................. 92 
5.3.1.1. Effect of an HF diet on body weight in 3xTgAD mice ............................................ 92 
5.3.1.2. Effect of an HF diet on energy balance and metabolic rate in 3-4, 7-8, 11-12 and 
15-16-month-old 3xTgAD mice in CLAMS metabolic cages............................................... 94 
5.3.1.2.1. Effect of an HF diet on body weight, caloric intake and water intake in 3-4-month-
old 3xTgAD mice in CLAMS metabolic cages .................................................................... 94 
5.3.1.2.2. Effect of an HF diet on metabolic rate in 3xTgAD mice at 3-4 months of age .... 96 
5.3.1.2.3. Effect of an HF diet on body weight, caloric intake and water intake of 7-8-month-
old 3xTgAD mice in CLAMS metabolic cages .................................................................... 98 
5.3.1.2.4. Effect of an HF diet on metabolic rate in 3xTgAD mice at 7-8 months of age .. 100 
5.3.1.2.5. Effect of an HF diet on body weight, caloric intake and water intake of 11-12-
month-old 3xTgAD mice individually housed in CLAMS metabolic cages........................ 102 
5.3.1.2.6. Effect of an HF diet on metabolic rate in 3xTgAD mice at 11-12 months of age
.......................................................................................................................................... 104 
5.3.1.2.7.  Effect of an HF diet on body weight, caloric intake and water intake in 15-16-
months-old 3xTgAD mice individually housed in CLAMS metabolic cages...................... 106 
5.3.1.2.8.  Effect of an HF diet on metabolic rate in 15-16-month-old 3xTgAD mice........ 108 
5.3.1.3. Effect of an HF diet on epididymal fat pad weight in 3xTgAD mice at 3-4, 7-8, 11-
12 and 15-16 months of age............................................................................................. 110 
5.3.2. Effect of an HF diet on behaviour and memory in 3xTgAD mice at 3-4, 7-8, 11-12 and 
15-16 months of age ............................................................................................................. 112 
5.3.2.1. Effect of an HF diet on open-field (OF) behaviour in 3xTgAD mice at 3-4, 7-8, 11-
12 and 15-16 months of age............................................................................................. 112 
5.3.2.2. Effect of an HF diet on Y-maze spontaneous alternation (SA) in 3xTgAD mice at 3-
4, 7-8, 11-12 and 15-16 months of age ............................................................................ 114 
5.3.2.3. Effect of an HF diet on the Morris water maze (MWM) task in 3xTgAD mice at 3-4, 
7-8, 11-12 and 15-16 months of age ................................................................................ 116 
5.3.2.4. Effect of an HF diet on memory in the novel object recognition (NOR) test in 
3xTgAD mice at 3-4, 7-8, 11-12 and 15-16 months of age............................................... 118 
5.3.2.5. Effect of an HF diet on memory in the odour recognition (OR) test in 3xTgAD mice 
at 3-4, 7-8, 11-12 and 15-16 months of age ..................................................................... 119 
5.4. Discussion .......................................................................................................................... 121 
5.4.1. Effect of an HF diet on energy balance in 3xTgAD mice ............................................ 121 
5.4.1.1. Energy balance of control 3xTgAD mice on a chow diet ..................................... 121 
5.4.1.2. Effect of an HF diet on energy balance in 3xTgAD mice ..................................... 122 
5.4.1.3. Previous HF studies in mouse models of AD ...................................................... 123 
 6 
 
5.4.1.4. Effect of an HF diet on energy balance summary................................................ 124 
5.4.2. Effect of an HF diet on behaviour and memory in 3xTgAD mice ................................ 125 
5.4.2.1. Behaviour and memory in control 3xTgAD mice on a chow diet ......................... 125 
5.4.2.2. An HF diet induced memory deficits in both Non-Tg control and 3xTgAD mice.. 125 
5.4.2.3. The effect of an HF diet on behaviour and memory in models of AD .................. 126 
5.4.2.4. An HF diet affects memory in cognitively normal rodents and humans............... 127 
5.4.2.5. Potential mechanisms underlying diet-induced memory deficits ......................... 128 
5.4.2.6. Effect of an HF diet on energy balance and behaviour and memory summary... 130 
Chapter 6 ....................................................................................................................................... 131 
6.1 Final discussion ................................................................................................................... 132 
Appendices .................................................................................................................................... 136 
Appendix A: Nutritional profiles of chow and HF diets............................................................... 137 
Appendix B: Genotyping of 3xTgAD and Non-Tg control mice ................................................. 139 
Appendix C: Published manuscript............................................................................................ 142 
References .................................................................................................................................... 150 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Final word count: 45,851  
 7 
 
List of figures 
 
Chapter 1: Introduction 
 
1.1. Post-mortem pathological hallmarks in the brain of an AD patient with visible amyloid plaques 
and neurofibrillary tau tangles (NFTs) …………………………………………………………………18 
1.2. Formation of A! plaques and NFT tau tangles ..………...………………………………………19 
1.3. Schematic representation of the energy balance system……………………………………….24 
 
Chapter 2: General materials and methods 
 
2.1. Comprehensive Laboratory Animal Monitoring System (CLAMS) …………………………….34 
2.2. Open-field (OF) test. ………………………………………………………………………………..36 
2.3. Intra-maze cues in the Y-maze spontaneous alternation (SA) test. …………………………..37 
2.4. Y-maze spontaneous alternation (SA) test. ……………………………………………………...37 
2.5. Time-line of the odour recognition (OR) test.. ………...………..…………………………….….39 
2.6. Schematic representation of the odour recognition (OR) test. ………………...……………….40 
2.7. Time-line of the novel object recognition (NOR) test. ……………………………………...…...41 
2.8. Schematic representation of the Novel Object Recognition (NOR) test. ……………………...42 
2.9. Set-up of the Morris water maze (MWM) …………………………………………………………44 
2.10. Extra maze spatial cues in the Morris water maze (MWM) ………………………………......45 
2.11. Time-line of the Morris water maze (MWM) task ………………………………………………46 
 
Chapter 3: Characterisation of energy balance in 3xTgAD mice 
 
3.1. 2-month-old male 3xTgAD mice displayed increased body weight and food intake ………...53 
3.2. 3xTgAD mice had altered body weight and food intake profiles ……………………………….54 
3.3. Decreased survival in female 3xTgAD mice ……………………………………………………..55 
3.4. 2-month-old 3xTgAD mice displayed no difference in metabolic rate …………………………56 
3.5. 12-month-old 3xTgAD mice had a higher metabolic rate …………………………………….…58 
3.6. 18-month-old 3xTgAD mice had a higher metabolic rate ……………………………………….60 
3.7. Male 129SV and C57BL/J6 mice displayed similar body weight and food intake profiles over 20 
months …………………………………………………………………………………………………..…61 
3.8. 20-month-old male 129SV and C57BL/J6 mice displayed similar body weight, food intake, 
water intake and metabolic rate …………………………………………………………………………62 
 
Chapter 4: Characterisation of behaviour and memory in 3xTgAD mice 
 
4.1. 3xTgAD mice displayed age-dependent changes in open-field (OF) behaviour ……………..72 
 8 
 
4.2. 3xTgAD mice showed age-dependent memory deficits in the Y-maze spontaneous alternation 
(SA) test. from 5 months of age …………………………………………………………………………73 
4.3. 3xTgAD mice had age-dependent memory deficits in the Morris water maze (MWM) probe test 
from 5 months of age ……………………………………………………………………………………..75 
4.4. 3xTgAD mice showed age-dependent memory deficits in the novel object recognition (NOR) 
test from 8 months of age ………………………………………………………………………………..76 
4.5. 3-month-old male 3xTgAD mice displayed memory deficits in the odour recognition (OR) test 
………………………………………………………………………………………………………………..77 
4.6. 129SV and C57BL/J6 mice had no difference in open-field (OF) behaviour at 3, 8, 12 and 18 
months of age ………………………………………………………………………………………………78 
4.7. 129SV and C57BL/J6 had no difference in memory in the Y-maze spontaneous alternation 
(SA) test/ at 3, 8, 12 and 18 months of age …………………………………………………………….79 
  
Chapter 5: Effect of an high fat diet on 3xTgAD mice 
 
5.1. Effect of a high fat (HF) diet on body weight in 3xTgAD mice at 3-4, 7-8, 11-12 and 15-16 
months of age ………………………………………………………………………………………………93 
5.2. Effect of a high fat (HF) diet on body weight, caloric intake and water intake in individually 
housed 3-4-month-old 3xTgAD mice in Comprehensive Laboratory Animal Monitoring System 
(CLAMS) cages …………………………………………………………………………………………….95 
5.3. Effect of a high fat (HF) diet on metabolic rate in 3-4-month-old 3xTgAD mice ………………..97 
5.4. Effect of a high fat (HF) diet on body weight, caloric intake and water intake in individually 
housed 7-8-month-old 3xTgAD mice in Comprehensive Laboratory Animal Monitoring System 
(CLAMS) cages ……………………………………………………………………………………..……...99 
5.5. Effect of a high fat (HF) diet on metabolic rate in 7-8-month-old 3xTgAD mice ……………...101 
5.6. Effect of a high fat (HF) diet on body weight, caloric intake and water intake in 11-12-month-old 
3xTgAD mice individually housed in CLAMS metabolic cages …………………………………...…103 
5.7. Effect of a high fat (HF) diet on metabolic rate in 11-12-month-old 3xTgAD mice ………...…105 
5.8. Effect of a high fat (HF) diet on body weight, caloric intake and water intake in 15-16-month-old 
3xTgAD mice individually housed in CLAMS metabolic cages ……………………………………...107 
5.9. Effect of a high fat (HF) diet on metabolic rate in 15-16-month-old 3xTgAD mice ………...…109 
5.10. Effect of high fat (HF) diet on epididymal fat pad weight in 3xTgAD mice at 3-4, 7-8, 11-12 
and 15-16 months of age ………………………………………………………………………………...111 
5.11. Effect of high fat (HF) diet on open-field (OF) behaviour in 3xTgAD mice at 3-4, 7-8, 11-12 
and 15-16 months of age ……………………………………………………………………………...…113 
5.12. Effect of a high fat (HF) diet on Y-maze spontaneous alternation (SA) performance in 3xTgAD 
mice at 3-4, 7-8, 11-12 and 15-16 months of age …………………………………………………….115 
5.13. Effect of a high fat (HF) diet on the Morris water maze (MWM) task in 3xTgAD mice at 3-4, 7-
8, 11-12 and 15-16 months of age ………………………………………………………………….…..117 
 9 
 
5.14. Effect of a high fat (HF) diet on memory in novel object recognition (NOR) test in 3xTgAD 
mice in 3-4, 7-8, 11-12 and 15-16 months of age …………………………………………………….118 
5.15. Effect of a high fat (HF) diet on memory deficits in odour recognition (OR) test in 3xTgAD 
mice at 3-4, 7-8, 11-12 and 15-16 months of age …………………………………………………….120 
5.16. Schematic representation of potential molecular pathways linking obesity and cognitive 
decline ……………………………………………………………………………………………………..129 
 
Appendices 
 
B1. Genotyping of 3xTgAD and Non-Tg control mice ………………………………………………..141 
 
 
 
 
 
 
 10 
 
List of tables 
 
Chapter 2: General materials and methods 
 
2.1. Diet composition of chow and high fat diets ………………………………………………………..33 
2.2. Scent combinations of the odour recognition (OR) task............................................................39 
2.3. Flagged platform training trial pattern of the Morris water maze (MWM) test…………………..47 
2.4. Morris water maze (MWM) submerged platform training and probe trial start position 
pattern………………………………………………………………………………………………………..48 
 
Chapter 3: Characterisation of energy balance in 3xTgAD mice 
 
3.1. Experimental cohorts for energy balance assessment (comprehensive laboratory animal 
monitoring system; CLAMS)…………………………………………………….…………………………51 
 
  
Chapter 5: Effect of a high fat diet on 3xTgAD mice 
 
5.1. Experimental cohorts for energy balance assessment……………………………..……………..90 
5.2. Experimental cohorts for behavioural evaluation…………………………………………….........91 
 
Chapter 6: Final discussion 
 
6.1. Summary of the characterisation of energy balance in 3xTgAD mice versus Non-Tg control 
mice……………………………………………………………………………………………..…………..132 
6.2. Summary of the characterisation of behaviour and memory in 3xTgAD mice versus Non-Tg 
control mice……………………………………………………......………………………………………133 
6.3. Summary of the effect of a high fat (HF) diet on a battery of cognitive tests in 3xTgAD and 
Non-Tg control mice………………………………………………………………………………………133 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 11 
 
THE UNIVERSITY OF MANCHESTER 
Abstract of thesis 
Submitted by Elysse Knight for the degree of Doctor of Philosophy and entitled Effect of a 
high fat diet on a mouse model of Alzheimer’s disease, December 2010. 
 
 
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder, characterised by 
deficits in language, behaviour and memory. Increasing evidence suggests that mid-life 
obesity and a diet high in fat are risk factors for AD. In contrast, life-threatening weight 
loss occurs and worsens as the disease progresses, despite adequate or increased food 
intake. A greater understanding of energy balance in AD may therefore uncover novel 
targets for therapy. The aim of this thesis was to test the hypothesis that 3xTgAD mice 
display altered energy balance and that experimental changes to this balance will alter 
cognition. To address this hypothesis, three key objectives were set up; to characterise 
the energy balance profile, characterise behaviour and memory, and evaluate the 
response to an high fat (HF) diet in a triple transgenic (3xTgAD) model, an experimental 
mouse model of AD. 
 
Energy balance was characterised in non-transgenic (Non-Tg) control and 3xTgAD mice, 
demonstrating altered body weight, food intake and metabolic rate in the 3xTgAD mouse 
model of AD. At 2-month of age male 3xTgAD mice displayed greater food intake and 
body weight, but no difference in metabolic rate, whereas from 12 months of age 3xTgAD 
mice weighed less, despite eating more, and had a higher metabolic rate than Non-Tg 
control mice. This provides evidence that there is a shift towards a hypermetabolic state 
from 12 months of age in 3xTgAD mice, which may represent a key stage in advancement 
of the disease process. Behaviour and memory were characterised in Non-Tg control and 
3xTgAD mice in a battery of tests at different ages. 3xTgAD mice showed changes in 
open-field activity/anxiety from 3 months of age. Memory impairments were first detected 
in 3xTgAD mice at 3 months of age as deficits in odour recognition memory, mirroring 
early impairments seen in AD patients. Deficits in spatial memory were then observed in 
both the Y-maze spontaneous alternation and Morris water maze tests from 5 months of 
age. Finally, deficits in non-spatial visual object memory were observed in 3xTgAD mice in 
the novel object recognition test at 8 months of age. Energy balance, behaviour and 
memory were assessed in Non-Tg control and 3xTgAD mice in response to an HF diet. 
Non-Tg control and 3xTgAD mice displayed similar energy balance profiles in response to 
an HF diet. The HF diet was found to worsen memory in Non-Tg mice in odour recognition 
at 3-4 and 7-8 months of age, in the Morris water maze at 7-8 months of age and in novel 
object recognition and spontaneous alternation at 11-12 and 15-16 months of age. 
Similarly, the HF diet worsened memory in 3xTgAD mice in odour discrimination at 3-4 
and 7-8 months of age, the Morris water maze at 7-8 and 11-12 months of age, and in 
spontaneous alternation at 15-16 months of age. As an HF diet induced memory 
impairments, in both Non-Tg control and 3xTgAD mice, it suggests that diet-induced 
deficits may therefore, not be specific to AD, but rather to cognition in general. 
 
Overall, these data demonstrate that 3xTgAD mice show AD-like age-dependent changes 
in energy balance, behaviour and memory. Furthermore, an HF diet produced 
impairments in memory in 3xTgAD mice, but these effects were not specific to AD, as an 
HF diet also led to deficits in control animals. These data support a role for energy 
balance in the progression of AD, although the underlying mechanisms remain poorly 
understood. 3xTgAD mice may therefore represent a good model to examine energy 
balance during AD and to evaluate targets for future therapies. 
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1.0. Overview 
 
This introduction provides a brief overview of Alzheimer’s disease (AD) and the various transgenic 
mouse models created. It will then examine the role of obesity and diet as risk factors for AD and 
review the studies assessing the role of diet and obesity in models of AD. Finally, the hypothesis 
and aims of this PhD will be presented. 
 
1.1. Alzheimer’s disease (AD)   
 
AD is a progressive age-dependent neurodegenerative disorder characterised by language, 
memory and behavioural deficits.  It is the most common cause of dementia in the elderly, currently 
affecting around 5% of those aged 65 or over (Hardy 2006). By 2050, it is estimated that 370 
million people worldwide will be aged 80 or older and that over 50% of this population will develop 
AD (United Nations 1998). There are currently no treatments to cure or delay the onset of AD, 
therefore further understanding the complex aetiology and progression of AD is important in an 
ageing population (Knight 2007).  
 
1.2. Behavioural and cognitive decline in AD patients 
 
There are two main types of memory, declarative and non-declarative memory. Declarative 
memory can be broken down into semantic (the ability to learn facts and concepts) and episodic 
memory (recalling past events and experiences) and is dependent on the hippocampus-medial 
temporal lobe (MTL) and the diencephalon, whereas non-declarative memory (habits and skills) is 
related to striatum, motor cortex and cerebellum (Squire 2004; Squire & Zola-Morgan 1991; 
Thompson & Kim 1996). 
 
In AD, one of the first signs of cognitive decline is the generalised disruption of declarative memory, 
including deficits in both semantic and episodic memory, which is often characterised by an 
abnormally rapid rate of forgetfulness (Artero et al 2003; Carlesimo & Oscar-Berman 1992; Morris 
1996; Welsh et al 1992). Deficits in episodic memory are one of the best indicators of early AD 
compared to other forms of dementia and have been reported in the pre-clinical stage of the 
disease (Artero et al 2003; Chen et al 2000b; Hodges 2006; Morris 1996; Welsh et al 1992; White 
& Ruske 2002). Mild cognitive impairments (MCIs) in recognition performance and free recall tasks 
have been observed in patients when compared to age-matched controls up to six years prior to 
diagnosis (White & Ruske 2002). The ability to encode and store new declarative information is 
impaired in AD patients from an early clinical stage and as AD progresses, other cognitive deficits 
including disruptions in language, spatial orientation, attention and executive functions manifest 
(Billings et al 2005; Chertkow & Bub 1990; Hodges 2006; Lambon Ralph et al 2003; Morris 1996; 
Perry & Hodges 1999). In contrast, procedural memory (habits and skills) remains relatively 
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unaffected until the late stages of the disease (Billings et al 2005; Chertkow & Bub 1990; Hodges 
2006; Knight 2007; Lambon Ralph et al 2003; Morris 1996; Perry & Hodges 1999).  
 
AD is associated with various behavioural and psychological symptoms including depression, 
anxiety, apathy, irritability, aggression, disinhibition and reduced curiosity (Brodaty & Low 2003; 
Honig & Mayeux 2001; Levy et al 1999; Masterman 2003; Pugh et al 2007; Ritchie & Lovestone 
2002). These all form part of the behavioural and psychological symptoms of dementia (BPSD), 
which are commonly seen in AD, in either the early or late stages of the disease, and are known to 
fluctuate throughout its progression (Cummings 2000; Daffner et al 1992; Spalletta et al 2004). 
Disturbances in sleep-wake patterns are also a common feature of the disease (Bliwise 1993; 
Bonanni et al 2005; Lee et al 2007; Montplaisir et al 1998) with AD patients displaying increased 
sleepiness during the day and increased wakefulness at night (Bonanni et al 2005). AD patients 
often exhibit a shift in their body clock, tending to wake up later in the day and going to sleep later 
than non-demented controls (Lee et al 2007). Similarly circadian shifts in eating patterns are 
observed in AD patients who have a tendency to have their biggest meal during breakfast and 
display increased preference for sweet food (Keene & Hope 1997b; Young 2001).  
 
The ability of AD sufferers to perform everyday activities becomes increasingly impaired over time, 
and eventually leads to permanent dependence on caregivers. Only when behavioural and 
cognitive deficits disrupt normal social and occupational function is AD clinically diagnosed (Morris 
1996), however, AD can only be definitively diagnosed following post-mortem histopathological 
examination of brain tissue (Small 1998; White & Ruske 2002). 
1.3. AD pathology 
 
The pathology of AD within the brain is characterised by extracellular amyloid-beta (A!) plaques 
and intracellular neurofibrillary tangles (NFTs) composed of hyperphosphorylated tau (see Figure 
1.1.)   
 
 
 
 
 
 
 
 
Figure 1.1. Post-mortem pathological hallmarks in the brain of an AD patient with visible 
amyloid plaques and neurofibrillary tau tangles (NFTs) 
 
Images of brains taken from: http://www.alz.org/brain/overview.asp. Photomicrograph of 
postmortem brain tissue taken from http://med.kuleuven.be/legtegg/Images/NFT_amyloid.jpg 
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It is believed that the inability to remove and/or the overproduction of fibrillar A! causes AD via an 
accumulation and deposition of amyloid and the production of NFTs (Hardy & Higgins 1992; Knight 
2007) (see Figure 1.2.). Together these pathological hallmarks are the trigger for the neural 
degeneration and cognitive decline observed in AD patients (Hardy et al 1998; Tanzi 2005). In AD, 
pathology can been seen in the entorhinal cortex, hippocampus, frontal cortex, basal forebrain, 
parietal lobe, occipital lobe, amygdala, locus coeruleus and raphe nucleus and other hallmarks 
include inflammation, cerebral amyloid angiopathy, neurophil threads, granulovacuolar 
degeneration, synaptic alterations, neuronal loss, Lewy and Hirano bodies (Esiri 1996; Tapiola 
2001).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A!, the major component of amyloid plaques is formed via proteolytic processing of amyloid 
precursor protein (APP), a type I transmembrane protein (Carlson 2003; LaFerla & Oddo 2005; 
Munter et al 2007; Shen & Kelleher 2007) (Figure 2). APP is first cleaved by !-secretase then by "- 
secretase (Carlson 2003; Gotz et al 2006; LaFerla & Oddo 2005; Munter et al 2007; Shen & 
Figure 1.2.  Formation of A! plaques and NFT tau tangles 
 
Alzheimer’s disease is characterised by dense intracellular neurofibrillary tau tangles (NFTs) 
and extracellular amyloid-beta (A!) plaques within the brain. A! peptide aggregates are formed 
via cleavage of amyloid precursor protein (APP) by !- and "- secretases resulting in A!40 and 
A!42. It is A!42, which forms insoluble amyloid fibrils readily that aggregate to form A! plaques 
that are considered to be the toxic species heavily implicated in the pathogenesis of AD. 
Alternatively, APP can and is cleaved by #-secretase, which does not generate the toxic species 
of A!. In AD tau becomes hyperphosphorlated, unstable and fragments to cause NFTs  
(Schematic redrawn from: http://www.nia.nih.gov/NR/rdonlyres/835CFCB2-6222-45CB-A8F0-
E4AD70220257/0/progress_report_pg34high.jpg) 
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Kelleher 2007). This process is known as the amyloidogenic pathway, in which the activity of !- 
secretase is attributed to !-site amyloid precursor protein-cleaving enzyme (BACE), whereas "- 
secretase activity is dependent upon presenilin (PS), anterior pharynx defective 1 (APH-1), 
presenilin enhancer 1 (PEN-1) and nicastrin (Gotz et al 2006).  Cleavage via !- and "- secretases 
results in a short (A!40) and long form (A!42) (Oakley et al 2006) of A!. A!42 forms insoluble 
amyloid fibrils readily and is considered the toxic species heavily implicated in the pathogenesis of 
AD. Studies have revealed that an increased production of insoluble A!42 is caused by an 
alteration in APP metabolism (Hardy et al 1998; Oakley et al 2006). Furthermore, patients with 
inherited mutations in APP and PS-1 display increased levels of toxic A!42 (Munter et al 2007). In 
the normal ageing brain, APP is cleaved by #-secretase (disintegrin and metalloproteinase – 
ADAM - 10), which does not generate the toxic species of A!. This is known as the non-
amyloidogenic pathway (Gotz et al 2006). In its normal state tau, a soluble protein, promotes 
microtubule assembly and stabilisation (LaFerla & Oddo 2005). There is no genetic link between 
AD and the tau gene, suggesting that tau lies downstream of A!. However, it remains unknown 
whether pathology and potential effects of tau are dependent or independent of A! (LaFerla & 
Oddo 2005). 
 
 
There are two forms of AD, familial (rare) and non-familial (common).  Early-onset familial AD 
(EOFAD) accounts for less than 5% of all AD cases with onset usually under 65 years of age 
(Bertram 2007). It is caused by autosomal dominant transmission of rare, yet highly penetrant, 
genetic mutations in presenilin (PS-1, PS-2) and APP (Hardy et al 1998; Tanzi 2005), however, the 
vast majority of cases occur after 65 years of age (late-onset AD; LOAD) and are termed 
“sporadic”. The aetiology of these “sporadic” cases is unknown, although increasing evidence 
suggests that genetic factors could be involved (Bertram 2007; Lippa et al 1996). Apolipoprotein-E 
(ApoE) has been shown to be a risk factor gene for AD, while both familial and sporadic forms of 
AD are associated with the allelic variation $4 (Luchsinger & Mayeux 2004; Mayeux et al 1993). 
More recently the Genome-Wide Association Studies (GWAS) identified three new genes; clusterin 
(CLU), complement (CRI) and PICALM linked with increased risk of LOAD (Harold et al 2009; 
Lambert et al 2009). It is important to note that the pathological hallmarks of AD are 
indistinguishable between EOFAD and LOAD cases (Gotz et al 2006).  
 
1.4. Experimental models of AD   
 
As mechanisms underlying age-related neurodegeneration and cognitive decline in AD remain 
elusive (due to the reliance on post-mortem tissue), various animal models have been created 
(Duff & Suleman 2004; Hardy et al 1998). Murine models have successfully replicated some AD-
like characteristics and develop age-dependent pathology, but thus far no model has displayed all 
the pathological and behavioural characteristics observed in humans (Duff & Suleman 2004; Oddo 
et al 2003a). This could be due to the role of environment and diet, amongst other factors, which 
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experimental models may not be exposed to, but also due to the complex nature of cognitive 
symptoms observed in humans, which do not have their obvious equivalent in animal models (Duff 
& Suleman 2004; Knight 2007; Oddo et al 2003a).  
 
Gene-targeted and transgenic mice (Tg) have been created with mutant APP (Hsiao et al 1996), 
PS-1 (Mehta et al 1998), PS-2 (Herreman et al 1999), tau (Lewis et al 2001) and ApoE (Garcia-
Alloza et al 2006; Oddo et al 2003a; Raber et al 1998). APP, PS-1, and PS-2 models are based on 
the overproduction of A! (due to overexpression of the aforementioned mutant human AD genes) 
and most develop age-dependent pathology (Duff & Suleman 2004). Mice overexpressing the 
mutant isoform of APP, PS-1 or PS-2 display A! plaques, while mutant tau mice show NFTs 
(Mandavilli 2006). Compared to the single transgenics, APP/PS-1 (Holcomb et al 1998) and 
APP/PS-2 (Richards et al 2003) double transgenics display accelerated accumulation and 
deposition of A!, but no NFTs.  Transgenic models of AD also display behavioural and learning 
deficits in various tasks, including basal behaviour (open field activity), motor activity (balance 
beam, string agility), learning and memory (Y-maze spontaneous alternation, object recognition, 
holeboard, elevated plus-maze, Morris water maze (MWM), circular platform and radial arm maze) 
(Arendash et al 2001; Chapman et al 1999; Dodart et al 1999; Gotz & Ittner 2008; Hsiao et al 1996; 
King & Arendash 2002; King et al 1999; Savonenko et al 2005).  These tasks are widely used in 
neuroscience and can examine various brain region specific aspects of learning and memory. More 
specifically to AD, these tasks have revealed that transgenic models of AD mice are born 
behaviourally normal and develop age-dependent deficits, with the age of onset varying between 3 
and 6 months of age, depending on the task and experimental mouse model of AD used (King & 
Arendash 2002). Most authors have only examined one or two cognitive tasks in any one study, 
with the exception of Arendash and King (Arendash & King 2002) who examined intra- and inter-
task relationships using a comprehensive battery of tasks (King & Arendash 2002). 
 
1.4.1. 3xTgAD model of AD 
 
A triple transgenic mouse model (3xTgAD) was developed by Oddo et al in 2003, which expresses 
mutant APP, PS-1 and tau. These mice display behavioural deficits and develop age-dependant A! 
plaque and tangle pathology, allowing the relationship between synaptic dysfunction, tangles and 
A! to be investigated (Oddo et al 2003b). Intraneuronal A! is first detectable in neurones of the 
neocortex of 3xTgAD mice, between 3-4 months of age, followed by CA1 then CA3 pyramidal 
neurones of the hippocampus by 6 months (Oddo et al 2003b). This is followed by an age-
dependent progression in A! pathology, most of which is A!42, the toxic species associated with 
cognitive deficits. Intraneuronal A! is also visible within the amygdala. Extracellular A! plaques are 
first observed in 3xTgAD mice at 6 months of age within layers 4 and 5 of the neocortex. 
Interestingly, intraneuronal A! deposition precedes NFT formation, which is only detectable at 12-
months (Oddo et al 2003a), supporting previous suggestions that tau is downstream of A! (LaFerla 
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& Oddo 2005). Our preliminary data found age-dependent intracellular A! pathology in layers 4 and 
5 of the neocortex, CA1 and CA3 pyramidal neurones of the hippocampus and the amygdala from 
as early as 1-2 months of age (Knight 2007; Rodriguez et al 2008). More recently we have 
observed that plaques are not visible until approximately 12 months of age and tau even later 
(Knight et al 2010). This is much later than originally reported by Oddo et al (2003b). 
 
3xTgAD mice also develop deficits in synaptic plasticity, including long-term potentiation (LTP), the 
long-lasting increase in synaptic transmission, which is considered one of the major molecular 
mechanism underlying learning and memory(Bliss & Collingridge 1993; Cooke & Bliss 2006; Oddo 
et al 2003b). Deficits in synaptic plasticity and LTP in 3xTgAD mice are associated with intracellular 
A! immunoreactivity, and appear prior to extracellular A! plaques and tangle deposition (Oddo et 
al 2003b). Such deficits in LTP are not observed in many other transgenic models of AD (Oddo et 
al 2003b), providing further evidence for the relevance of the 3xTgAD model to the human 
condition of AD. 
 
3xTgAD mice display behavioural and cognitive deficits in sensorimotor function (wire rod and wire 
hang tests), spontaneous and circadian activity (open-field, plus maze, corner index measure, 
white-black box, dark-light maze tests), learning and memory (MWM) (Billings et al 2005). Billings 
et al (2005) determined that the initial cognitive impairments manifest as a deficit in retention, which 
correlates with the accumulation of intraneuronal A! (Billings et al 2005). The authors assessed 
cognitive deficits using the cued version of the MWM task, which is dependent on the hippocampus 
and inhibitory avoidance (IA), which is reliant on both the hippocampus and the amygdala. The 
authors found no impairments in the MWM at 2 months of age, when no overt A! and tau 
pathology has been previously reported. At 4 months, some behavioural deficits are observed, 
which are accompanied with some intraneuronal A!. However no extracellular A! plaques were 
seen at this stage. By 6 months of age, when mice have diffusible A! plaques in the cortex and 
intraneuronal A! in pyramidal neurones of the hippocampus, cortex and amygdala, mice were able 
to learn, but required more training than Non-Tg control mice. Contextual fear conditioning was 
also impaired at 6 months of age in 3xTgAD mice. These findings indicate that behavioural deficits 
progress in an age-dependent manner, the onset of which precedes plaque and tangle formation 
(LaFerla & Oddo 2005). In addition, these cognitive impairments can be rescued via clearance of 
intraneuronal A! with intracerebroventricular injection of anti- A! antibody (Billings et al 2005).  
 
Experimental models have allowed detailed examination of the complex mechanisms involved in 
the pathogenesis of AD, and have revealed a wealth of information about the various factors that 
affect and influence the incidence of AD.  
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1.5. Risk factors for AD 
 
Various risk factors have been implicated in the incidence of AD including age (advanced), Down’s 
syndrome, injury (head), sex (female), education (low), atherosclerosis (cardiovascular disease), 
susceptibility gene mutations (APP, PS-1, PS-2, ApoE) and environmental factors (diet, toxins, 
aluminium and viruses) (Thomas 2001). Emerging evidence suggests that obesity, an increasing 
health problem in developed societies, may also be a risk factor for AD (Gustafson et al 2003; 
Kivipelto et al 2005; Rosengren et al 2005; Whitmer et al 2005; Whitmer et al 2007). It is widely 
believed that the incidence of AD could be halved if the disease onset could be delayed by five 
years, therefore modification of factors such as diet could prove a crucial strategy for AD 
management (Pasinetti et al 2007).  
 
1.6. Obesity and energy balance  
 
Defined by an excess accumulation of adipose tissue, obesity (a body mass index; BMI % 30 kg m
-
2
) is now considered a worldwide epidemic and is associated with many chronic diseases including 
cardiovascular disease, hypertension, hypercholesterolemia, insulin resistance, type II diabetes, 
arthritis, asthma, several types of cancer and low-grade inflammation (Mokdad et al 2003; Naderali 
et al 2009).  
 
Body weight is regulated by the energy balance system (see Figure 1.3.), which controls the 
amount of food eaten and energy expended. Energy expenditure is composed of three components 
that include physical activity, diet-induced thermogenesis and basal metabolic rate (Levine 2005). 
Basal metabolic rate is the energy expended by an individual at rest, for normal cell and organ 
function within the body, and accounts for approximately 60% of total daily energy expenditure in 
individuals with a sedentary occupation (Joosen & Westerterp 2006; Levine 2005). Diet-induced 
thermogenesis accounts for approximately 10% of the total daily energy expenditure and is the 
thermic effect of food associated with digestion, absorption and storage of food. Physical activity or 
activity-induced thermogenesis is the most variable component from person to person, with 
individuals who exercise regularly it can account for up to approximately 10% of the total daily 
energy expenditure. There is also the activity of daily living, including maintaining posture when not 
recumbent, fidgeting and spontaneous muscle contraction. In most people this accounts for the rest 
of the total daily energy expenditure. There are also energy costs in response to altered 
temperature, medication and emotion which can effect total daily energy expenditure (Levine 
2005). 
 
The majority of obesity is associated with decreased levels of physical activity and increased 
consumption of sugar and saturated fats, causing an imbalance between caloric intake and energy 
expenditure (Spiegelman & Flier 2001). It is only when there is a positive energy balance, when 
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caloric intake is more than energy expenditure, that energy is stored in the form of triglycerides in 
adipose tissue (Spiegelman & Flier 2001).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.7. AD and energy balance 
 
Emerging reports suggest that obesity and poor diet are associated with increased risk of AD. 
Additionally, there appears to be a bimodal effect of adiposity on cognition, as during mid-life 
obesity increases risk of AD, whereas during late-life both increased BMI and being underweight 
are associated with increased risk. However, there is conflicting evidence that a high BMI late in life 
can reduce the risk of AD. This evidence will be reviewed in the next section.  
 
1.7.1. Mid-life obesity and risk of AD 
 
During mid-life (defined as approximately between 40 and 60 years of age (Friedland et al 2001)), 
evidence suggests that obesity is a risk factor for AD later in life (Fitzpatrick et al 2009; Rosengren 
et al 2005; Whitmer et al 2005; Whitmer et al 2008). At mid-life, a BMI between 20 and 22 is 
associated with the lowest risk of AD later in life, whereas a BMI over 30 was associated with a 
linear increase in risk (Rosengren et al 2005). Rosengen and colleagues also describe a BMI of 
less than 20 being associated with increased risk of AD later in life, although this was not 
significant. However, this study has been criticised as patients diagnosed in their early follow up 
period were not excluded (Gorospe & Dave 2007; Wang 2002). This is particularly important as 
Figure 1.3. Schematic representation of the energy balance system. Figure redrawn from 
(Schwartz et al 2000).  
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studies have shown that dementia patients that were previously obese can lose up to 50% of their 
body weight pre-dementia (Gorospe & Dave 2007; Wang 2002). The importance and aetiology of 
weight loss in AD will be discussed in more detail later.  
 
The relationship between mid-life BMI and risk of future dementia was also examined by Kivipelto 
et al (2005), in a study with an average follow-up of 21 years, finding increased risk of AD later in 
life in participants with mid-life obesity (Kivipelto et al 2005). More recently, Fitzpatrick et al (2009) 
performed a prospective study on 2798 adults without dementia over a 4.5-year follow-up period, 
finding probable AD in 245 individuals. The study found increased risk of dementia in obese 
individuals (BMI > 30) versus those with a normal weight (BMI 20-25) at mid-life (Fitzpatrick et al 
2009). Similarly, Whitmer et al (2005) completed a 27-year longitudinal population based study and 
found that mid-life obesity increased the risk of dementia later in life. In this study, obese patients 
had a 74% increased risk of developing dementia, while overweight patients had a 35% greater risk 
of dementia, compared to those within the normal weight range as defined by BMI and skin-fold 
thickness (Whitmer et al 2005). This was the first study to examine the risk of dementia in relation 
to skin-fold thickness (taken in the scapular and tricep region) and mid-life adiposity. Unfortunately, 
no data relating to nutrition, dieting or weight cycling was recorded (Whitmer et al 2005). More 
recently, the same authors examined the relationship between central obesity and risk of dementia 
later in life. It is important to distinguish central obesity (or “apple-shaped” obesity where fat is 
deposited around the abdomen) from peripheral obesity (or “pear-shaped” obesity where fat is 
deposited around the hips and thighs) (Rexrode et al 2001; Whitmer et al 2005), as it is central 
obesity that is highly associated with cardiovascular disease, insulin resistance, increased 
inflammatory markers and adipokines, all of which are suggested to play a role in dementia 
(Whitmer et al 2005). Whitmer et al (2008) examined sagittal abdominal diameter (SAD) as a 
measure of central obesity during mid-life (Whitmer et al 2008). The authors found that increased 
SAD significantly increased the risk of dementia three decades later in life. Participants with high 
SAD (> 25 cm) during mid-life had nearly a threefold increase in risk of dementia compared to 
those with the lowest SAD. Those participants with high SAD and high BMI were most at risk. 
Interestingly, participants with high SAD, yet normal BMI, displayed increased risk of dementia 
when compared to those with low SAD and normal BMI (Whitmer et al 2008).  This study confirms 
the importance of taking physical measurements of obesity rather than relying on BMI, when 
examining the role of obesity in dementia.  
 
1.7.2. Later-life obesity and risk of AD 
 
The studies presented thus far provide evidence that mid-life obesity is associated with increased 
risk of AD in later life (> 65 years). The evidence regarding the effect of obesity on AD in later-life 
is, however, less clear.  
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Gustafson et al (2003) performed an 18-year follow-up study examining BMI and risk of AD and 
found that elderly participants who developed dementia had a higher BMI and were overweight, 
when compared to non-demented controls. Furthermore, at 70 years of age, participants displayed 
a 36% increased risk of AD for every annual unit increase in BMI (Gustafson et al 2003). In 
contrast, Buchman et al (2005) determined that declining BMI later in life was associated with 
increased risk of AD. Every annual unit decrease in BMI lead to a 35% increase risk of AD 
(Buchman et al 2005). The authors suggest that this decline in BMI may reflect ongoing 
pathological processes contributing to the development of AD (Buchman et al 2005). More recently, 
Razay et al (2006) examined the relationship between late-life BMI, waist-hip ratio and AD, finding 
a significant association with being obese or underweight (Razay et al 2006).  This U-shaped 
association between later-life BMI and dementia has been supported by a meta-analysis study of 
10 prospective cohorts looking at BMI, skin-fold thickness and waist circumference (Beydoun et al 
2008). More recently, in a prospective study of 2798 participants, being underweight (BMI < 20) at 
later-life was associated with increased risk of AD, whereas obesity (> 35-30) was associated with 
a reduced risk when compared with participants with a normal BMI (BMI = 20-30) (Fitzpatrick et al 
2009). Similarly, another prospective study in a cohort of 1836 patients, with a mean age over 71 
years, with an average follow-up of 7 years observed higher BMI was associated with reduced risk 
of AD (Hughes et al 2009). In contrast to previous reports, these studies appear to indicate that 
late-life obesity has a protective effect on cognition (Naderali et al 2009).  
 
The evidence presented thus far demonstrates that mid-life obesity increases the risk of future AD, 
whereas later in life both increased adiposity and being underweight are associated with increased 
risk, but this is not consistent, as some studies have shown that a high late-life BMI has a 
protective effect on cognition. 
 
1.7.3. Diet and risk of AD 
 
The majority of obesity is due to increases in food intake and usually an increase in fat 
consumption within the diet. Studies now show that high calorie or high fat (HF) diets affect risk of 
AD (Luchsinger & Mayeux 2004). A western diet (HF, high calorie) has been shown to be a high 
risk factor in the prevalence of AD (Holden 1999). Furthermore, elevated mid-life levels of 
cholesterol (usually observed in obese humans and individuals consuming an HF diet) have also 
been identified as a risk factor for AD (Pappolla et al 2003) and have been shown to be correlated 
with A! deposition (Kivipelto et al 2002). Both lipid metabolism and modulation of cholesterol in 
response to fat intake are related to ApoE, a known risk factor gene for AD (Berglund 2001; 
Luchsinger et al 2002; Petot et al 2003). High cholesterol levels are observed in people at high risk 
of AD with the ApoE$ 4 allele, whereas those with the ApoE$ 2 allele are at low risk of AD and have 
lower levels of cholesterol (Berglund 2001; Luchsinger & Mayeux 2004). Luchsinger et al (2002) 
completed a cohort study of 980 elderly people " 65 years of age over a 4 year period finding that 
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those who possessed the ApoE $ 4 allele were in the highest quartile of calorie intake and total fat 
and had a high risk of AD (Luchsinger et al 2002). Other studies have demonstrated that 
regardless of ApoE genotype, high levels of trans-unsaturated and saturated fatty acids are 
associated with high risk of AD and associated cognitive decline (Luchsinger & Mayeux 2004). 
More recently, studies have attempted to look at dietary patterns in AD finding reduced risk being 
associated with decreased consumption of red meat, organ meat and butter (Gu et al 2010). 
Similarly another study demonstrated that AD is associated with increased consumption of meat, 
refined sugar, high-fat dairy products, butter and eggs (Gustaw-Rothenberg 2009). 
 
In summary, the evidence presented to date implicates obesity and an HF/high cholesterol diet as 
risk factors for AD. However, the mechanisms underlying these associations of obesity and diet on 
AD remain poorly understood. Emerging evidence also suggests that environmental factors, 
especially nutrition, act in early life to program the risks for the onset of cardiovascular and 
metabolic disease in adult life (Alexe et al 2006; Holt & Byrne 2002; Morley 2006). However, it is 
not clear how changes in diet throughout life affect the onset or progression of AD. Even though 
AD is associated with old age, it is now known that the onset occurs years before any clinical 
symptoms manifest. This makes research into diet an important area of study, as it is an easily 
modifiable intervention, which may play a role in the onset and/or progression of AD. 
 
1.7.4. Dietary modification in AD models 
 
Increased caloric intake, especially saturated fats and obesity, are linked with higher incidence of 
AD in humans. These findings have been confirmed in work done in experimental models of AD, 
where animals maintained on a high fat diet display enhanced pathology and memory deficits.  
1.7.4.1. HF diets 
 
Studies in AD mouse models, demonstrate that mice fed an HF or high cholesterol diet, gain weight 
show increased AD-related pathology (George et al 2004; Ho et al 2004; Kohjima et al 2010; Levin-
Allerhand et al 2002; Pedrini et al 2009; Refolo et al 2000; Shie et al 2002) and enhanced memory 
impairments compared to chow fed controls (Ho et al 2004). Ho et al (2004) examined the effect of 
an HF diet in female APP mice, finding that by 9 months of age HF fed APP mice developed insulin 
resistance, increased A! pathology within the neocortex and hippocampus of the brain, and 
impaired spatial learning in the MWM task (Ho et al 2004). To date, only one study has examined 
the effect of an HF diet on energy balance in 3xTgAD mice. When fed a 60% HF diet between 4-13 
months of age, Non-Tg mice control gained more weight compared to respective controls on a 
chow diet, whereas the body weight of 3xTgAD mice was not significantly higher on HF diet. 
Despite this, HF fed 3xTgAD mice showed an increase in cortical A! and tau levels (Julien et al 
2008). Very few studies have looked at both pathology and behaviour in response to an HF diet in 
Chapter 1                                                                                                             General Introduction 
28 
 
any model of AD. To date, in 3xTgAD mice, only pathology has been investigated in response to an 
HF diet, while the effect on behaviour is unknown 
 
1.7.4.2. Calorie restricted diets 
 
In contrast to HF diets, studies have demonstrated that caloric restriction (CR) reduces A! 
pathology within the brain. Patel et al (2005) examined CR in two transgenic models of AD, male 
mice overexpressing APP, and double transgenic APP and PS-1 mice, and found a 40% and 55% 
reduction respectively in A! plaque pathology following CR (Patel et al 2005). Mice on the CR diet 
were given 60% of the food eaten by the ad-libitum fed mice. Similarly, Wang et al (2005) found 
amyloid pathology was almost completely attenuated in the neocortex and hippocampus of female 
Tg2576 mice placed on a CR diet, based on 70% of the average daily caloric intake of ad-libitum 
mice for nine months. The authors found improved glucose intolerance and a 3-fold lower fat pad 
weight in the CR animals (Wang et al 2005). Neither of the above studies examined the effect of 
CR on behavioural and memory deficits and no control Non-tg mice were used.  
 
Halagappa et al (2007) examined the effect of 40% CR or intermittent fasting (IF) on behaviour and 
pathology in 3xTgAD mice. Male and female 3xTgAD mice were placed on a feeding regime at 3 
months of age and open field activity and the MWM task were assessed up to 14 months of age. At 
this point, pathology was assessed by analysing A!1-40, A!1-42, tau and phospho-tau. The 
authors found that at 14 months of age CR and IF increased the reduction in locomotor activity and 
improved performance in the MWM task. Accordingly, A!40 and A! 42 were lower following CR in 
3xTgAD mice, although this was not seen with IF. CR also reduced phospho-tau levels. The 
authors suggest that IF may prevent synapses from being damaged by A! and that dietary effects 
may suppress AD via upstream or downstream regulation of A! (Halagappa et al 2007).  
 
1.7.5. Weight loss and AD 
 
Although obesity has been identified as a risk-factor for AD, weight loss is a common feature of the 
disease, affecting between 30 and 40% of patients with mild to moderate AD (Gillette Guyonnet et 
al 2007; Gillette-Guyonnet et al 2000; Guerin et al 2005; White et al 1996). Furthermore, the risk of 
weight loss increases with severity and progression of AD (White et al 1998) and has been shown 
to be a predictor of mortality (Pugh et al 2007). In a geriatric population, weight loss of 4% or more 
in one year significantly correlates with increased risk of mortality (Wallace et al 1995).  Guyonnet 
et al (1998) followed a cohort of 76 home-living patients with mild to moderate AD, finding that 
during the follow-up year, 45% of patients displayed a weight loss of 4% or more (Guyonnet 1998).  
 
The reasons for this life-threatening weight loss are currently unknown. In order to lose lean or fat 
mass, energy intake must not be adequate to meet body requirements. It has been suggested that 
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the weight loss may be due to a reduction in dietary energy intake, as AD patients may have 
problems accessing food, or feeding themselves, or caregivers may have lack of information 
regarding nutrition or be too exhausted to provide adequate care (Gillette-Guyonnet et al 2000). 
However, food intake in individuals with AD is not usually lower, but in fact is adequate for their 
body weight, or even increased (Burns et al 1989; Keene & Hope 1997a; b; Niskanen et al 1993; 
Singh et al 1988; Smith et al 1999; Spindler et al 1996). Singh et al (1988) observed that AD 
patients weighed approximately 21% less than age-matched cognitively normal controls, yet no 
deficits in food intake or malabsorption were detectable (Singh et al 1988). Burns et al (1988) 
observed lower BMI, mid-arm circumference, arm muscle bulk and skin-fold thickness in patients 
with dementia, yet they displayed a higher energy needs (Burns et al 1989). Similarly, Spindler et al 
(1996) did a 1-year study looking at nutritional status, finding that AD patients had a significantly 
higher energy intake compared to aged-matched cognitively normal controls, yet their body weight 
was not significantly different. AD patients had significantly lower activity counts, measured using 
an accelerometer sewn into the clothes (Spindler et al 1996). More recently, weight loss, nutritional 
status and physical activity in AD patients were examined by Wang et al (2004) who observed 
significant weight loss in more than half of patients, which could not be explained, as those patients 
tended to consume more calories per kilogram of body weight per day. When food composition 
was analysed, the AD patients tended to eat more carbohydrates in their diet compared to controls 
(Wang et al 2004). Keene and Hope (1997) examined food intake and preference in dementia, 
finding that when food is not restricted, dementia patients display hyperphagia and an increased 
preference for sweet food (Keene & Hope 1997a; b). 
 
The evidence presented thus far suggests that AD patients may have higher energy requirements 
than healthy individuals to maintain their body weight, and that when this energy demand is not met 
weight loss occurs, implying that energy expenditure is increased in AD. Energy expenditure is 
composed of three main factors, resting energy expenditure, diet-induced thermogenesis and 
energy of physical activity (van Baak 1999). Various studies have examined energy expenditure in 
AD patients and the results are contradictory, as no difference (Donaldson et al 1996; Niskanen et 
al 1993; Poehlman et al 1997), a decrease (Prentice et al 1989; Wang et al 1997) or an increase 
(Wolf-Klein et al 1995) in energy expenditure has been reported. Reasons for these inconsistencies 
are unknown, but maybe related to the severity and/or stage of the disease. Furthermore, in order 
to understand if an increase in energy expenditure is responsible for the weight loss observed in 
AD patients, measurements of energy expenditure during the dynamic phase of weight loss will be 
required. 
 
AD appears to be associated with two problems in energy balance; mid-life obesity increases the 
risk of developing AD later in life, whereas life-threatening weight loss occurs and worsens as the 
disease progresses. Additionally, evidence suggests that weight loss may even precede clinical 
diagnosis of AD (Barrett-Connor et al 1996). Barrett-Connor et al examined body weight in a 
sample of community-dwelling people from three clinics from 1972 to 1993 (Barrett-Connor et al 
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1996). After three visits, patients were classified as being cognitively intact or having probable or 
possible AD.  No weight loss was observed in cognitively intact individuals, whereas those that 
were later diagnosed with AD presented with significant weight loss after the baseline visit (Barrett-
Connor et al 1996; Nourhashemi & Vellas 2008). These results have been mirrored in other 
studies, where accelerated weight loss was found to be a significant predictor of those individuals 
who converted from cognitively normal to AD (Johnson et al 2006; Nourhashemi & Vellas 2008). 
Weight loss may therefore reflect the disease process, with a shift in body weight representing an 
early indicator of AD, prior to clinical presentation. Mechanisms behind the weight loss are currently 
unknown, since food intake is usually adequate or even increased in AD patients. For this reason, 
further research into energy balance in AD is clearly of interest and may provide additional 
evidence underpinning the pathological mechanisms involved in AD.    
 
The evidence presented thus far implicates obesity and a HF/high cholesterol diet as risk factors 
for AD. However, as this introduction has shown, obesity may actually be beneficial later in life as 
weight loss later in life can be life-threatening. It is clear that energy balance in AD is complicated 
and poorly understood, and requires further examination before diet related AD therapies can be 
used. 
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1.8. Summary and PhD hypothesis 
 
There are many risk factors associated with AD, including an HF diet and obesity, observations 
which are supported by studies in both single and double transgenic models of AD where a high fat 
diet increases A! deposition within the brain and associated memory deficits. Despite this, the 
mechanisms underlying the effects of obesity and HF diets on AD are poorly understood. 
Furthermore, it remains unknown whether an HF diet enhances the onset and/or worsens the 
severity of AD-like pathology and memory deficits in 3xTgAD mice. Emerging evidence also 
suggests that environmental factors, especially nutrition, act in early life to program the risks for the 
onset of cardiovascular and metabolic disease in adult life. However, it is not clear how changes in 
diet throughout life affect the onset or progression of AD. Even though AD is associated with old 
age, it is now known that the onset occurs years before any clinical symptoms manifest, and so 
understanding the effect of environmental factors such as an HF diet throughout life is important in 
an increasingly obese and aging society. 
 
While obesity increases the risk of developing the AD, life-threatening weight loss occurs and 
worsens as the disease progresses. Evidence suggests that weight loss may even precede 
diagnosis of AD (Barrett-Connor et al 1996), therefore reflecting the disease process, and a shift in 
body weight may represent an early indicator of AD prior to clinical presentation. Mechanisms 
behind the weight loss are currently unknown, since food intake is usually adequate or even 
increased in AD patients. For this reason, further research into energy balance in AD is clearly of 
interest and may provide further evidence underpinning the pathological mechanisms involved in 
AD. To date, very few studies have examined energy balance in transgenic models of AD.  
 
The overall aim of this PhD project is to test the hypothesis that 3xTgAD mice have altered energy 
balance and that experimental changes to this balance will alter cognition. 
 
To address this hypothesis the three main objectives of this PhD are to: 
 
- characterise the energy balance profile of 3xTgAD mice 
- characterise behaviour and memory in a battery of tests in 3xTgAD mice 
- evaluate the effect of an HF diet on cognition in 3xTgAD mice 
 
In order to examine these objectives, cohorts of 3xTgAD mice and age-matched Non-Tg controls 
will have their body weight and food intake measured longitudinally. If alterations in energy balance 
are detected, then metabolism will be investigated in an attempt to understand these changes. 
Behavioural and memory tests will then be established to determine whether 3xTgAD mice display 
deficits, with a view to see how they are affected if energy balance is changed experimentally using 
an HF diet. 
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2.1. Animals 
 
3xTgAD mice expressing mutant PS1M146V, APPSwe, TauP301L and non-transgenic (Non-Tg) 
C57BL/J6 x 129SV were created and supplied by Frank LaFerla (Irvine, CA) (Oddo et al 2003b). 
Male C57BL/J6 and 129SV mice, the individual strains of the hybrid C57BL/J6 x 129SV background 
on which the 3xTgAD and Non-Tg control mice were created, were purchased at 4 weeks of age 
from Harlan UK Ltd. (Bicester, Oxon, UK). The mice were kept in standard housing conditions 
(humidity 50-60 %, temperature 21± 1˚C, 12:12 hour light-dark cycle with lights on at 8.00am) and 
given ad libitum access to standard rodent chow and water. They were also ear-punched for 
identification. All animal experiments were carried out in accordance with the animals (Scientific 
Procedures) Act 1986.  
2.2. Examination of energy balance 
 
In order to evaluate whether 3xTgAD mice display differences in energy balance when compared 
to Non-Tg control mice, body weight, food intake and metabolism were examined in cohorts of 
male and female 3xTgAD and Non-Tg controls. A separate cohort of male C57BL/J6 and 129SV 
mice, were also monitored to examine potential strain specific differences in body weight, food 
intake and metabolic rate. 
 
2.2.1. Diet 
 
Once weaned, at approximately 4 weeks of age, the mice were placed on standard laboratory 
chow (diet BK001E, B&K Universal LTd., UK). At 2 months of age the mice were then either kept 
on chow or placed on a 60 % high fat (HF) diet (diet 58G9, TestDiet, Richmond, IN, USA) (see 
Table 2.1.). See Appendix A for detailed nutritional profiles of both chow and HF diets.   
 
 
 
 
 
 
 
 
 
 
 Table 2.1. Diet composition of chow and high fat diets 
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2.2.2. Longitudinal body weight and food intake analysis 
 
To examine energy intake the mice had food intake and body weight monitored weekly. As the 
animals were group housed, food intake for the whole cage was weighed and divided by the 
number of mice per cage to calculate the amount of food eaten per mouse each week.  During this 
period any deaths were recorded for survival analysis. Caloric intake was calculated by multiplying 
the amount of diet eaten in g by the physiologic fuel value of the diet (3.3kcal/g for standard 
laboratory chow and 5.21 kcal/g for the HF diet). 
2.2.3. Indirect calorimetric measurement of metabolic rate 
 
To measure metabolic rate the mice were placed in comprehensive lab animal monitoring system 
(CLAMS) calorimetry cages (Columbus Instruments, Columbus, OH, USA) for 5 d (see Figure 2.1). 
The body weight of each mouse was entered into the system to allow calculation of metabolic rate, 
which takes body weight into account. Air samples were taken from each cage every 10 min. 
Moisture was initially removed from the sample by a column of desiccant before passage through a 
sensor, which measured the levels of oxygen consumption (VO2) and carbon dioxide production 
(VCO2) produced. After 24 h habituation, VO2 and carbon VCO2 were measured every 10 min for 4 
d. The respiratory quotient (RQ) was then calculated by dividing VCO2 produced by VO2 consumed. 
During the period in the CLAMS calorimetry cages, animals were given nesting material and were 
provided with ad libitum access to food and water. Body weight, food intake and water intake were 
measured daily. Energy balance over the 4 d was calculated as the caloric intake (kcal/day) minus 
heat energy expenditure (heat kcal/day). Heat kcal/h was calculated directly by the CLAMS 
apparatus.  
 
 
 
 
 
 
 
 
 
 
Figure 2.1. Comprehensive Laboratory Animal Monitoring System (CLAMS)  
 
To measure metabolic rate the mice were housed individually in comprehensive lab animal 
monitoring system (CLAMS) indirect calorimetry cages for 5 d. After 24 h habituation, oxygen 
consumption (VO2) and carbon dioxide production (VCO2) were measured every 10 min for 4 d.  
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2.3. Assessment of behaviour and memory 
 
To evaluate behaviour and memory, cohorts of male Non-Tg control and 3xTgAD mice were 
subjected to open-field (OF), Y-maze spontaneous alternation (SA), smell recognition (SR), novel 
object recognition (NOR) and Morris water maze (MWM) tasks. A separate cohort of C57BL/J6 and 
129SV mice were also subjected to the OF and SA task to determine any potential strain specific 
differences in behaviour and memory. On the days of behavioural evaluation, home cages were 
placed in the testing room 30 min prior to testing to allow habituation. All behavioural observations 
were made between 10.00am and 4.00pm. The order of observation during this period was 
randomised across animals. No more than one behavioural task was completed during any single 
day.  The OF, SA, SR/NOR arenas and mazes did not have bases, therefore blue roll (Kimberly-
Clark, UK) was placed underneath and replaced between animals. Except for the MWM, all arenas, 
mazes and objects were cleaned with 70 % ethanol between animals.  
 
2.3.1. Open-field (OF) behaviour test 
 
The OF behaviour test is a measure of exploration, general activity levels and anxiety in response 
to a novel environment. 
 
Apparatus 
 
The OF arena consisted of a red opaque Perspex box placed on the floor of a behavioural testing 
room (see Figure 2.2.). A video camera (Vista protos IV, UK) held 1 m above the arena by a tripod 
was connected to a computer with 2020 PLUS tracking software (HVS Image, Buckingham, UK). 
The seated experimenter was situated approximately 3 m away from the OF arena, out of sight of 
the animals.  A live video feed of the observation was visible to the experimenter on an Acer laptop 
connected to the video camera, allowing the experimenter to score the observation.  
 
Behavioural procedure 
 
Each animal was placed in the centre of the OF arena (see Figure 2.2.) and allowed to explore for 
5 min.  
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The experimenter observed the live video feed and noted the total number of times the animal 
reared within the arena. Rearing was defined as the behaviour where a mouse goes on its hind 
legs. It is used as a measure of environmental exploration. The total number included rearing in the 
centre of the arena as well as against the arena walls. The total number of defecations in the arena 
was also recorded. This can be a measure of anxiety, as a more anxious mouse will defecate more 
in a novel environment (Gimenez-Llort et al 2007). 
 
OF test analysis 
 
The 2020 PLUS tracking software (HVS Image, Buckingham, UK) divided the arena into 16 cells 
and calculated the number of cell entries and the percentage of time spent moving. The number of 
rearings and defecations were totalled for each animal.  
2.3.2. Y-maze continous spontaneous alternation (SA) test 
 
The SA test is a measure of short-term working memory and also a measure of exploratory activity.  
As the behaviour in this task is not reinforced by a reward or foot shock it is considered 
“spontaneous”.  
 
Apparatus 
 
A black opaque Perspex Y-maze (see Figure 2.4.) with arms labelled A, B and C was used for the 
SA test. The maze contained cues located at the end of each arm to assist the mouse in identifying 
Figure 2.2. Open-field (OF) test  
 
In turn, each animal was then placed in the centre of the arena and allowed to explore for 5 
min. During this period, the number of cell entries, percentage time moving, number of rearings, 
and the number of defecations were recorded.  
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each arm (see Figure 2.3. for arm cues). Cues were also available around the room to further 
assist the mouse. The maze was placed on a table with the seated experimenter located directly in 
front of arm A. Thus the experimenter also acted as a spatial cue.  
 
 
 
 
 
 
 
Behavioural procedure 
 
Each animal was placed was placed in turn in arm A of the Y-maze (see Figure 2.4.) and allowed 
to explore for 8 min. During this period the arm entries made by each animal were recorded 
manually by the seated experimenter. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3. Intra-maze cues in the Y-maze spontaneous alternation (SA) test 
 
Intra-maze cues (A, B and C) located at the end of arms in the Y-maze SA test. 
 
Figure 2.4. Y-maze spontaneous alternation (SA) test  
 
In turn, each animal was then placed in arm A of the Y-maze and allowed to explore for 8 min. 
During this period the total number and specific arm choices were recorded.  
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SA test analysis 
 
Continous SA was defined as a successive entry into three different arms, on overlapping triplet 
sets. The best strategy to escape the maze is to check each arm in succession to determine if 
there is an exit. The SA test is thought be a test of working memory as the mouse must use the 
cues located at the end of each arm and around the experimental behaviour room to determine 
which arm they were not in previously (Hughes 2004). Examining the total number or arm choices 
is also a measure of exploratory behaviour. The percentage number of alternations was calculated 
as the number of actual alternations divided by the maximum number of alternations (the total 
number of arm entries minus two). 
 
2.3.3. Odour recognition (OR) test 
 
The odour recognition (OR) test is a test of short-term non-associative memory based on the 
natural exploration of novelty in mice (Saddoris 2006; 2007). 
 
Apparatus 
 
The OR arena consisted of a black opaque polycarbonate circular arena (see Figure 2.6.) with no 
base. Scented balls were placed in the centre of the OR arena 5 cm from the edge of the arena 
and 8 cm away from each other. The scented balls consisted of a yellow hollow ball (6 cm 
diameter, Chad Valley, UK) which had small holes punched into them (0.3 cm diameter).  Into 
these holes cotton wool was inserted until the ball was completely full. The morning of the 
behavioural testing the balls were wiped clean with 70% ethanol and then a total of 0.5 ml of scent 
(orange, lemon, vanilla or almond, Dr. Oetker Ltd, UK) was evenly distributed across all the holes 
onto the cotton wool. This procedure was performed in another room 30 min before behavioural 
testing while the animals habituated to the behavioural testing room. Once scented, the balls were 
individually kept in airtight zip lock bags until required. The balls were returned to their bags when 
not in use. A camera (Sanyo Xacti VPC-C4, SANYO Fisher, CA) held 1 m above the OR arena 
recorded colour MP4 video clips of each animal performing the task. 
 
Behavioural procedure 
 
Habituation 
 
Animals from each cohort were placed in turn in an empty OR arena and allowed to explore for 5 
min. Cohorts were habituated over 2 d in a randomised order throughout the day.  
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Trials  
 
After habituation all cohorts underwent the OR test, which comprised of two phases (see Figure 
2.5. for time-line). 
 
 
 
 
 
 
 
During phase 1, the mouse was placed in the OR arena and allowed to explore two identical 
unfamiliar scented balls for 10 min (see Figure 2.6). The mouse was then housed individually in a 
clean new holding cage with ad libitum access to food and water for 3 min. During this time one of 
the two balls the mouse was previously allowed to explore was removed and replaced with a novel 
scented ball (see Table 2.2. for scent combinations). The novel scented ball was randomly placed 
in either the left or right position of one of the previously explored balls. During the second phase, 
the mouse was placed back into the arena and allowed to explore the familiar scented ball and the 
novel scented ball for 4 min (see Figure 2.6). 
 
 
 
 
 
 
 
Phase 1 Phase 2     
V V V O, O V, V L, L V   
O O O A, A O, O V, V O   
A A A O, O A, A L, L A   
L L  L V, V L, L A, A L   
 
 
 
 
 
 
Table  2.2. Scent combinations of the odour recognition (OR) test 
 
During phase 1, the mouse was presented with two identical scents of vanilla (V), orange (O), 
almond (A) or lemon (L). During phase 2, the mouse had either the left or the right familiar scent 
replaced with a novel scent according to the table. For example, if the mouse was presented with 
two vanilla scented balls during the phase one they were presented with either orange or lemon 
replacing the vanilla on the left or the right side of the OR arena.  
 
Figure 2.5. Time-line of the odour recognition  (OR) test 
 
The OR test consisted of a habituation phase and two trial phases. 
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OR test analysis 
 
MP4 video-clips recorded during OR trials were converted to an AVI format using Pazera MP4 to 
AVI converter 1.3 (Pazera-Software, PL). The duration (seconds) spent exploring the scented balls 
was then measured using Observer 5.0 software (Noldus, Wageningen, The Netherlands). 
Exploration was defined as the amount of time the animals spent with their nose pointing within 2 
cm of the scented balls. The percentage time spent exploring the scented balls was calculated for 
phase 1 and phase 2.  
Figure 2.6. Schematic representation of the odour recognition (OR) test.  
 
The OR test consisted of two phases 1 (A) and 2 (B). During phase 1, the mouse was placed in 
the OR arena facing the wall and allowed to explore the arena and two identically-scented balls 
for 10 min. After an interval of 3 min (phase 2) one of the familiar scented balls was substituted 
by a novel scented ball (in the identical position) and the mouse was again allowed to explore 
the arena for 4 min. The amount of time spent exploring the novel scented ball in comparison to 
the familiar scented ball (measured as the amount of time the nose spent within 2 cm of the 
object) indicated the ability of the mouse to determine whether the scent of the ball was novel 
or not.  
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2.3.4. Novel object recognition (NOR) test 
 
The NOR test is a test of short-term non-associative memory based on the natural exploration of 
novelty in mice (Ennaceur 2010; Ennaceur & Delacour 1988; Ennaceur & Meliani 1992). 
 
Apparatus 
 
The NOR arena consisted of a black opaque polycarbonate circular arena (30 cm) with no base  
(see Figure 2.8.) Two wooden painted trial objects, varied in shape and colour (Universe of 
Imagination, Geoffrey, Inc., U.K.), were placed in the centre of the NOR arena, 5 cm from the edge 
of the arena and 8 cm away from each other. A camera (Sanyo Xacti VPC-C4, SANYO Fisher, CA) 
held 1 m above the NOR arena recorded colour MP4 video clips of each animal performing the 
task. 
 
Behavioural procedure 
 
Habituation 
 
Animals from each cohort were placed in turn in an empty NOR arena and allowed to explore for 5 
min. Cohorts were habituated over 2 d in a randomised order throughout the day.  
 
Trials 
 
After habituation all cohorts underwent the NOR test which comprised of two trial phases (see 
Figure 2.7. for time-line). 
 
 
 
 
 
 
 
During trial phase 1, the mouse was placed in the NOR arena and allowed to explore two identical 
unfamiliar objects for 10 min (see Figure 2.8.). The mouse was then housed individually in a clean 
new holding cage with ad libitum access to food and water for an interval of 1 h. During this time, 
one of the two objects the mouse was previously allowed to explore was removed and replaced 
Figure 2.7. Time-line of the novel object recognition  (NOR) test 
 
The NOR test consisted of a habituation phase and two trial phases. 
 
Chapter 2                                                                                            General materials and methods 
42 
 
with a novel object. During trial phase 2, the mouse was placed back into the arena and allowed to 
explore the familiar object and the novel object for 4 min (see Figure 2.8.). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NOR test analysis 
 
MP4 video clips recorded during NOR trials were converted to an AVI format using Pazera MP4 to 
AVI converter 1.3 (Pazera-Software, PL). The duration (seconds) spent exploring the objects was 
then measured using Observer 5.0 software (Noldus, Wageningen, The Netherlands). Object 
explorationwas was defined as the amount of time animals spent with their nose pointing within 2 
cm of an object. The percentage of time spent exploring objects was calculated for phase 1 and 
phase 2. 
Figure 2.8. Schematic representation of the Novel Object Recognition (NOR) test  
 
Mice were individually habituated to the arena for 5 min for 2 d prior to the NOR test.  The NOR 
test consisted of two trial phases 1 (A) and 2 (B). During trial phase 1 the mouse was placed in 
the NOR arena facing the wall and allowed to explore the arena and two identical unfamiliar 
objects for 10 min. After an interval of 1 h (trial phase 2) one of the familiar objects was 
substituted by a novel object (in the identical position) and the mouse was again allowed to 
explore the arena for 4 min. The amount of time spent exploring the novel object in comparison 
to the familiar object (measured as the amount of time the nose spent within 2 cm of the object) 
indicated the ability of the mouse to determine whether an object was novel or not.  
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2.3.5. Morris water maze (MWM) task 
 
The MWM is a test of spatial reference memory (Morris et al 1982). 
 
 
Apparatus 
 
MWM 
 
The MWM consisted of a circular white opaque plastic tank 1.2 m in diameter with walls 25 cm high 
(see Figure 2.9.).  
 
MWM room configuration and experimenter position 
 
The MWM was located in the centre of a room, surrounded by interlocking screens to mask the 
surrounding environment (see Figure 2.9.). This was done to keep the conditions around the maze 
consistent between trials and experiments, as well as to hide the position of the experimenter and 
stop the experimenter from becoming a distal cue. Once the mouse was placed in the water the 
experimenter hid from view and remained in position next to the laptop where the trial could be 
observed. A CCTV tracking camera (Vista protos IV, UK) with Water 2010 software from HVS 
image was over the MWM.  
 
MWM platform 
 
The platform consisted of a square piece of acrylic plastic (10 cm by 10 cm) with an acrylic dowel 
as the vertical post, which was attached to a square piece of metal.  
 
MWM flagged cue 
 
The flagged cue consisted of a wooden cylinder painted red (6 cm high by 3 cm diameter). The top 
of the object was covered in white masking tape to avoid detection from the tracking system, when 
placed on top of the platform during the flagged platform-learning phase.  
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Figure 2.9. Set-up of the Morris water maze (MWM)  
 
The MWM consisted of a circular white opaque plastic tank 1.2 m in diameter with walls 25 
cm high. The water was made opaque using water-soluble white paint and maintained at a 
temperature of 21-22 
o
C. The platform consisted of a square piece of acrylic plastic with an 
acrylic dowel as the vertical post, which was attached to a square piece of metal. During 
flagged and submerged platform training, the platform was 0.5 cm under the water level, 
making it invisible to the mouse. The MWM was located in the centre of a room, surrounded 
by interlocking screens to mask the surrounding environment. This was done to keep the 
conditions around the maze consistent between trials and experiments, to hide the position of 
the experimenter and to stop the experimenter from becoming a distal cue. Above the water 
maze, a CCTV camera was located to track the mice during swimming. The camera was 
positioned between two strip lights, centrally located above the pool. The camera was 
connected to a laptop with Water 2010 tracking software by HVS image. During flagged 
platform training, no extra maze spatial cues were present, other than a red wooden block 
placed on top of the platform to guide the mouse towards the platform. During submerged 
platform training and the probe trial, extra maze spatial cues were placed on the inside of the 
screen to aid spatial navigation.  
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Extra maze spatial cues 
 
During submerged platform training and the probe trial, spatial cues were placed on the inside of 
the screen to aid spatial navigation. These consisted of four 3-dimensional objects (see Figure 
2.10. for objects and Figure 2.9. for object locations) differing in size, colour and texture. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Water 
 
The water was made opaque using water-soluble white paint (Universe of Imagination, Geoffrey 
Inc., U.K.) and maintained at a temperature of 21-22 
o
C. Prior to each day of training, the water 
temperature was measured. Water was removed each day until the platform was visible. Hot white 
opaque water was then used, to replace the water removed, until the desired water temperature 
was obtained and reached the desired water level 0.5 cm above the platform, so that the platform 
was no longer visible. The paint at the bottom of the water maze was also stirred each day.  
 
 
 
Figure 2.10. Extra maze spatial cues in the Morris water maze (MWM)  
 
Extra maze spatial cues located around the MWM used to locate the platform during 
submerged platform training and the probe trial.  
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Tracking system 
 
Above the water maze, a CCTV camera was located to track the mice during swimming. The 
camera was positioned between two strip lights, centrally located above the pool and was 
connected to a laptop that contained Water 2010 tracking software by HVS image (see Figure 
2.9.). The water maze tracking software was calibrated and configured prior to the water maze 
training. The aperture of the camera was adjusted to minimise reflectance of water up to the 
camera, which may interfere with tracking. The border locations of the pool were then defined, 
including placement of platform locations. The tracking software was then tested to make sure the 
mouse was being tracked correctly.  
 
Behavioural procedure 
 
The MWM task consisted of flagged platform training, submerged platform training and a probe trial 
(see Figure 2.11 for a time-line) based on protocol by Vorhees & Williams (2006).  
 
 
 
 
 
 
 
 
 
 
 
Flagged platform training 
 
As a control, prior to MWM submerged platform training, a flagged learning task was performed. 
This pre-training involved the mouse swimming from a series of random start positions to a set of 
random flagged platform locations (see Table 2.3.). Mice were either given one (see chapter 4) or 
two days (see chapter 5) of flagged platform training. No extra maze spatial cues were present 
during this stage of the task, therefore making it a non-spatial task. This experimental pre-training 
procedure teaches the mice that only by searching for the proximal cue located on the submerged 
platform can they escape. This non-spatial pre-training teaches the mice the basic sensorimotor 
requirements and procedure of the MWM task (Vorhees & Williams 2006). The mouse was placed 
in the desired start position of the MWM at water level, facing the tank wall. As soon as the mouse 
was released, the tracking program was started.  Once the mouse reached the platform, the timer 
Figure 2.11. Time-line of the Morris water maze (MWM) task 
 
The MWM task consisted of flagged platform training, submerged platform training and a probe 
trial. 
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was stopped. If the mouse did not reach the platform within the trial limit of 2 min, they were guided 
to it. Once on the platform, the mouse was allowed to remain there for 10 s to further orient itself. If 
the mouse jumped off the platform, they were guided back to it and held in position on the platform 
for 10 s. After this time, the mouse was dried and placed in a holding cage until all the other mice in 
that cage performed the first trial. Once all the mice performed trial one, then the process started 
again with the next start position and flagged platform location for trial two (see Table 2.3. for MWM 
flagged platform start positions). The procedure was repeated until all the mice performed 4 trials 
that day (Vorhees & Williams 2006). Mice were given four trials a day for 1 (see chapter 4) or 2 d 
(see chapter 5). 
 
 
 
 
 
 
 
Submerged platform training 
 
To test spatial reference, memory mice underwent submerged platform training in the MWM. Trials 
were performed as during the flagged platform training with the following differences; spatial cues 
were put in place (see Figure 2.10. for cues and Figure 2.9 for cue locations) to aid navigation 
during submerged platform training and no flag was placed on top of the platform. The platform 
was placed in the SW position of the MWM (see Figure 2.9.) where it remained for all the trials. 
Mice were given four trials a day for 5 (see chapter 4) or 8 d (see chapter 5) (see Table 2.4. for 
submerged platform start positions). Mice were given four different start positions each day and 
were required to use the spatial cues, situated around the MWM, to locate the platform. Decreasing 
escape latency over successive training days indicated learning (Vorhees & Williams 2006). 
 
 
 
 
 
 
 
 
 
Flagged platform training 
Test day Trial 1 Trial 3 Trial 3 Trial 4 
1 N-SE E-NE S-SW W-SE 
2 S-NE N-NW W-NE E-SE 
Table 2.3. Flagged platform training trial pattern of the Morris water maze (MWM) test  
 
The first letter denotes the start position (N; north, S; south, E; east, W; west) and the second 
letter denotes the cued platform position (NE; north east, NW; north west, SE; south east, SW; 
south west). Table taken from MWM protocol by Vorhees & William (2006). 
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Probe trial 
 
To test memory retention of the platform location, mice underwent a probe trial 24 h after the final 
submerged platform training trial. During the probe trial, the platform was removed from the MWM. 
The mouse was then placed in a novel start position in the MWM (see Table 2.4.) and allowed to 
swim for a fixed interval of 30 s.  After this time, the mouse was then removed, dried and returned 
to its home cage. A mouse that has remembered the location of the platform should spend most of 
their time swimming around where the platform was previously located (Vorhees & Williams 2006). 
 
MWM task analysis 
 
2020 PLUS tracking software (HVS Image, Buckingham, UK) calculated the escape latency and 
swim speed, during both flagged platform and submerged platform training for each mouse over 
trials, and the percentage time in the target quadrant, during the probe trial for each mouse. Mean 
escape latency and swim speed over four trials within a day was calculated for each mouse.  
 
Submerged platform training 
Test day Trial 1 Trial 2 Trial 3 Trial 4 
1 N E SE NW 
2 SE N NW E 
3 NW SE E N 
4 E NW N SE 
5 N SE E NW 
6 SE N NW E 
7 E NW SE N 
8 NW E N SE 
9 (probe) NE    
Table 2.4. Morris water maze (MWM) submerged platform training and probe trial start 
position pattern  
 
The platform was located in the south west (SW) quadrant of the MWM during submerged 
platform training. Each testing day of submerged platform training included one trial from each of 
the four start positions (N; north, NW; north west, E; east, SE; south east. A probe test was 
performed 24 h after the final trial of submerged platform training. The platform was removed and 
the mouse was placed in the north east (NE) quadrant of the MWM. Table taken from MWM 
protocol by Vorhees & Williams (2006). 
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2.4. Culling 
2.4.1. Perfusion 
 
Prior to culling, the animals had their body weight recorded. The animals were then terminally 
anaesthetised with 3.5 % isoflurane (30 % O2 and 70 % N2O) and the chest cavity opened, to 
expose the heart by cutting through the diaphragm and rib cage. A butterfly needle was then 
inserted into the same puncture site in the left ventricle used to take the blood sample and 
clamped. An incision was then made in the right atrium, after which 0.9 % saline (treated with 1ml 
Diethylpyrocarbonate (DEPC) overnight, autoclaved then stored at 4°C) was perfused 
transcardially at a rate of 20 ml/min, using a perfusion pump (Harvard Apparatus, UK) for 2 min.  
 
2.4.2. Tissue extraction 
 
After saline perfusion, all tissue samples were removed and immediately placed on dry ice to 
prevent degradation. Tail snips were taken and genotyped (see Appendix B). Epididymal fat 
surrounding the testicles of the male mice were removed and weighed before freezing. Liver, 
spleen and kidney were also taken and stored at -80°C for future analysis. The brain was rapidly 
removed and cut sagittally with a razor blade. The cerebellum, hippocampus and cortex were 
excised from the right hemisphere of the brain for future biochemical analysis. The pituitary was 
also taken. The left hemisphere was post-fixed in 5 ml of 4% paraformaldehyde (PFA) at room 
temperature for 24 h. The brain was then cryoprotected in 30% sucrose (in 0.1 M phosphate buffer 
(PB)) at 4°C. Once sunk (approximately 24 h), the brain was carefully removed, snap-frozen in 
isopentane on dry ice and stored at -80˚C until future sectioning for histological analysis. 
 
2.5. Statistical analysis 
 
Data are represented as mean ± standard error of the mean (SEM). See individual chapters for 
detailed statistical analysis. Statistical significance levels are as follows; *p < 0.05, **p < 0.01 and 
***p < 0.001.  
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3.1. Introduction and objectives 
 
Energy balance appears to be affected throughout the progression of AD. While mid-life obesity 
increases the risk of developing AD(Fitzpatrick et al 2009; Rosengren et al 2005; Whitmer et al 
2005; Whitmer et al 2008), life-threatening weight loss occurs and worsens as the disease 
progresses (Gillette Guyonnet et al 2007; Gillette-Guyonnet et al 2000; Guerin et al 2005; White et 
al 1996). The preliminary aim of this PhD, therefore, was to examine potential differences in energy 
balance in the 3xTgAD mouse model of AD, compared to Non-Tg control mice. In order to evaluate 
energy balance, body weight, food intake and metabolic rate were examined in cohorts of 3xTgAD 
and Non-Tg control mice at 2, 12 and 18 months of age. A separate cohort of 129SV and 
C57BL/J6, the individual background strains upon which 3xTgAD mice were created, were also 
monitored to examine potential strain specific differences in body weight, food intake and metabolic 
rate.  
 
3.2. Materials and methods  
3.2.1. Experimental design 
 
Cohorts of 3xTgAD and age-matched Non-Tg control mice as well as 129SV and C57BL/J6 mice 
had energy balance monitored (see Table 3.1.).  Cohorts 1, 2 and 4 had weekly body weight and 
food intake measured from weaning until 2, 12 or 20 months of age (see Method 2.2.1. - 2.2.2).  At 
the end of the monitoring mice from each cohort were placed into CLAMS calorimetry cages to 
evaluate metabolic rate (see Method 2.2.3). Over this period, body weight, food intake and water 
intake were monitored (see Method 2.2.3.) and a 24 h average calculated. The mice were then 
culled (see Method 2.4.). 
 
Table 3.1. Experimental cohorts for energy balance assessment (comprehensive laboratory 
animal monitoring system; CLAMS) 
 
Cohort Monitoring  
period 
Gender 
 
Genotype Cohort size Cohort in 
CLAMS 
1 4 weeks - 2 months Male Non-Tg 
3xTgAD 
n = 8 
n = 8 
n = 4 
n = 4 
2 4 weeks - 12 months Male 
 
Female 
Non-Tg 
3xTgAD 
Non-Tg 
3xTgAD 
n = 6 
n = 6 
n = 9 
n = 8 
n = 10 
n = 4 
- 
- 
3 18 months Male Non-Tg 
3xTgAD 
n = 4 
n = 4 
n = 4 
n = 4 
4 4 weeks -20 months Male 129SV 
C57BL/J6 
n = 6 
n = 6 
n = 4 
n = 4 
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3.2.2. Statistical analysis 
 
Longitudinal body weight between 3xTgAD and Non-Tg control mice and between 129SV and 
C57BL/J6 was examined using repeated measures analysis of variance (ANOVA) with SigmaStat 4 
(Systat Software Inc., IL, USA). Differences in survival were determined using Logtest survivalship 
curve analysis, with Prism (Graphpad, San Diego, CA, USA).  No statistical analysis was performed 
on estimated average weekly food intake per mouse, as these data were derived from group-
housed animals. Statistical differences between 3xTgAD and Non-Tg cohorts and between 129SV 
and C57BL/J6 mice for 24 h average body weight, food intake, water intake, volume of oxygen 
consumption (VO2), volume of carbon dioxide production (VCO2) and respiratory quotient (RQ) over 
the 4 d in CLAMS calorimetry cages were determined using Student’s t-tests with Prism (Graphpad, 
San Diego, CA, USA).    
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3.3. Results  
3.3.1. Characterisation of the energy balance profile in 3xTgAD mice 
3.3.1.1. 2-month-old male 3xTgAD mice displayed increased body weight and food intake 
 
Between 6 and 8 weeks of age, 3xTgAD mice displayed 27 - 31% higher body weight (p < 0.05) 
compared with Non-Tg control mice (Figure 3.1.A). Estimated average weekly food intake per 
mouse, between 5 - 8 weeks of age, appeared greater in 3xTgAD (18 - 55%) than Non-Tg control 
mice (Figure 3.1.B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. 2-month-old male 3xTgAD mice displayed increased body weight and food 
intake 
 
Weekly body weight (A) and food intake (B) were monitored in cohorts of male 3xTgAD (n = 8) 
and Non-Tg control mice (n = 8) from weaning to 2 months of age. Body weight is represented 
as mean ± SEM. Repeated measures analysis of variance (ANOVA), *p < 0.05. 
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3.3.1.2. 12- month -old 3xTgAD displayed altered body weight and food intake profiles 
 
Over a 12-month period, male 3xTgAD mice had different body weight (Figure 3.2.A) and food 
intake (Figure 3.2.B) profiles, compared to Non-Tg control mice. Between 5 weeks and 4 months of 
age 3xTgAD mice displayed 12 - 33% higher (p < 0.05) body weight than Non-Tg control mice. In 
contrast, between 7.5 - 8.5 and 9.5 - 12 months of age, body weight was lower (by 8 - 9% and 11 - 
18% respectively) in 3xTgAD compared to Non-Tg control mice (p < 0.05). However, despite these 
biphasic differences in body weight in 3xTgAD mice, the estimated average weekly food intake per 
mouse was greater throughout the monitoring period, as over the 12 months, 3xTgAD mice ate 
37% more food than Non-Tg controls. 
 
Over 12 months, female 3xTgAD mice displayed no significant difference in body weight (Figure 
3.2.C) compared to female Non-Tg control mice. The estimated average weekly food intake per 
mouse was greater throughout the monitoring period, and over the 12 months, female 3xTgAD 
mice ate 16% more food (Figure 3.2.D). A marked variation in body weight and food intake was 
observed between animals in the female cohort, becoming more apparent with increasing age.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2. 3xTgAD mice had altered body weight and food intake profiles 
 
Cohorts of male and female 3xTgAD (n = 6 and n = 8 respectively) and Non-Tg control mice (n 
= 6 and n = 9 respectively) had weekly body weight (A & C) and food intake (B & D) measured 
over 12 months. Body weight is represented as mean ± SEM. Repeated measures analysis of 
variance (ANOVA), *p < 0.05.  
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3.3.1.3. Decreased survival in female 3xTgAD mice 
 
At the end of the 12-month body weight and food intake monitoring period, survival was examined 
in male (Figure 3.3.A) and female (Figure 3.3.B) 3xTgAD and Non-Tg controls. At 12 months of 
age, there was a 100% survival rate for both male and female Non-Tg control mice (n = 6 and n = 9 
respectively). No significant difference in survival curves was observed between male 3xTgAD (n = 
6) and Non-Tg (n = 6) control mice (p > 0.05), as only one death was observed in the male 3xTgAD 
cohort at 9 months of age. In contrast, there was a decrease (p < 0.01) in survival rate in female 
3xTgAD, when compared to Non-Tg controls. Between 6-12 months of age, five deaths were 
observed in a cohort of eight female 3xTgAD mice. By 12 months of age there was 37% survival 
within the female cohort. Due to decreased survival observed in female 3xTgAD mice, subsequent 
studies were only performed in male mice.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3. Decreased survival in female 3xTgAD mice 
 
Over 12 months, survival was examined in cohorts of male (A) and female (B) 3xTgAD (male, n 
= 6 and female, n = 8) and Non-Tg control mice (male, n = 6 and female, n = 9). Logtest 
survivalship curve test, ** p < 0.01. 
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3.3.1.4. 2-month-old 3xTgAD mice displayed no difference in metabolic rate 
 
When housed individually in CLAMS calorimetry cages at 2 months of age, a greater mean body 
weight (34%; p < 0.001, Figure 3.4.A), 24 h food intake (17%; p < 0.05, Figure 3.4.B) and water 
intake (42%; p < 0.05 Figure 3.4.C) was observed in 3xTgAD mice, when compared to Non-Tg 
control mice. Indirect calorimetry at 2 months of age, to measure metabolic rate, revealed that both 
3xTgAD and Non-Tg control mice display similar 24 h rhythms in VO2 consumption (Figure 3.4.D.), 
VCO2 production (Figure 3.4.E.) and RQ (Figure 3.4.F). VO2, VCO2 and RQ levels were lowest 
during the light, largely inactive, phase of the day and highest during the dark, active phase. Both 
VO2 and VCO2 levels peaked early during the dark phase. No statistical differences in mean 24 h 
VO2, (Figure 3.4.G.), VCO2 (Figure 3.4.H.) or RQ (Figure 3.4.I.) were detected between 3xTgAD 
and Non-Tg control mice. During the monitoring period, both groups of mice exhibited a similar 
degree of positive energy balance (Non-Tg, 5.2 ± 0.3 kcal/day versus 3xTgAD, 5.4 ± 0.7 kcal/day).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4. 2-month-old 3xTgAD mice displayed no difference in metabolic rate 
 
At 2 months of age, cohorts of male 3xTgAD (n = 4) and Non-Tg (n = 4) control mice were 
individually housed in Comprehensive Lab Animal Monitoring System (CLAMS) calorimetry 
cages for four days to evaluate metabolic rate. During the period in CLAMS, 3xTgAD mice had 
mean 24 h body weight (A), food intake (B) and water intake (C) monitored. Rhythms in VO2 
(D), VCO2 (E) and RQ (F) and mean 24 h VO2 (G), VCO2 (H) and RQ (I) were assessed. Data 
are mean ± SEM. Student’s t-tests, *p < 0.05, ***p < 0.001.  (D, E, F), white bars represent the 
light, inactive phase of the day whereas black bars represent the dark active phase.  
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3.3.1.5. 12-month-old 3xTgAD mice had a higher metabolic rate 
 
When housed individually in calorimetry cages, 12-month-old 3xTgAD mice exhibited a lower mean 
24 h body weight (15%; p < 0.01, Figure 3.5.A), despite a 30% higher mean 24 h food intake (p < 
0.05, Figure 3.5.B), compared to Non-Tg control mice. No significant difference in water intake 
(Figure 3.5.C) was observed between 3xTgAD and Non-Tg control mice. At 12 months of age 
indirect calorimetry, to measure metabolic rate, revealed that both 3xTgAD and Non-Tg control 
mice display 24 h rhythms in VO2 consumption (Figure 3.5.D), VCO2 production (Figure 3.5.E) and 
RQ (Figure 3.5.F). VO2, VCO2 and RQ levels were lowest during the light, largely inactive, phase of 
the day and highest during the dark, active phase. Both VO2 and VCO2 levels peaked early during 
the dark phase. During the light and dark phase, VO2 and VCO2 rhythms were higher in 3xTgAD, 
compared to Non-Tg control mice.  Rhythms in RQ were visible, but more variable in both 3xTgAD 
and Non-Tg mice. RQ peaked early during the dark phase in 3xTgAD mice and later in the dark 
phase in Non-Tg control mice. Statistical analysis revealed that 3xTgAD mice had a higher 
metabolic rate, as assessed by a greater 24 h mean VO2 (24%; p < 0.01, Figure 3.5.G) and VCO2 
(29%; p < 0.001, Figure 3.5.H), when compared with Non-Tg control mice. No significant difference 
in mean daily RQ was observed between 3xTgAD and Non-Tg control mice (Figure 3.5.I). During 
the monitoring period, both groups of mice exhibited a positive energy balance and there was no 
significant difference between groups (Non-Tg, 4.3 ± 1.9 kcal/day versus 3xTgAD, 5.8 ± 0.8 
kcal/day). 
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Figure 3.5. 12-month-old 3xTgAD mice had a higher metabolic rate  
 
At 12 months of age, cohorts of male 3xTgAD (n = 5) and Non-Tg (n = 6) control mice were 
individually housed in Comprehensive Lab Animal Monitoring System (CLAMS) calorimetry 
cages for four days to evaluate metabolic rate. During the period in CLAMS, 3xTgAD mice had 
mean 24 h body weight (A), food intake (B) and water intake (C) monitored. Rhythms in VO2 
(D), VCO2 (E) and RQ (F) and mean 24 h VO2 (G), VCO2 (H) and RQ (I) were assessed. Data 
are mean ± SEM. Student’s t-tests, *p < 0.05, **p < 0.01. (D, E, F), white bars represent the 
light, inactive phase of the day whereas black bars represent the dark, active phase.   
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3.3.1.6. 18-month-old 3xTgAD mice had a higher metabolic rate 
 
When housed individually in calorimetry cages, 18-month-old 3xTgAD mice exhibited a lower mean 
24 h body weight (13%; p < 0.01, Figure 3.6.A), despite a 14% higher mean 24 h food (p < 0.05, 
Figure 3.6.B) and water intake (69%; p < 0.01, Figure 3.6.C), compared to Non-Tg control mice. At 
18 months of age, indirect calorimetry, to measure metabolic rate, revealed that 3xTgAD mice 
display 24 h rhythms in VO2 consumption (Figure 3.6.D), VCO2 production (Figure 3.6.E) and RQ 
(Figure 3.6.F). VO2, VCO2 and RQ levels in 3xTgAD mice were lowest during the light, largely 
inactive phase of the day and highest during the dark, active phase. For 3xTgAD mice, VO2, VCO2 
and RQ peaked during the middle of the dark phase. At 18 months of age, Non-Tg mice displayed 
very weak rhythms in VO2 and VCO2.  Rhythms in RQ were visible in Non-Tg mice, peaking around 
the onset of the dark phase.  Rhythms in VO2 and VCO2 appeared higher in 3xTgAD mice 
compared to Non-Tg control mice during the light and dark phase, however the difference was 
greater during the dark phase. Statistical analysis revealed that 3xTgAD mice had a higher 
metabolic rate, as assessed by a greater 24 h mean VO2 (23%; p < 0.01, Figure 3.6.G) and VCO2 
(24%; p < 0.01, Figure 3.6.H), when compared with Non-Tg control mice. No significant difference 
in mean daily RQ was observed between mice (Figure 3.6.I). During the metabolic monitoring 
period, both groups of mice exhibited a positive energy balance and there was no significant 
difference between groups (Non Tg, 5.14 ± 0.3 kcal/day versus 3xTgAD, 7.33 ± 1.1 kcal/day). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3                                                                Characterisation energy balance in 3xTgAD mice  
 
60 
 
 
 
 
 
 
 
 
Figure 3.6. 18-month-old 3xTgAD mice had a higher metabolic rate  
 
At 18 months of age, cohorts of male 3xTgAD (n = 4) and Non-Tg (n = 4) control mice were 
individually housed in Comprehensive Lab Animal Monitoring System (CLAMS) calorimetry 
cages for four days to evaluate metabolic date. During the period in CLAMS, 3xTgAD mice had 
mean 24 h body weight (A), food intake (B) and water intake (C) monitored. Rhythms in VO2 
(D), VCO2 (E) and RQ (F) and mean 24 h VO2 (G), VCO2 (H) and RQ (I) were assessed. Data 
are mean ± SEM. Student’s t-tests, *p < 0.05, **p < 0.01. (D, E, F), white bars represent the 
light, inactive phase of the day whereas black bars represent the dark, active phase.  
 
Chapter 3                                                                Characterisation energy balance in 3xTgAD mice  
 
61 
 
3.3.2. Characterisation of the energy balance profile in 129SV and C57BL/J6 strains 
3.3.2.1. Male 129SV and C57BL/J6 mice displayed similar body weight and food intake 
profiles over 20 months 
 
Over a 20-month period, there was no significant difference in growth profile (Figure 3.7.A) and 
food intake (Figure 3.7.B) between male 129SV and C57BL/J6 mice. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7. Male 129SV and C57BL/J6 mice displayed similar body weight and food 
intake profiles over 20 months 
 
Cohorts of male C57B/LJ6 (n = 6) and 129SV (n = 6) mice had body weight (A) and food intake 
(B) monitored from weaning to 20 months of age. Body weight is represented as mean ± SEM. 
Repeated measures analysis of variance (ANOVA). 
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3.3.2.2. 20-month-old male 129SV and C57BL/J6 mice displayed similar body weight, food 
intake, water intake and metabolic rate 
 
When individually housed in CLAMS calorimetry cages at 20 months of age, 129SV and C57BL/J6 
mice displayed no significant differences in mean 24 h body weight (Figure 3.8.A), food intake 
(Figure 3.8.B) or water intake (Figure 3.8.C). Indirect calorimetry, to measure metabolic rate, 
revealed that 20-month-old 129SV and C57BL/J6 mice displayed similar 24h rhythms in VO2 
consumption (Figure 3.8.D), VCO2 production (Figure 3.8.E) and RQ (Figure 3.8.F). VO2, VCO2 and 
RQ levels were lowest during the light, largely inactive phase of the day and highest during the 
dark, active phase. Both VO2 and VCO2 levels peaked early during the dark phase. No statistical 
differences in mean 24 h VO2, (Figure 3.8.G), VCO2 (Figure 3.8.H) or RQ (Figure 3.8.I) were 
detected between 129SV and C57BL/J6 mice.  
Figure 3.8. 20-month-old male 129SV and C57BL/J6 mice displayed similar body weight, 
food intake, water intake and metabolic rate 
 
At 20 months of age, cohorts of male 129SV (n = 4) and C57BL/J6 (n = 4) mice were 
individually housed in Comprehensive Lab Animal Monitoring System (CLAMS) calorimetry 
cages for four days to evaluate metabolic rate. During the period in CLAMS, 3xTgAD mice had 
mean 24 h body weight (A), food intake (B) and water intake (C) monitored. Rhythms in VO2 
(D), VCO2 (E) and RQ (F) and mean 24 h VO2 (G), VCO2 (H) and RQ (I) were assessed. Data 
are mean ± SEM. Student’s t-tests. (D, E, F), white bars represent the light, inactive phase of 
the day whereas black bars represent the dark, active phase. 
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3.4. Discussion 
 
Energy balance appears to be affected throughout the progression of AD. While mid-life obesity 
increases the risk of developing AD, life-threatening weight loss occurs and worsens as the 
disease progresses. The results of this PhD show that female 3xTgAD mice displayed no 
difference in energy balance profile, whereas male 3xTgAD mice showed an altered energy 
balance profile. We demonstrate for the first time that, at 2 months of age, 3xTgAD mice eat and 
weigh more than non-transgenic controls, while showing no changes in metabolism. In contrast, 
from 12 months of age, 3xTgAD mice continue to eat more than the controls, yet weigh less and 
display a hypermetabolic state. No difference in body weight, food intake and metabolic profiles 
was observed between 129SV and C57BL/J6 mice, therefore any alterations in energy balance 
observed in 3xTgAD mice is unlikely due to a background genetic effect.!
 
3.4.1. Energy balance and survival in female 3xTgAD mice 
 
Female 3xTgAD mice displayed no significant difference in body weight and food intake, when 
compared to age-matched Non-Tg control mice. This is the first time longitudinal analysis of body 
weight and food intake has been done in female 3xTgAD mice. Only one other study has reported 
body weight in female 3xTgAD mice, finding that they are significantly heavier at 12 months of age 
(Gimenez-Llort et al 2007). In the present study, there was variability in body weight in female 
mice, which increased with age. This increase in variability appeared to be linked with the reduced 
survival observed in female 3xTgAD mice after 6 months of age.  This is the first time decreased 
survival has been noted in this model, though the reason for this is unknown.  However, it has been 
seen in other transgenic models of AD, where 90% of male and 54.5% of female APP/PS1 mice 
survive to 10 months of age, whereas 100% of male and female wild-type controls survive (Pugh et 
al 2007). This is interesting, as it follows almost exactly what was observed in the present study. 
The authors discussed that prior to premature death, the mice did not show any changes in body 
weight or signs of illness and thus, the reason for premature death is unknown. Again, this is 
similar to what we observed, as death occurred very quickly. Reduced survival has also been noted 
in male and female Tg2576 mice through to 19 months of age (Arendash & King 2002; King & 
Arendash 2002), although no gender difference in survival was observed. The reasons for 
decreased survival in female 3xTgAD mice in the current study are currently unknown and require 
further examination.  
 
3.4.2. Altered energy balance in male 3xTgAD mice 
 
To our knowledge, this is the first time a longitudinal energy balance profile has been established 
from weaning in 3xTgAD mice. At 2 months of age, male 3xTgAD mice weighed significantly more 
than Non-Tg controls, but displayed no difference in metabolic rate. However, at 12 and 18 months 
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of age, male 3xTgAD mice weighed less and had a higher metabolic rate, compared with Non-Tg 
control mice. Male 3xTgAD mice were hyperphagic at all ages examined. No differences in body 
weight, food intake and metabolic rate were observed between individual background strains 
(129SV and C57BL/J6 mice) of 3xTgAD mice, therefore any alterations in energy balance 
observed in 3xTgAD mice is unlikely due to background genetic effect. In the present study we 
noted an increase in body weight early in life; however it is not known whether this increase was 
due to accelerated growth or an increased deposition of fat. No difference in body length was noted 
(data not shown), however more detailed analysis would be required in future studies, where body 
length and body composition (e.g. using DEXA) could be examined. Brain pathology was also 
assessed in the male cohorts in the present study (data not shown) (Knight et al 2010). At 2 
months of age, intraneuronal A! pathology was seen in the cortex, hippocampus, and amygdala, 
and became more apparent by 12 months of age, when occasional A! plaques as well as a small 
number of hyperphosphorylated tau positive neurones were visible within the hippocampus. At 18 
months of age, a more severe AD pathology was noted with increased A! plaques and 
hyperphosphorylated tau-positive neurones within the hippocampus. Thus, the shift towards a 
hypermetabolic state appears to start before significant disease pathology (plaques and tangles), 
although future studies would be required to determine exactly when changes in metabolic rate 
occur. 
 
Very few studies have investigated body weight and food intake in 3xTgAD mice. One study 
reported that body weight of 2-month-old male 3xTgAD mice is either not different or increased 
depending on the individual experiment, while 6-month-old mice weigh more than controls 
(Gimenez-Llort et al 2007). At 6 months of age, we reported that 3xTgAD mice were no longer 
heavier than Non-Tg mice. Gimenez-Llort and colleagues examined body weight in separate 
groups of mice, at two time points, and did not continue after 6 months of age, making direct 
comparisons with the present study difficult. Another study did evaluate weekly body weight from 3 
until 14 months of age, in a mixed male and female cohort (Halagappa et al 2007), however, details 
were not published, other than to say that at 14 months of age, 3xTgAD mice weigh on average 5-
10 g less than Non-Tg mice. These data are similar to the present study where male 3xTgAD mice 
weighed approximately 5 g less than Non-Tg mice at 12 months of age. However, as we found 
gender differences in energy balance profiles, it is difficult to compare our data with those of 
Halagappa and colleagues. On the whole, in accordance with the present data, previous studies in 
3xTgAD mice show that they are heavier earlier in life, and at some time point later, they are lighter 
than Non-Tg controls. No studies have previously examined longitudinal metabolic rate in any 
model of AD.  
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3.4.3. Energy balance in other mouse models of AD 
 
Currently very few studies have performed longitudinal studies, looking at body weight and food 
intake in other mouse models of AD. In contrast to the present data, the limited studies that have 
examined body weight in male and female APP and APP/PS-1 mice report that it is lower 
throughout life compared to control mice (Lalonde et al 2005; Lalonde et al 2002; Touma et al 
2007). The majority of these studies, however, have only examined body weight at a single age 
and did not monitor food intake. Those studies that have looked at food intake found that both male 
and female APP 23 and APP/PS-1 mice eat more food, despite weighing less throughout their 
lives, suggesting altered energy expenditure, similar to that seen in the present study (Pugh et al 
2007; Vloeberghs et al 2008).  As discussed above, various APP and APP/PS-1 models of AD 
have lower body weight throughout life, which may be present from birth. However, the data 
presented in this PhD in 3xTgAD mice may mirror the onset and progression of AD more closely, 
as obesity is a known risk factor during mid-life, but life-threatening weight loss occurs as the 
disease progresses, despite adequate or increased food intake. These results, therefore, present 
for the first time, in a transgenic AD model, a biphasic body weight profile in the presence of 
increased food intake.  
 
3.4.4. Why do aged male 3xTgAD mice have lower body weight? 
 
In order to lose body weight, the energy gained from food (energy intake) must be less than the 
energy used (energy expenditure) resulting in a negative energy balance. This can be caused by 
decreased food intake and/or an increase in energy expenditure, which is determined by three 
components including physical activity, diet-induced thermogenesis and basal metabolic rate 
(Levine 2005).  
 
Lower body weight observed in this study in 3xTgAD mice at both 12 and 18 months is not due to 
decreased food intake, as 3xTgAD mice showed an increase appetite at all ages, which correlates 
with clinical findings where food intake is adequate or even increased in AD patients (Burns et al 
1989; Keene & Hope 1997a; b; Niskanen et al 1993; Spindler et al 1996). In addition to enhanced 
appetite, 3xTgAD mice exhibited an increased metabolic rate at 12 and 18 months of age. However 
at this age, 3xTgAD mice were in positive, not negative energy balance, which could be due to the 
hyperphagia observed at these ages. Consequently, as 3xTgAD mice already weighed less than 
Non-Tg control mice, a period of negative energy balance could have occurred previously. 
Evaluation of energy intake and expenditure at more time points throughout the life of 3xTgAD 
mice would be needed to examine the relationship between energy balance and changes in body 
weight. It is possible to have weight loss in the presence of positive energy balance as, for 
example, when there are problems in food absorption in the gut or if there is a reduction in the 
amount of metabolisable energy that can be obtained from food. The latter can be seen if there is 
an increase in the energy lost in urine (e.g. altered protein use, impaired kidney function or 
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diabetes mellitus). As a negative energy balance was not observed in 3xTgAD mice, changes in 
gut absorption or metabolisable energy could therefore explain the lower body weight seen in these 
mice after 12 months of age (Knight et al 2010). 
 
3.4.5. Why do aged male 3xTgAD mice have higher metabolic rate?  
 
One reason why aged 3xTgAD mice may have lower body weight than Non-Tg control mice could 
be a higher metabolic rate, as we see in our mice. An increase in metabolic rate could be caused 
by factors including raised physical activity, diet-induced thermogenesis or basal metabolic rate.  
 
Increased physical activity 
 
At 12 months of age, when 3xTgAD mice were hypermetabolic, they did not show increased 
general activity within the OF test (see Chapter 4). However, the OF test is not a true test of 
activity, but rather a test of anxiety, therefore a complete 24 h evaluation of activity remains to be 
examined in 3xTgAD mice, in order to determine whether raised physical activity plays a role in the 
hypermetabolic rate seen in 3xTgAD mice at 12 and 18 months of age. Other studies performed in 
our lab suggest, that at approximately 10 months of age, 3xTgAD mice start to exhibit increased 
dark phase activity (data unpublished), which could explain the hypermetabolism observed. 
Similarly Gimenez-Lort and colleagues (2007) found a trend towards increased night/day activity 
ratio at 6 months of age (Gimenez-Llort et al 2007). In contrast, more recently a study found altered 
circadian activity in 3xTgAD mice, showing increased locomotor activity during the day and 
decreased activity at night at both less than 6-months of age and more than 6-months of age 
(Sterniczuk et al 2010). These studies are interesting, as an increase in physical activity, which is 
often referred to as “wandering” or “pacing”, is commonly seen in AD patients during the day and at 
night (Ballard et al 1991; White et al 2004). Raised physical activity has been noted in previous 
studies in APP and APP/PS-1 mice, which perform a higher total number of moves in the Y-maze 
SA task from 3 months of age (Holcomb et al 1998; Holcomb et al 1999), show an increase in 24 h 
home cage activity from 5 months of age (Pugh et al 2007) and move more within an OF from 6 
months of age (Dodart et al 1999). Pugh and colleagues also noted that APP/PS-1 mice display no 
difference in OF behaviour yet mice have decreased body weight despite increased food intake, 
similar to that seen in the present study (Pugh et al 2007).  Increased physical activity may 
therefore play a role in the increased energy requirement in 3xTgAD mice, however as activity was 
only examined crudely in these mice in the present study, future work could assess activity in more 
detail, at different ages and correlate the findings with energy balance. 
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Diet –induced thermogenesis 
 
It is possible that diet-induced thermogenesis could explain the hypermetabolism observed in aged 
3xTgAD mice, as these mice consume more food. However, this is unlikely, as food intake is 
increased in metabolically normal 2-month-old male 3xTgAD mice.   
 
Increased basal metabolic rate 
 
The higher metabolic rate observed in male 3xTgAD mice could possibly be due to increased basal 
metabolic rate, which has been seen in other disorders, including cancer (Bosaeus et al 2002), 
burns (Pereira & Herndon 2005), sepsis (Trager et al 2003) and chronic obstructive pulmonary 
disease (Schols 2003a; Schols 2003b), where weight loss is a serious complication (Morgan & 
Gordon 2008; Stephens & Fearon 2008). As with the present study, hypermetabolism in these 
disorders remains poorly understood. Many factors could increase basal metabolic rate, such as 
increased whole body protein turnover, and as AD patients show changes in urine protein 
concentration, this could suggest an increase in protein use (Fonteh et al 2007). Basal metabolic 
rate can also be raised by changes in thyroid function (Kapaki et al 2006) and increases in basal 
sympathetic nervous system activity (Pascualy et al 2000), both of which are seen in AD patients. 
Proton leakage within mitochondrion could also explain increased basal metabolic rate, as 
mitochondrial damage is seen in AD patients (Baloyannis 2006; Hulbert & Else 2004; Moreira et al 
2006; Morgan & Gordon 2008; Parihar & Brewer 2007). Furthermore, A! is seen to make 
membrane pores (holes) within mitochondrion (Kayed et al 2004) and has been found localised 
within mitochondrion (Atamna & Frey 2007; Morgan & Gordon 2008).  
 
3.4.6 Altered energy balance in AD patients? 
 
Mounting evidence has demonstrated that AD patients display significant weight loss despite 
adequate or even increased energy intake (Gillette Guyonnet et al 2007; Gillette-Guyonnet et al 
2000).  It has been hypothesised that higher energy expenditure may explain this weight loss. The 
existence of a hypermetabolic state has been previously reported in AD patients, who show higher 
energy requirements than cognitively normal controls, despite lower body weight (Wolf-Klein et al 
1995). However, other studies have shown no change or even a decrease in metabolic rate 
(Donaldson et al 1996; Niskanen et al 1993; Poehlman et al 1997; Prentice et al 1989; Wang et al 
1997). The small number of patient studies examining metabolic rate to date have been limited in 
their sample size, some only describe short-term measurements, whereas others do not have 
appropriate controls (predicted calculations rather than a control cohort population). It is also 
possible that many of these patients were not in an active weight loss phase and body weight was 
stable or between episodes of weight loss. Furthermore, not all AD patients report weight loss 
(Guerin et al 2005), therefore energy intake and expenditure would need to be examined from 
much earlier in the disease in a homogenous population of AD patients who are in a dynamic 
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phase of weight loss or have previously lost weight. Although a change in metabolism in AD 
patients is still to be determined, our results in 3xTgAD mice suggest that an increase in metabolic 
rate may be responsible for the weight loss observed in AD patients.  
 
3.5. Conclusion 
 
AD is a progressive neurodegenerative disorder, characterised by deficits in language, behaviour 
and memory. Increasing evidence suggests that mid-life obesity is a risk factor for AD, whereas 
weight loss often occurs before clinical diagnosis and continues during development of the disease. 
Weight loss may therefore reflect the disease process, and a shift in body weight represents an 
early indicator of AD, prior to clinical presentation. Mechanisms behind the weight loss are currently 
unknown, since food intake is usually adequate or even increased in AD patients. Increasing 
evidence from both preclinical and clinical studies suggest that altered metabolism may contribute 
to the weight loss observed in AD, however, metabolism has not been previously investigated 
directly in transgenic mouse models of AD. The data presented in this chapter, therefore, 
demonstrate for the first time altered body weight, food intake and metabolic rate in the 3xTgAD 
mouse model of AD, and provide evidence that there is a shift towards a hypermetabolic state from 
12 months of age in 3xTgAD mice, which may represent a key stage in advancement of the 
disease process. However, it remains to be determined when the switch towards a hypermetabolic 
state occurs. Furthermore, it is unknown if this switch coincides with or is responsible for the lower 
body weight observed in aged 3xTgAD mice. Future studies could look at more time points to 
identify when a change in metabolic rate occurs, while also looking at factors which could raise 
metabolic rate in order to understand the underlying mechanisms. 
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4.1. Introduction and objectives 
 
AD is characterised by progressive deficits in behaviour (Brodaty & Low 2003; Honig & Mayeux 
2001; Levy et al 1999; Masterman 2003; Pugh et al 2007; Ritchie & Lovestone 2002) and memory 
(Artero et al 2003; Carlesimo & Oscar-Berman 1992; Morris 1996; Welsh et al 1992), therefore the 
second aim of this PhD was to characterise behaviour and memory in cohorts of male Non-Tg 
control and 3xTgAD mice by using a battery of different behavioural tests, including the open-field 
(OF), Y-maze spontaneous alternation (SA), odour recognition (OR), novel object recognition 
(NOR) and Morris water maze (MWM) tests at different ages. This characterisation study was also 
done to determine baseline behaviour and memory so that future studies could assess the effect of 
dietary interventions on the onset and progression of cognitive deficits. A separate cohort of 
C57BL/J6 and 129SV mice were also subjected to the OF and SA tasks at different ages to 
determine any potential strain specific differences in behaviour and memory. 
 
4.2. Materials and methods 
4.2.1. Experimental design 
4.2.1.1. OF test 
 
To examine anxiety and general activity, separate cohorts of male 3xTgAD and age-matched Non-
Tg control mice underwent the OF test (see Method 2.3.1.) at 3 months (Non-Tg, n = 8 and 
3xTgAD, n = 7), 5 months (Non-Tg, n = 10 and 3xTgAD, n = 9), and 12 months (Non-Tg, n = 12 
and 3xTgAD, n = 11) of age. A cohort of male C57BL/J6 (n = 6) and 129SV (n = 6) mice had OF 
behaviour examined at 3, 5, 12 and 18 months of age.  
4.2.1.2. SA test 
 
To examine spatial working memory, separate cohorts of male 3xTgAD and age-matched Non-Tg 
control mice were submitted to the Y-maze SA test (see Method 2.3.2.) at 3 months (Non-Tg, n = 8 
and 3xTgAD, n = 7), 5 months  (Non-Tg, n = 10 and 3xTgAD, n = 9), and 12 months (Non-Tg, n = 
12 and 3xTgAD, n = 11) of age. A cohort of male C57BL/J6 (n = 6) and 129SV (n = 6) mice had SA 
examined at 3, 5, 12 and 18 months of age. 
4.2.1.3. MWM task 
 
To examine spatial memory, separate cohorts of male 3xTgAD and age-matched Non-Tg control 
mice underwent the MWM task at 3 months (Non-Tg, n = 8 and 3xTgAD, n = 7), 5 months (Non-Tg, 
n = 8 and 3xTgAD, n = 9), and 12 months (Non-Tg, n = 12 and 3xTgAD, n = 11) of age. The MWM 
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task consisted of 1 d of flagged platform training, followed by 5 d of submerged platform training 
and a probe test 24 h after the final day of submerged platform (see Method 2.3.5.)  
 
4.2.1.4. NOR test 
 
In order to examine short-term non-spatial object memory, separate cohorts of male 3xTgAD and 
age-matched Non-Tg control mice were subjected to the NOR test (see Method 2.3.4.) at 3 months 
(Non-Tg, n = 12 and 3xTgAD, n = 12) and 8 months (Non-Tg, n = 10 and 3xTgAD, n = 9) of age.   
 
4.2.1.4. OR test 
 
In order to examine short-term smell memory, separate cohorts of male 3xTgAD and age-matched 
Non-Tg control mice underwent the OR test (see Method 2.3.3.) at 3 months of age (Non-Tg, n = 
12 and 3xTgAD, n = 12).   
 
4.2.2. Statistical analysis 
 
Evaluation of OF behaviour, SA, NOR and OR between 3xTgAD and Non-Tg control mice and OF 
behaviour and SA between C57BL/J6 and 129SV mice were examined using Student’s t-tests using 
Prism (Graphpad, San Diego, CA, USA). MWM training was assessed between cohorts on 
individual training days and compared within cohorts between the first day of training and 
successive days of training to assess improvement over time using two-way repeated measures 
analysis of variance (ANOVA) (SigmaStat 4, Systat Software Inc., IL, USA). Evaluation of the probe 
test between 3xTgAD and age-matched Non-Tg controls was examined using Student’s t-tests 
using Prism (Graphpad, San Diego, CA, USA).    
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4.3. Results 
4.3.1. Characterisation of behaviour and memory deficits in 3xTgAD mice 
4.3.1.1. 3xTgAD mice displayed age-dependent changes in open-field (OF) behaviour 
 
When placed in an OF arena, 3-month-old male 3xTgAD mice displayed 51% significantly fewer 
cell entries (p < 0.01; Figure 4.1.A), 33% less time moving (p < 0.001; Figure 4.1.D) and 66% fewer 
rearings (p < 0.001; Figure 4.1.G) than age-matched Non-Tg control mice. There was no significant 
difference in the number of defecations between 3xTgAD and age-matched Non-Tg control mice 
(Figure 4.1.J). When placed in an OF arena, 5-month-old male 3xTgAD mice made 53% 
significantly fewer cell entries (p < 0.01; Figure 4.1.B), spent 37% less time moving (p < 0.01, 
Figure 4.1.E), made 50% fewer rearings (p < 0.05; Figure 4.1.H) and had 58% more defecations  
(p < 0.05; Figure 4.1.K) than age-matched Non-Tg control mice. However, at 12 months of age 
male 3xTgAD mice reared less (38%, p < 0.01; Figure 4.1.I) but showed no significant difference in 
the number of cell entries (Figure 4.1.C), the percentage time moving (Figure 4.1.F) or the number 
of defecations (Figure 4.1.L) when compared to Non-Tg control mice. Overall, 3xTgAD mice 
exhibited age-dependent changes in OF behaviour, which included a transient reduction in cell 
entries and percentage time moving yet rearing exploration was reduced in 3xTgAD mice at all 
ages tested. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1.  3xTgAD mice displayed age-dependent changes in open-field (OF) behaviour 
 
Separate cohorts of 3xTgAD (n = 7-11) and Non-Tg (n = 8-12) control mice were placed in an OF 
arena and allowed to explore for 5 min at 3, 5 and 12 months of age. The number of cell entries 
(A-C), percentage time moving (D-F), number of rearings (G-H) and number of defecations (J-L) 
were recorded. Student’s t-test, *p < 0.05, **p < 0.01, ***p < 0.001. Data are mean ± SEM. 
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4.3.1.2. 3xTgAD mice showed age-dependent memory deficits in the Y-maze spontaneous 
alternation (SA) test from 5 months of age 
 
When placed in a Y-maze, 3-month-old male 3xTgAD mice showed no significant difference in the 
percentage number of alternations (Figure 4.2.A) but performed 34% fewer total number of moves 
(p < 0.05; Figure 4.2.D) when compared to age-matched Non-Tg control mice. By 5 months of age 
3xTgAD mice performed a lower (18%) percentage number of alternations (p < 0.05; Figure 4.2.B) 
and also moved less (30%, p < 0.05; Figure 4.2.E) when compared to age-matched Non-Tg control 
mice. When placed in a Y-maze, 12-month-old male 3xTgAD mice also displayed a lower number 
(23%) of percentage alternations (p < 0.01; Figure 4.2.C) but no significant difference in the total 
number of moves was detected (Figure 4.2.F) when compared to age-matched Non-Tg control 
mice. Overall, 3xTgAD mice displayed age-dependent memory deficits in the Y-maze SA test from 
5 months of age and a transient reduction in activity.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2. 3xTgAD mice showed age-dependent memory deficits in the Y-maze 
spontaneous alternation (SA) test from 5 months of age 
 
Separate cohorts of 3xTgAD (n = 7-11) and Non-Tg (n = 8-12) control mice were placed in a Y-
maze for 8 min at 3, 5 and 12 months of age. The percentage of spontaneous alternations (A-C) 
and the total number of moves (D-F) were recorded. Student’s t-test, *p < 0.05, **p < 0.01. Data 
are mean ± SEM. 
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4.3.1.3. 3xTgAD mice had age-dependent memory deficits in the Morris water maze (MWM) 
task probe test from 5 months of age 
 
 
During flagged platform training, there was no significant difference in escape latency between 
3xTgAD and Non-Tg control mice other than at trial two at 3 months, trial four at 5 months and trial 
one at 12 months of age (p < 0.05, Figure 4.3.A-C) where 3xTgAD mice had significantly faster 
escape latencies. During submerged platform training, Non-Tg control mice showed significant 
improvement in escape latency over training days at 3 (day 5 versus day 1; p < 0.05, Figure 4.3.D), 
5 (day 5 versus day 1; p < 0.05, Figure 4.3.E) and 12 months of age (day 3-5 versus day 1; p < 
0.05 - p < 0.01, Figure 4.3.F), whereas 3xTgAD mice showed no evidence of learning at all ages 
tested. On individual training days there was no significant difference in escape latency between 
Non-Tg control and 3xTgAD mice at either 3, 5 or 12 months of age. When broken down into a 
trial-by-trial analysis, no difference in escape latency was seen in 3xTgAD mice at any age 
between the first trial of a training day and the last trial on the previous day was observed. During 
the probe test there was no significant difference in the percentage time spent in the target 
quadrant, where the platform was previously located, between 3xTgAD and Non-Tg control mice at 
3 months of age (Figure 4.3.G). However, at both 5 and 12 months of age 3xTgAD showed 
significant memory deficits during the probe test, indicated by a lower percentage time spent in the 
target quadrant than Non-Tg control mice (47% and 40% for 5- and 12-month-old mice 
respectively; p < 0.001 and p < 0.01, Figure 4.3.H-I). Examination of swim paths revealed most 
Non-Tg mice at all ages went directly or indirectly to the target quadrant and then spent most of 
their time in the target quadrant searching for the platform. In contrast most 3xTgAD mice at all 
ages spent their time equally distributed amongst all the quadrants. At 3 months most 3xTgAD 
mice appeared to go to the target quadrant then moved away searching elsewhere for the target 
quadrent. At 5 and 12 months 3xTgAD were more variable with some heading for the target 
quadrant then swimming elsewhere but most just appeared to swim randomly around the pool. 
Some appeared to swim in laps around the pool at the same distance from the pool wall to the 
platform, instead of using the local cues to direct them to the target quadrant. No significant 
difference in swim speed was noted between Non-Tg control and 3xTgAD mice at all ages tested 
(data not shown). Overall, 3xTgAD mice displayed normal flagged platform learning yet no 
improvement in submerged platform training between 3-12 months of age. 3xTgAD mice displayed 
a significant memory deficit in the probe test from 5 months of age.  
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Figure 4.3. 3xTgAD mice had age-dependent memory deficits in the Morris water maze 
(MWM) probe test from 5 months of age 
  
Separate cohorts of 3xTgAD mice (n = 7-11) and age-matched Non-Tg control mice (n = 8-12) 
underwent the MWM task at 3, 5 and 12 months of age. Cohorts were given four trials over 1 d 
of flagged platform training (A-C). Mice were then given four trials a day for 5 d of submerged 
platform training (D-F). Twenty-four hours after the final trial mice were given a probe test with 
no platform (G-I). Example swim paths during the probe test are displayed. The green spot 
indicates the start location and the red dot indicates the end location. The box indicates the 
location where the platform was located during submerged platform training. For escape 
latency, two-way repeated measures analysis of variance (ANOVA) with Scheffe post-hoc 
analysis, *p < 0.05; Non-Tg versus 3xTgAD during flagged platform training, *p < 0.05, **p < 
0.01; Non-Tg mice day 1 versus days 3-5 of submerged platform training. For percentage time 
in target quadrant, Student’s t-test; **p < 0.01, ***p < 0.001. Data are mean ± SEM. 
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4.3.1.4. 3xTgAD mice displayed age-dependent memory deficits in the novel object 
recognition (NOR) test from 8 months of age 
 
During phase 1, both 3- and 8-month-old male 3xTgAD and age-matched Non-Tg control mice 
spent a similar percentage of time exploring the identical novel objects 1 and 2 (Figure 4.4.A-B). 
During phase 2, after an interval of 1 h, both 3-month-old male 3xTgAD and Non-Tg control mice 
spent a significantly higher percentage of time exploring the novel object than the familiar object, 
previously presented in phase 1 (45% and 39% respectively; p < 0.05 Figure 4.4.C). At 8 months of 
age, during phase 2 of the task, Non-Tg control mice spent a significantly higher percentage of time 
exploring the novel object than the familiar old object (56%; p < 0.01, Figure 4.4.D), whereas 
3xTgAD mice spent a similar percentage of time exploring both novel and familiar objects, 
indicating a deficit in memory. Overall, 3xTgAD mice showed age-dependent memory deficits in the 
NOR test from 8 months of age. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4. 3xTgAD mice showed age-dependent memory deficits in the novel object 
recognition (NOR) test from 8 months of age  
 
Separate cohorts of Non-Tg control and 3xTgAD mice underwent the NOR test at 3 and 8 
months of age. During phase 1 (A-B) 3xTgAD (n = 9-12) and Non-Tg (n = 10-12) mice were 
placed in a NOR arena for 10min with two identical novel objects (novel 1 and novel 2). During 
phase 2 (C-D), after an interval of 1 h, mice were placed back into the arena with one familiar 
object (presented in phase 1) and one novel object. Student’s t-test, *p < 0.05, **p < 0.01. Data 
are mean ± SEM. 
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4.3.1.5. 3xTgAD mice showed memory deficits in odour recognition (OR) test at 3 months of 
age. 
 
During phase 1, both 3-month-old male 3xTgAD and Non-Tg control mice spent a similar 
percentage of time exploring identically-scented novel balls 1 and 2 (Figure 4.5.A). During phase 2, 
after an interval of 3 min, 3-month-old male Non-Tg control mice spent a significantly higher 
percentage of time exploring the novel scented ball than the familiar scented ball previously 
presented in phase 1 (65%; p < 0.001 respectively, Figure 4.5.B), whereas 3xTgAD mice spent a 
similar percentage of time exploring both novel and familiar scented balls. 3xTgAD mice therefore 
display a memory deficit in the OR test at 3 months of age. It is important to note that male 3xTgAD 
were able to smell at this age, as they showed an increase in the exploration of female urine over 
water, streaked on separate pieces of acetate (data not shown). 
 
 
 
 
 
 
 
 
Figure 4.5. 3-month-old male 3xTgAD mice displayed memory deficits in the odour 
recognition (OR) test 
 
During phase 1 (A) 3-month-old 3xTgAD (n = 12) and Non-Tg control mice (n = 12) were placed 
in OR arena for 10 min with two identically scented novel balls (novel 1 and novel 2). During 
phase 2 (B), after an interval of 3 min, the mice were placed back into the arena with one 
familiar scented ball (presented in phase 1) and one novel scented ball. Student’s t-test, ***p < 
0.001. Data are mean ± SEM. 
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4.3.2. Evaluation of behaviour and memory in 129SV and C57BL/J6 mouse strains. 
4.3.2.1. 129SV and C57BL/J6 mice displayed no difference in open field (OF) behaviour at 3, 
8, 12 and 18 months of age 
 
When placed in an OF arena, male 129SV and age-matched C57BL/J6 mice displayed no 
significant difference in the number of cell entries (Figure 4.6. A, E, I & M), percentage time moving 
(Figure 4.6.B, F, J & N), number of rearings (Figure 4.6.C, G, K & O) and number of defecations 
(Figure 4.6.D, H, L & P) at 3, 8, 12 and 18 months of age. 129SV and C57BL/J6 mice therefore 
exhibited similar behaviour in the OF at all ages tested. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6. 129SV and C57BL/J6 mice had no difference in open-field (OF) behaviour at 3, 
8, 12 and 18 months of age  
 
129SV (n = 6) and C57BL/J6 (n = 6) mice were placed in an OF arena and allowed to explore 
for 5 min at 3, 8, 12 and 18 months of age. The number of cell entries (A-D), percentage time 
moving (E-H), number of rearings (I-L) and the number of defecations (M-P) were recorded. 
Student’s t-test. Data are mean ± SEM. 
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4.3.2.2. 129SV and C57BL/J6 mice showed no difference in memory in the Y-maze 
spontaneous alternation (SA) test at 3, 8, 12 and 18 months of age 
 
When placed in a Y-maze, 129SV and C57BL/J6 mice displayed no significant difference in the 
percentage number of alternations at 3, 8, 12 or 18 months of age (Figure 4.7.A, C, E & G) No 
significant difference in the total number of moves was observed between 129SV and C57BL/J6 
mice at 3 and 12 months of age, yet a significant difference was observed at 8 and 18 months of 
age (Figure 4.7.B, D, F & H). Overall, no strain specific differences in memory in Y-maze SA test 
were observed between 129SV and C57BL/J6 mice at all ages tested. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7. 129SV and C57BL/J6 had no difference in memory in the Y-maze 
spontaneous alternation (SA) test at 3, 8, 12 and 18 months of age  
  
129SV (n = 6) and C57BL/J6 mice (n = 6) were placed in a Y-maze for 8 min at 3, 8, 12 and 
18 months of age. The percentage of spontaneous alternations (A-D) and total number of 
moves (E-H) were recorded. Student’s t-test, *p < 0.05. Data are mean ± SEM. 
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4.4. Discussion 
 
Since AD is characterised by progressive deficits in behaviour and memory, the second aim of this 
PhD was to characterise behaviour and memory deficits in 3xTgAD mice. Behaviour and memory 
were characterised in male Non-Tg control and 3xTgAD mice in a battery of tests at different ages. 
3xTgAD mice displayed altered OF behaviour from 3 months of age, whereas memory was 
impaired at 3 months of age in the OR test, from 5 months of age in both SA and MWM tests and 
from 8 months of age in the NOR test. Behaviour and memory were also assessed in 129SV and 
C57BL/J6 mice (the background strains for the 3xTgAD mice) and no difference was observed 
between mice at 3, 8, 12 and 18 months of age (apart from a small difference in activity in 8- and 
18-month-old mice). Therefore the differences observed here in the 3xTgAD mice are unlikely to be 
due to a genetic drift towards one of the background strains in these mice.  
 
4.4.1. Open-field (OF) behaviour test 
 
Anxiety, apathy, disinhibition and reduced curiosity all form part of the behavioural and 
psychological symptoms of dementia (BPSD), which are commonly seen in AD (Daffner et al 1992; 
Spalletta et al 2004). These symptoms can appear in either the early or late stages of the disease 
and are known to fluctuate throughout its progression (Cummings 2000; Spalletta et al 2004). Even 
small stressors, such as a change in routine or environment, are known to play a role in BPSD in 
AD patients (Smith et al 2004). 
  
In the present study, the OF test was used to evaluate general activity, exploration and anxiety of 
3xTgAD mice in response to a novel environment. At 3 and 5 months of age 3xTgAD mice 
displayed a decrease in activity as the number of cell entries and percentage time moving were 
reduced when compared to Non-Tg mice, however this difference was no longer seen at 12 
months of age. 3xTgAD mice also displayed reduced rearing exploration at 3, 5 and 12 months of 
age and increased defecation within the OF only at 5 months of age. Thus, overall there was a 
transient reduction in activity, while rearing was reduced at all ages. Previous studies in 3xTgAD 
mice have shown normal cell entry activity but less rearing from approximately 2 months of age 
and cell entry becomes reduced from 6 months of age (Billings et al 2005; Gimenez-Llort et al 
2007; Nelson et al 2007). Gimenez-Llort and colleagues also noted increased defecation within the 
OF at 2.5 and 6 months of age, which is no longer seen at 12 months of age. The results presented 
in this PhD thesis demonstrate that 3xTgAD mice display changes in OF behaviour in accordance 
with previous studies. The reason why 3xTgAD mice move around less at 3 and 5 months of age is 
unknown, but may be due to increased anxiety within the OF. When a mouse is more anxious or 
unmotivated to explore in a novel environment, it will spend less time moving. While decreased OF 
activity and rearing exploration are observed at 3 and 5 months of age, defecation within the OF 
was increased only at 5 months of age. The reason why defecation was not increased at 3 months 
is unknown. Normal defecation in 3xTgAD mice observed at 12 months is consistent with no 
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difference in OF activity seen at this age. Increased defecation within an OF has previously been 
described as anxiety or the inability to cope with mild stressors or novelty (Gimenez-Llort et al 
2007). The results from the present study appear to indicate that 3xTgAD mice may be more 
anxious than Non-Tg control mice, especially at 3 and 5 months of age, and that these differences 
are less visible in mice by 12 months of age.  
 
Emotional behaviour is dependent on the amygdala, which is known to be affected during early 
stages of AD by both A! and NFTs pathology (Braak & Braak 1991; Espana et al 2010; Hyman et 
al 1990). Both volumetric and metabolic changes in the amygdala have been associated with 
BPSD in AD (Bruen et al 2008; Espana et al 2010; Rosen et al 2006). Early changes in OF 
behaviour and potential increased anxiety are consistent with intraneuronal A! pathology observed 
within the amygdala in the present 3xTgAD colony from 1 month of age (Knight 2007). Other 
groups have reported intraneuronal A! pathology from 2 months of age and NFT pathology from 6 
months of age within the amygdala of 3xTgAD mice (Mastrangelo & Bowers 2008). These findings 
confirm other studies in 3xTgAD mice examining emotional behaviour using other tasks such as 
the elevated plus maze, the light/dark box or the Boissier 16 hole-board (Gimenez-Llort et al 2007). 
3xTgAD mice display innate and conditioned fear at early ages, which the authors correlate with A! 
pathology found specifically within the basolateral amygdala of 3xTgAD (Espana et al 2010).  
 
It has been suggested that stress response and the hypothalamic-pituitary-adrenal axis (HPA) may 
be altered in 3xTgAD mice (Rothman & Mattson 2009). Endogenous plasma corticosterone (rodent 
stress hormone) levels are elevated in 3xTgAD mice from 9 months of age (Green et al 2006). 
However, this is in contrast to the data presented here, where 3xTgAD mice appeared more 
anxious between 3-5 months of age compared to 12 months of age. Studies have shown that 
increasing chronic stress by social isolation (Dong et al 2004; Dong et al 2008) or restraint stress 
(Lee et al 2009) worsen spatial learning and/or increase AD pathology in models of AD. 
Furthermore, intraperitoneal injection of dexamethazone, a synthetic adrenocortical steroid, 
increases intraneuronal A! and tau in 4-month-old 3xTgAD mice (Green et al 2006). Similarly to 
AD animal models, dyregulation of the stress response and HPA are observed throughout the 
progression of AD in humans (Rothman & Mattson 2009). AD patients have higher basal levels of 
circulating cortisol (human stress hormone) (Davis et al 1986; Masugi et al 1989; Swanwick et al 
1998; Umegaki et al 2000) and chronic stress has been shown to worsen cognitive deficits 
(Rothman & Mattson 2009). However, HPA dysfunction did not worsen as cognition declined 
further indicating that increased cortisol levels may only be relevant during early disease 
progression (Swanwick et al 1998).  
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4.4.1.1. OF behavioural test conclusions and future studies 
 
Results from the OF test indicate that 3xTgAD mice showed age-dependent changes in OF 
behaviour, correlating with previous studies in 3xTgAD mice and mirroring BPSD observed in AD 
patients. Future studies would be needed to investigate BPSD-like behaviour in the current colony 
of Non-Tg control and 3xTgAD mice in more detail. Tests such as the elevated plus maze, the 
light/dark box, the Boissier 16 hole-board and contextual fear conditioning could be used and 
correlated with brain pathology and corticosterone levels. It may also be useful to investigate 
BPSD-like behaviour in 3xTgAD mice over a wider age range, firstly to determine whether 3xTgAD 
mice are born with altered BPSD-like symptoms and secondly to investigate what happens in mice 
after 12 months of age when significant plaque pathology is present in the colony.  
 
4.4.2. Y-maze spontaneous alternation (SA) memory test 
 
The predominant feature of AD is memory impairment. During early stages of the disease, short-
term or working memory is affected (Huntley & Howard 2010; Ramsden et al 2008). AD patients 
show deficits in digit and word span tests, which requires patients to remember lists of increasing 
complexity (Hulme et al 1993). AD patients also show deficits in a number of spatial short-term or 
working memory tasks, such as the Corsi block-tapping test. In this non-verbal task, cubes are 
tapped in a novel sequence of increasing difficulty by an examiner, immediately after which 
participants must reproduce the exact sequence (Fischer 2001; Grossi et al 1993; Guariglia 2007; 
Hulme et al 1993; Trojano et al 1994). For obvious reasons verbal tests of short-term working 
memory cannot be used in AD models. The Y-maze SA test, however, is a relevant test of spatial 
short-term working memory as well as a measure of exploration. SA is dependent on an animal 
remembering which arms it has previously entered and is thought to be hippocampal-dependent 
(Douglas 1989; Hughes 2004). The involvement of the hippocampus is supported by studies 
demonstrating that bilateral or dorsal hippocampal lesions eliminate SA behaviour in rats and mice 
(Douglas 1989) (Ikonen et al 1999). Furthermore, drugs such as scopolamine, which are known to 
have amnestic effect on working memory, have been shown to impair SA in rodents (Beninger et al 
1986; Sarter et al 1988).   
 
In the present study in male 3xTgAD mice, SA memory was normal at 3 months of age but a 
memory deficit was observed at 5 and 12 months of age. These results match those observed in 
other male 3xTgAD mice which display deficits in SA memory at 6 months of age (Zhang et al 
2010). Female 3xTgAD mice have normal SA behaviour at 3 and 6 months but they then display 
deficits at 9-12 months of age (Carroll et al 2007). Several other studies have also reported a 
reduction in SA in other AD mouse models, with deficits apparent from 3 months of age (Holcomb 
et al 1998; Hsiao et al 1996; King & Arendash 2002). The SA test is also a measure of exploration; 
a normal mouse will use the spatial cues around the room to work out an escape route, whereas an 
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anxious or unmotivated mouse will move around less and not attempt escape. Previous work in 
3xTgAD mice has shown that no difference in the total number of moves are observed at 9-12 
months of age, when mice showed memory deficits in the Y-maze (Carroll et al 2007). In the 
present study, while activity was lower at 3 and 5 months of age, there was no significant difference 
at 12 months of age. These results also support the reduction in activity in the OF, observed in the 
present and previous studies in 3xTgAD mice (Billings et al 2005; Gimenez-Llort et al 2007).  
 
4.4.2.1. Y-maze SA test conclusions and future studies 
 
The results of the present study demonstrate that 3xTgAD mice show age-dependent deficits in 
spatial short-term working memory in the Y-maze SA test, confirming previous studies in 3xTgAD 
mice and in other models of AD, and also mirroring deficits in spatial short-term working memory 
observed in AD patients. Future studies could investigate what happens in mice after 12 months of 
age, when significant plaque pathology is present in our colony and examine the onset of SA 
deficits in female 3xTgAD mice.  
 
4.4.3. Morris water maze (MMW) memory task 
 
AD patients have deficits in spatial memory, including memory for spatial patterns (Sahakian et al 
1988), spatial locations (Adelstein et al 1992), spatial paired-associate learning (Swainson et al 
2001), object locations within a grid (Bucks & Willison 1997), route learning (Cherrier et al 2001; 
Kessels et al 2005) and spatial disorientation. Spatial disorientation is defined as a difficulty in 
orientating and navigating through surroundings and is common in AD (Barrash 1998; Cherrier et al 
2001; Henderson et al 1989). During early stages of the disease, AD patients display spatial 
disorientation in unfamiliar places and, as the disease progresses, disorientation in familiar places 
often occurs (Cherrier et al 2001).  
 
The MWM task is a relevant spatial memory test, in which mice must learn to use cues to navigate 
around a pool of cloudy water to find the location of a submerged platform over successive training 
days (submerged platform training). Twenty-four hours after the final training trial, the platform is 
removed and the percentage time spent in the target quadrant is assessed (probe trial). This is a 
test of both short and long-term spatial memory, which is dependent on the hippocampus (Morris et 
al 1982; Olton & Papas 1979). Studies have shown that lesions to the hippocampus result in a 
deficit in learning the location of the platform in the MWM task. In AD patients, deficits in spatial 
memory correlate with changes in hippocampal volume and pathology (Blackwell et al 2004; 
Kessels et al 2001; Kessels et al 2005; Rodriguez et al 2000). 
 
In the present study, prior to testing memory in the submerged platform trials, mice were subjected 
to flagged platform training. This is a very important test, as it determines if mice can see properly 
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and whether mice are able to learn how to use cues and swim towards them to escape onto the 
platform. It tests whether there are differences in swimming ability and the capability to learn the 
task between groups of mice. It is also used to minimise stress, as it teaches mice that there is an 
escape route and hence reduces stress during the subsequent submerged platform training. This 
part of the test does not involve memory, so no differences between 3xTgAD and control mice 
should be observed. If 3xTgAD mice displayed difficulty in flagged platform training it would make 
interpretation of any deficit in submerged platform training difficult. 3xTgAD mice, in this thesis 
study however, showed no problem in flagged platform learning, consistent with previous studies in 
3xTgAD mice (Clinton et al 2007; Zhang et al 2010).  
 
During submerged platform training, Non-Tg control mice showed significant improvement over 
training days at 3, 5 and 12 months of age, whereas 3xTgAD mice did not show any improvement, 
suggesting a learning deficit at all ages tested. There was, however, no difference in escape 
latency between Non-Tg control and 3xTgAD mice on individual training days at all ages. Previous 
studies have demonstrated that 3xTgAD mice have normal submerged platform training at 2 
months of age with memory deficits starting from 4-5 months of age (Billings et al 2005; Clinton et 
al 2007; Gimenez-Llort et al 2007; Nelson et al 2007; Zhang et al 2010). The reason why 3xTgAD 
mice, in the present study, did not show memory impairments in training on individual days, when 
compared to Non-Tg mice, is unknown. In the study by Billings and colleagues, 4-month-old 
3xTgAD mice showed no difference in submerged platform training, however when broken down 
on a trial-by-trial basis, 3xTgAD mice displayed significant deficits in memory retention between the 
first trial of the day and the last trial of the previous day (Billings et al 2005). When submerged 
platform training was broken down in the present study, no trial-by-trial differences were observed 
(data not shown). It was difficult to determine whether cohorts showed learning within a day, as the 
start position used in the present protocol was sometimes closer to the platform than on other 
occasions. In order to evaluate learning within submerged training days, future studies could 
randomise start positions for individual mice, however this is not possible with the current tracking 
software. During the probe test, 24 h after the final trial of submerged platform training, 3-month-old 
3xTgAD mice showed normal memory retention, whereas both 5 and 12-month-old mice displayed 
significant deficits in memory. These results agree with other studies, in which 3xTgAD mice have 
normal retention memory in MWM probes at 2 months of age, with onset of deficits occurring from 
4-6 months of age (Billings et al 2005; Clinton et al 2007; Zhang et al 2010). Similarly, other models 
of AD display age-dependent deficits in the MWM from 4 months of age (Chen et al 2000a; 
Holcomb et al 1999; Hsiao et al 1996; Westerman et al 2002). Swim paths were also assessed in 
Non-Tg and 3xTgAD mice. There was however variation in paths and platform search stragety 
between individual animals and it was not possible to break the probe down into time bins, 
therefore it was difficult to assess differences in detail.  
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4.4.3.1. MWM task conclusions and future studies 
 
Although there are no directly comparable tests in AD patients to the MWM, it is a relevant test of 
spatial reference memory. Memory deficits were detected in 3xTgAD mice in the MWM task, 
matching previous studies in 3xTgAD mice and other models of AD. Future studies could 
characterise spatial learning in the MWM in more detail, to further understand the deficits observed 
and to examine the onset of MWM deficits in female 3xTgAD mice. Future studies could also 
assess swim paths in more detail investigating search strategies of Non-Tg and 3xTgAD mice. The 
results of individual mice in the MWM could also be correlated with performance in other 
behavioural tests. 
 
4.4.4. Novel object recognition (NOR) memory test  
 
In screening for AD in humans, there are many tests to evaluate non-spatial visual memory. These 
tests are meant to screen for deficits in semantic and episodic memory function, thought to be 
dependent on intact medial temporal lobe function (Egerhazi et al 2007; Lee et al 2003). Both the 
perirhinal cortex and the hippocampus form part of the medial temporal lobe, which is known to be 
affected in human AD patients (Squire & Zola-Morgan 1991). In the pattern recognition memory 
task subjects are presented with a series of 12 visual patterns on a touch sensitive computer 
screen. Then 20 min after the recognition phase, the subject is required to pick out a pattern 
previously seen, versus a completely novel one (Egerhazi et al 2007; Owen et al 1995). In the 
delayed matching to sample task, the subject is shown a pattern for 4.5 s and is instructed to study 
it, then after a delay of 4 or 12 s the subject must select the previously presented pattern out of a 
selection of other very similar patterns (Lee et al 2003). The pattern recognition memory and 
delayed matching to sample tasks are both sensitive to damage in the medial temporal lobe 
(Egerhazi et al 2007; Lee et al 2003). 
 
The NOR test is a relevant test of non-spatial visual memory in rodents, similar to the pattern 
recognition and delayed matching to sample tests given to human AD patients. In the NOR test, 
mice are exposed to two identical objects and, after a set retention time, one of the objects is 
replaced with a novel one. The NOR test is considered a test of short-term memory that is free 
from reference memory (need for external cues), making it a non-spatial visual memory test that is 
based on the natural exploration of novelty in mice (Ennaceur 2010; Ennaceur & Delacour 1988; 
Ennaceur & Meliani 1992), which can be solved by either recall or familiarity. It is a useful test as it 
is not dependent on positive or negative reinforcement, such as food or electric shocks. The NOR 
test appears to be dependent on the perirhinal cortex in rodents (Ennaceur et al 1996), as lesions 
to the perirhinal cortex causes deficits in object recognition (Ennaceur et al 1996). 
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In the present study, 3xTgAD mice showed normal memory in the NOR test at 3 months of age but 
memory was impaired at 8 months of age. In accordance with the present results, previous studies 
have demonstrated that male 3xTgAD mice display normal memory at 2 and 6 months of age and 
a deficit at 9 and 15 months of age when the NOR test is performed with a 1.5 h and 24 h delay 
(Clinton et al 2007). More recently, male 3xTgAD mice exhibit deficits in a 24 h NOR test at 6 
months of age (Zhang et al 2010) matching onset of impairments in the NOR test in other models 
of AD (Dodart et al 1999).   
4.4.4.1. NOR test conclusions and future studies 
 
In the present study, 3xTgAD mice showed normal memory in the NOR test at 3 months of age and 
deficits at 8 months of age. These results are similar to previous work in 3xTgAD and other models 
of AD; this, together with similarities with some AD screening tests, makes this a useful memory 
test for 3xTgAD mice. Future studies could look at more inter-trial delays, such as 15 min, 30 min, 
4 h, 24 h and 5 d to evaluate short and long term non-spatial visual object memory in more detail. 
Future studies could also evaluate NOR in female mice, to investigate potential gender differences 
in non-spatial visual memory.  
 
4.4.5. Odour recognition (OR) task 
 
Impairment in olfactory discrimination is one of the earliest symptoms of AD in humans (Devanand 
et al 2000; Gilbert et al 2004; Tabert et al 2005). Furthermore, patients with MCI, who present with 
deficits in working memory together with deficits in olfactory recognition memory, are more likely to 
progress to AD within 2 years (Devanand et al 2000; Gilbert et al 2004). A commonly used test in 
AD is the Pennsylvania smell identification test, in which participants who are presented with an 
odour are then requested to identify the familiar odour amongst other ones not previously 
presented (Doty et al 1984). AD patients have been shown to have severe deficits in this task early 
during disease progression (Mesholam et al 1998).   
 
The OR test is a relevant test of short-term smell memory in mice, based on the natural exploration 
of novelty. At 3 months of age, 3xTgAD mice had a significant deficit in the OR, whereas Non-Tg 
control mice were able to complete the task. This test demonstrates for the first time that 3xTgAD 
mice display deficits in a simple smell memory task, at an age when memory impairment is not 
observed in any other memory task tested here. Thus, the OR test appears to be a sensitive test 
for detecting early changes in 3xTgAD mice. It is important to note that 3xTgAD mice were able to 
smell at this age, as they demonstrated an increased exploration of female urine over water (data 
not shown).  
 
No studies to date have investigated a smell memory in 3xTgAD mice, although limited studies 
have been performed in other mouse models of AD. APP mice were tested using the novel odour 
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span task, a non-spatial olfactory working memory task, in which mice are exposed to an 
increasing number of scents and are required to identify the novel odour (Young et al 2007). When 
given a 12 scent span test, 3-4-month-old APP mice are unimpaired, whereas when tested with 22 
scent span test, they display significant deficits. However, at 8 and 12 months of age, APP mice 
show significant deficits in both 12 and 22 odour span tests (Young et al 2008). Smell memory 
deficits have also been reported in other studies using APP mice at 6.5 - 8 months of age (Guerin 
et al 2009). In this latter study, the authors investigated the exploration time of mice in response to 
proprinonic acid versus no odour, where mice were food deprived and given food rewards for 
correct responses (Guerin et al 2009). More recently, APP mice were shown to have normal odour 
discrimination at 3-4 months of age while deficits were observed after 6 months of age (Wesson et 
al 2010). Changes in smell memory may be due to pathological changes in the brains of these 
mice, as degeneration or AD pathology have been observed in areas of the brain involved in smell 
perception/processing, such as the olfactory bulb, the locus coeruleus, the entorhinal cortex and 
the piriform cortex (Guerin et al 2009; Jacobsen et al 2006; Kawarabayashi et al 2001; Lehman et 
al 2003; Wesson et al 2010; Young et al 2008).  
 
Similarly, in AD patients, pathology starts in the perirhinal and entorhinal cortex and spreads out 
from the medial temporal lobe (Braak & Braak 1995; Slotnick 2001; Young et al 2008). A role for 
the amygdala in olfactory memory has also been suggested in both rodents and humans 
(Buchanan et al 2003). Although smell memory has never been assessed in 3xTgAD mice prior to 
this study, pathology has been noted in relevant brain regions, such as the olfactory bulb, the 
amygdala and the hippocampus which may explain deficits in OR test observed (Hamilton et al 
2010). 
 
4.4.5.1. OR test conclusions and future studies 
 
For the first time, the present study demonstrates that 3xTgAD mice displayed deficits in the OR 
test at 3 months of age. Interestingly the deficit in the OR test occurs at an age when 3xTgAD mice 
are unimpaired in the NOR or any other task. This fits in with olfactory discrimination being one of 
the earliest deficits in AD, making 3xTgAD mice an excellent model to assess smell memory. 
Deficits in OR, presented here, occur much earlier than reported in other mouse models of AD. 
Studies in Tg2576, using tasks such as the span task have observed deficits in smell memory from 
6 months of age, when deficits start to appear in other tasks, such as the MWM. Tests such as the 
olfactory span test used in Tg2576 mice have been proven sensitive to investigate smell memory, 
however these tasks require food restriction or rewards. We have previously demonstrated that 
3xTgAD mice are more motivated for food rewards than Non-Tg mice in behavioural tasks (Knight 
2007), making odour span tasks not appropriate in this model. Other studies have commented on 
the potential of confounding factors in traditional odour discrimination tasks (Linster et al 2002; 
Wesson et al 2008; Wesson et al 2010). Future studies could evaluate OR at more time points in 
both male and female 3xTgAD mice, examining earlier ages to determine whether 3xTgAD mice 
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are born with OR deficits and whether deficits are prolonged. Onset of deficits could also be 
correlated to pathology.  
 
4.4.6. 129SV and C57BL/J6 strains 
 
Behaviour and memory were also assessed in 129SV and C57BL/J6 mice (the background strains 
for the 3xTgAD mice) and no difference in OF behaviour or SA memory was observed between 
strains at 3-18 months of age. There was a difference in the total number of moves at 8 and 18 
months of age in the Y-maze SA test, however overall it appears that differences in behaviour and 
memory observed here in 3xTgAD mice were unlikely to be due to a genetic drift towards one of 
the background strains. 
 
4.5. Conclusion 
 
During the progression of AD, patients display changes in BPSD and memory deficits including 
those seen in olfactory discrimination, spatial memory and visual memory. The second aim of this 
PhD study was to characterise behaviour and memory deficits in male Non-Tg control and 3xTgAD 
mice, in a battery of tests over several ages. The OF, SA, MWM, NOR and OR tests were chosen 
as they are not reliant on food reinforcers and because they reveal deficits similar to those seen in 
human AD patients. Using these tests, 3xTgAD mice showed changes in BPSD-like OF behaviour 
from 3 months of age, earlier than previously reported. Memory impairments are first detected in 
3xTgAD mice as deficits in smell memory, which mirror very early deficits in olfactory discrimination 
seen in AD patients. Deficits in spatial memory were then observed in both the SA and MWM tests 
from 5 months of age. Finally deficits in non-spatial visual object memory were observed in 
3xTgAD mice in the NOR tests at 8 months of age. These results demonstrate that 3xTgAD mice 
show age-dependent changes in BPSD-like behaviour and memory deficits that are consistent with 
previous work in 3xTgAD mice, other models of AD and in AD patients. 3xTgAD mice therefore 
represent a relevant model to evaluate BPSD-like behaviour and memory in response to 
environmental changes.  
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5.1. Introduction and objectives 
 
Emerging evidence suggests that both obesity (Fitzpatrick et al 2009; Rosengren et al 2005; 
Whitmer et al 2005; Whitmer et al 2008) and the consumption of a high fat (HF) diet are risk factors 
for AD (Holden 1999; Luchsinger & Mayeux 2004; Luchsinger et al 2002). Furthermore, an HF diet 
can impair memory or increase pathology in single or double transgenic models of AD (George et 
al 2004; Ho et al 2004; Kohjima et al 2010; Levin-Allerhand et al 2002; Pedrini et al 2009; Refolo et 
al 2000; Shie et al 2002). The final aim of this PhD, therefore, was to examine the effect of an HF 
diet on energy balance, as well as the onset and progression of behaviour and memory deficits in 
3xTgAD mice. In order to evaluate whether altering energy balance affects the onset and 
progression of AD, cohorts of 3xTgAD and age-matched Non-Tg control mice were placed on an 
HF or standard chow diet. Body weight, food intake, metabolic rate and behaviour were examined 
in separate cohorts of 3xTgAD and Non-Tg control mice at 3-4, 7-8, 11-12 and 15-16 months of 
age.  
 
5.2. Materials and methods 
5.2.1. Experimental design 
  
5.2.1.1. Energy balance 
 
Cohorts of male 3xTgAD and age-matched Non-Tg mice were fed a chow diet between 4-8 weeks 
of age. At 8 weeks of age mice were kept on chow or put on an HF diet (see Table 5.1.). Body 
weight and food intake were measured from weaning until 3-4, 7-8, 11-12 and 15-16 months of age 
(see Method 2.2.1. - 2.2.2.). 
 
Table 5.1. Experimental cohorts for energy balance assessment (high fat; HF) 
 
Cohort Monitoring  
period 
Non-Tg/ 
Chow diet 
Non-Tg/ 
HF diet 
3xTgAD/ 
Chow diet 
3xTgAD/ 
HF diet 
1 4 weeks - 3-4 months n = 11 n = 12 n = 10 n = 10 
2 4 weeks - 7-8 months n = 12 n = 11 n = 10 n = 10 
3 4 weeks -11-12 months n = 10 n = 10 n = 10 n = 11 
4 4 weeks -15-16 months n = 8 n = 9 n =10 n = 11 
 
 
 
At the end of each period, the mice (n = 8 for each group) were then housed individually in CLAMS 
calorimetry cages for 4 days to examine metabolic rate (see Method 2.2.3.). Body weight, caloric 
intake and water intake were also monitored (see Method 2.2.3.) and 24 h average calculated. All 
mice were then culled (see Method 2.4.) and epididymal fat pad was weighed. 
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5.2.1.2. Behaviour and memory 
 
To evaluate the effect of a high fat diet on behaviour and memory in 3xTgAD mice, cohorts (see 
Table 5.2.) were tested in the Open-field (OF) (see Method 2.3.1.), Y-maze spontaneous 
alternation (SA) (see Method 2.3.2.), novel object recognition (NOR) (see Method 2.3.4.), odour 
recognition (OR) (see Method 2.3.3.) and Morris water maze (MWM) (see Method 2.3.5.) tests at 
3-4, 7-8, 11-12 and 15-16 months of age. As results from the behaviour and memory 
characterisation study (see Chapter 4) showed that the percentage of time moving and number of 
cell entries within the OF were both an indicator of activity and showed the same results, only the 
number of cell entries made within the OF were assessed in this study. During the MWM task, mice 
were given 2 d of flagged platform training and 8 d of submerged platform training. As swim paths 
during the probe test were difficult to interpret with the current software they were not assessed in 
this study. These tests were performed before measurement of metabolic rate in CLAMS (see 
5.2.1.1).  
 
Table 5.2. Experimental cohorts for behavioural evaluation (high fat; HF) 
 
Cohort Age Non-Tg/ 
Chow diet 
Non-Tg/ 
HF diet 
3xTgAD/ 
Chow diet 
3xTgAD/ 
HF diet 
1 3-4 months n = 11 n = 12 n = 10 n = 10 
2 7-8 months n = 11 n = 11 n = 10 n = 10 
3 11-12 months n = 10 n = 10 n = 9 n = 10 
4 15-16 months n = 8 n = 6 n = 8 n = 10 
 
 
5.2.2. Statistical analysis 
 
Evaluation of longitudinal body weight between cohorts was examined via three-way repeated 
measures analysis of variance (ANOVA) with Scheffe post-hoc analysis using Statview 5 (SAS 
Institute, Cary, NC, USA). Statistical differences between 24 h average body weight, food (caloric) 
intake, and water intake, and 12 h oxygen consumption (VO2), carbon dioxide production (VCO2), 
respiratory quotient (RQ), energy balance over the 4 d in CLAMS calorimetry cages, OF behaviour 
and SA between cohorts were examined using two-way ANOVA with Tukey’s post-hoc analysis 
using JMP (SAS Institute, Cary, NC, USA). Evaluation of NOR and OR was examined using 
Student’s t-tests (Graphpad, San Diego, CA, USA). MWM training was assessed between cohorts 
on individual training days and compared within cohorts between the first day of training and 
successive days of training to assess improvement over time via three-way repeated measures 
ANOVAs with Scheffe post-hoc analysis using Statview 5 (SAS Institute, Cary, NC, USA). The 
probe test was analysed using a two-way ANOVA with Tukey’s post-hoc analysis using JMP (SAS 
Institute, Cary, NC, USA). The epididymal fat pad weight was assessed between cohorts using a 
two-way ANOVA with Tukey’s post-hoc analysis using JMP (SAS Institute, Cary, NC, USA). 
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5.3. Results 
5.3.1. Effect of an HF diet on energy balance in 3xTgAD mice 
5.3.1.1. Effect of an HF diet on body weight in 3xTgAD mice 
 
Cohort 1: weaning to 3-4 months of age 
 
Before changing diets, both groups of 3xTgAD mice weighed more than their respective Non-Tg 
controls on a chow diet (weeks 6-8, p < 0.05 - p < 0.001, Figure 5.1.A). The cohort of 3xTgAD mice 
that were kept on a chow diet continued to weigh more than the Non-Tg chow fed control mice up 
to 13 weeks of age (p < 0.01 - p < 0.001). On an HF diet, the Non-Tg mice weighed more than the 
Non-Tg mice on a chow diet (weeks 11-13; p < 0.01- p < 0.001) reaching up to a similar body 
weight as 3xTgAD on a chow diet. In contrast, 3xTgAD mice on an HF diet did not weigh more than 
the 3xTgAD mice on a chow diet for the entire monitoring period. The 3xTgAD mice on an HF diet 
weighed more than Non-Tg mice on an HF diet only at weeks 10 and 11 (p < 0.05 – p < 0.01). 
 
Cohort 2: weaning to 7-8 months of age 
 
Both groups of the 3xTgAD mice weighed more than their respective Non-Tg controls prior to 
switching diets (weeks 5-8; p < 0.05 - p < 0.001, Figure 5.1.B). The 3xTgAD mice that were 
maintained on a chow diet were significantly heavier compared to the Non-Tg controls (on chow) 
up to 4.5 months of age (p < 0.05 - p < 0.001), after which there was no significant difference in 
body weight between the groups. In contrast, there was no significant difference in body weight 
between the 3xTgAD and the Non-Tg mice whilst they were maintained on an HF diet. However, 
3xTgAD and Non-Tg mice on an HF diet weighed more than their respective chow fed controls 
(from 3 and 4 months of age for Non-Tg and 3xTgAD mice respectively; p < 0.05 – p <0.001).  
 
Cohort 3: weaning to 11-12 months of age 
 
Prior to changing diets, both groups of 3xTgAD mice weighed more than their respective Non-Tg 
controls on a chow diet (weeks 5-8, p < 0.05 - p < 0.01, Figure 5.1.C). The cohort of 3xTgAD mice 
kept on a chow diet weighed more than Non-Tg mice on a chow diet up to 4.5 months of age (p < 
0.05 - p < 0.001), after which the body weight was not significantly different between the groups. 
On an HF diet the Non-Tg mice weighed more than the 3xTgAD mice between 4.5 and 8 months of 
age (p < 0.05 - p < 0.001). However, both HF fed 3xTgAD and Non-Tg mice weighed more than 
their respective controls maintained on a chow diet (from 2.5 and 4.5 months of age for Non-Tg 
and 3xTgAD mice respectively; p < 0.05 – p <0.001). 
 
 
Chapter 5                                                                              Effect of a high fat diet on 3xTgAD mice 
 
93 
 
Cohort 4:  weaning to 15-16 months of age 
 
Both groups of 3xTgAD weighed more than their respective Non-Tg controls on a chow diet prior to 
changing diets (weeks 5-8, p < 0.001, Figure 5.1.D). 3xTgAD mice maintained on a chow diet 
weighed more than Non-Tg mice on a chow diet up to 4.5 months of age (p < 0.05 - p < 0.001), 
after which there was no significant difference in body weight between the groups. In contrast, 
body weight was not significantly different between the 3xTgAD and Non-Tg mice on an HF diet. 
However, when maintained on an HF diet, the 3xTgAD and Non-Tg mice weighed more than their 
respective chow fed controls (from 2 and 4.5 months of age for Non-Tg and 3xTgAD mice 
respectively; p < 0.05 – p <0.001). 
 
Figure 5.1. Effect of a high fat (HF) diet on body weight in 3xTgAD mice at 3-4, 7-8, 11-12 
and 15-16 months of age 
 
Cohorts of male 3xTgAD and age-matched Non-Tg control mice were fed a chow diet between 
4-8 weeks of age. At 8 weeks of age cohorts were either kept on chow (Non-Tg; n = 8-12 and 
3xTgAD; n = 10) or placed on an HF diet (Non-Tg; n = 9-12 and 3xTgAD; n = 10-11). All 
cohorts had weekly body weight measured. Repeated measures analysis of variance (ANOVA) 
with Scheffe post-hoc analysis. *p < 0.05, **p < 0.01, ***p < 0.001 3xTgAD/chow versus Non-
Tg/chow. &p < 0.05, &&p < 0.01, &&&p < 0.001 3xTgAD/HF versus Non-Tg/HF. #p < 0.05, ##p 
< 0.01, ###p < 0.001 Non-Tg/HF diet versus Non-Tg/chow. $p < 0.05, $$p < 0.01, $$$p < 
0.001 3xTgAD/HF versus 3xTgAD/chow. Data are mean ± SEM.  
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5.3.1.2. Effect of an HF diet on energy balance and metabolic rate in 3-4, 7-8, 11-12 and 15-
16-month-old 3xTgAD mice in CLAMS metabolic cages 
 
5.3.1.2.1. Effect of an HF diet on body weight, caloric intake and water intake in 3-4-month-
old 3xTgAD mice in CLAMS metabolic cages 
 
Two-way ANOVA examining body weight (Figure 5.2.A) revealed that there was an effect of 
genotype (F3,28 = 23.57, p < 0.001) and diet (F3,28 = 14.99, p < 0.001) but no interaction (F3,28 = 
2.29, p > 0.05). Two-way ANOVA examining caloric intake (Figure 5.2.B) revealed that there was 
an effect of genotype (F3,28 = 4.48, p < 0.05) and diet (F3,28 = 8.81, p < 0.001) but no interaction 
(F3,28 = 1.38, p > 0.05).Two-way ANOVA examining water intake (Figure 5.2.C) revealed that there 
was an effect of genotype (F3,28 = 7.9, p < 0.01) but no effect of diet (F3,28 = 0.95, p > 0.05) nor any 
interaction (F3,28 = 1.59, p > 0.05).  
 
Posthoc analysis revealed that when housed individually in CLAMS calorimetry cages at 3-4 
months of age, the 3xTgAD mice on a chow diet showed an increased body weight (14%; p < 
0.001, Figure 5.2.A), and mean 24h water intake (54%; p < 0.05 Figure 5.2.C) but no significant 
difference in mean 24 h caloric intake (Figure 5.2.B) than the Non-Tg mice on a chow diet. The 
Non-Tg mice on an HF diet weighed more than the Non-Tg mice on a chow diet (12%; p < 0.01) 
and consumed more calories (36%; p < 0.05), whereas an HF diet had no effect on body weight, 
calorie intake, or water intake in the 3xTgAD when compared to the 3xTgAD mice on a chow diet. 
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Figure 5.2. Effect of a high fat (HF) diet on body weight, caloric intake and water intake in 
individually housed 3-4-month-old 3xTgAD mice in Comprehensive Laboratory Animal 
Monitoring System (CLAMS) cages 
 
Between 4-8 weeks of age cohorts of male triple transgenic 3xTgAD and Non-Tg control mice 
were fed a chow diet, then at 8 weeks the mice were either kept on chow or placed on an HF 
diet (n = 8 /group). At 3-4 months of age body weight (A), caloric intake (B) and water intake (C) 
were monitored in individually housed mice over 4 days in CLAMS calorimetry cages. Data are 
24h means ± SEM. Two-way analysis of variance (ANOVA) with Tukey’s post-hoc analysis, *p 
< 0.05, ***p < 0.001 3xTgAD/chow versus Non-Tg/chow, #p < 0.05, ##p < 0.01 Non-Tg/HF 
versus Non-Tg/chow.  
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5.3.1.2.2. Effect of an HF diet on metabolic rate in 3xTgAD mice at 3-4 months of age 
 
At 3-4 months of age, indirect calorimetry to measure metabolic rate revealed that both the male 
3xTgAD and Non-Tg control mice fed a chow diet displayed similar 24 h rhythms in VO2 
consumption (Figure 5.3.A), VCO2 production (Figure 5.3.B) and RQ (Figure 5.3.C). VO2, VCO2 and 
RQ levels were lowest during the light, largely inactive, phase of the day and highest during the 
dark, active phase. On an HF diet, both the 3xTgAD and the Non-Tg mice displayed very similar 24 
h rhythms in VO2 consumption (Figure 5.3.A), weak rhythms in VCO2 production (Figure 5.3.B) and 
no rhythm in RQ (Figure 5.3.C) when compared to respective chow-fed controls. 
 
Two-way ANOVA examining light phase VO2  (Figure 5.3.D) revealed that there was an effect of 
diet (F3,28 = 4.92, p < 0.05) but no effect of genotype (F3,28 = 0.26, p > 0.05) nor any interaction 
(F3,28 = 3.32, p > 0.05). Two-way ANOVA examining dark phase VO2 (Figure 5.3.G) revealed that 
there was an effect of diet (F3,28 = 38.88, p < 0.001) but no effect of genotype (F3,28 = 0.02, p > 
0.05) nor any interaction (F3,28 = 2.73, p > 0.05).Two-way ANOVA examining light phase VCO2 
(Figure 5.3.E) revealed that there was an effect of diet (F3,28 = 48.14, p < 0.001) but no effect of 
genotype (F3,28 = 0.45, p > 0.05) nor any interaction (F3,28 = 3.36, p > 0.05). Two-way ANOVA 
examining dark phase VCO2 (Figure 5.3.H) revealed that there was an effect of diet (F3,28 = 143.4, 
p < 0.001) but no effect of genotype (F3,28 = 0.155, p > 0.05) yet there was an interaction between 
diet and genotype (F3,28 = 4.55, p < 0.05).Two-way ANOVA examining light phase RQ (Figure 
5.3.F) revealed that there was an effect of diet (F3,28 = 308.5, p < 0.001) but no effect of genotype 
(F3,28 = 1.02, p > 0.05) nor any interaction (F3,28 = 0.18, p > 0.05). Two-way ANOVA examining dark 
phase RQ (Figure 5.3.I) revealed that there was an effect of diet (F3,28 = 981.2, p < 0.001) but no 
effect of genotype (F3,28 = 1.4, p > 0.05) yet there was an interaction between diet and genotype 
(F3,28 = 9.09, p < 0.001). 
 
Posthoc analysis revealed that during the dark phase, the mean 12 h RQ (3%; p < 0.05, Figure 
5.3.I) was lower in the 3xTgAD mice than Non-Tg mice fed a chow diet, but there was no difference 
in any other parameter measured. Compared to a chow diet, the 3xTgAD mice fed an HF diet had 
lower mean 12 h VCO2 (18%; p < 0.01, Figure 5.3.E) and lower RQ (14%; p < 0.001, Figure 5.3.F) 
during the light phase and lower VO2 (16%; p < 0.05, Figure 5.3.G), CO2 (32%; p < 0.001, Figure 
5.3.H) and RQ (21%; p < 0.001, Figure 5.3.I) during the dark phase. Compared to a chow diet, the 
Non-Tg mice fed an HF diet displayed lower mean 12 h VO2 (15% and 26%; p < 0.05 and p< 0.001, 
Figure 5.3.D-G), VCO2 (31% and 42%; p < 0.001, Figure 5.3.E-H) and RQ (15% and 24%; p < 
0.001, Figure 5.3.F-I) during both light and dark phases. During the metabolic monitoring period, all 
cohorts of the mice were in positive energy balance. All cohorts exhibited a similar degree of 
positive energy balance (3xTgAD chow, 4.6 ± 0.7 kcal/day, 3xTgAD HF, 5.7 ± 0.9 kcal/day) except 
that the Non-Tg mice on an HF diet were in more positive balance than on a chow diet (Non-Tg 
chow, 2.6 ± 0.7 kcal/day versus Non-Tg HF, 6.2 ± 1.0 kcal/day, p < 0.05).  
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Figure 5.3.  Effect of a high fat (HF) diet on metabolic rate in 3-4-month-old 3xTgAD mice 
 
Between 4-8 weeks of age, cohorts of male triple transgenic 3xTgAD and Non-Tg control mice 
were fed a chow diet, then at 8 weeks the mice were either kept on chow or placed on an HF 
diet. At 3-4 months of age cohorts (n = 8 /group) of individually housed mice were placed in 
Comprehensive Lab Animal Monitoring System (CLAMS) calorimetry cages to examine 
metabolic rate over four days. Rhythms in VO2 (A) and VCO2 (B) and RQ (C), mean 12 h light 
phase VO2 (D), VCO2 (E) and RQ (F) and 12 h mean dark phase VO2 (G), VCO2 (H) and RQ (I) 
were assessed.  Data are 12h means ± SEM. Two-way analysis of variance (ANOVA) with 
Tukey’s post-hoc analysis, *p < 0.05 3xTgAD/chow versus Non-Tg/chow, #p < 0.05, ##p < 0.01 
and ###p < 0.001 3xTgAD/HF versus 3xTgAD/chow or Non-Tg/HF versus Non-Tg/chow. 
(A,B,C), white bars represent the light, inactive phase of the day, and black bars represent the 
dark active phase.  
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5.3.1.2.3. Effect of an HF diet on body weight, caloric intake and water intake of 7-8-month-
old 3xTgAD mice in CLAMS metabolic cages 
 
Two-way ANOVA examining body weight (Figure 5.4.A) revealed that there was no effect of 
genotype (F3,28 = 3.36, p > 0.05) an effect of diet (F3,28 = 67.27, p < 0.001) but no interaction (F3,28 = 
0.74, p > 0.05). Two-way ANOVA examining caloric intake (Figure 5.4.B) revealed that there was 
an effect of genotype (F3,28 = 6.89, p < 0.05) and diet (F3,28 = 23.7, p < 0.001) but no interaction 
(F3,28 = 0.03, p > 0.05).Two-way ANOVA examining water intake (Figure 5.4.C) revealed that there 
was an effect of genotype (F3,28 = 6.37, p < 0.05) and diet (F3,28 = 48.17, p < 0.001) but no 
interaction (F3,28 = 1.15, p > 0.05).  
 
Posthoc analysis revealed that when housed individually in CLAMS calorimetry cages at 7-8 
months of age, the Non-Tg and the 3xTgAD mice on a HF diet weighed more (55% and 38%; p < 
0.001, Figure 5.4.A), ate more calories  (48% and 35%; p < 0.01 and p < 0.05, Figure 5.4.B) and 
drank less water (44% and 47%; p < 0.001, Figure 5.4.C) than their respective controls on a chow 
diet. There was no difference in body weight, caloric intake and water intake between the 3xTgAD 
and the Non-Tg mice on either diet. 
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Figure 5.4. Effect of a high fat (HF) diet on body weight, caloric intake and water intake in 
individually housed 7-8-month-old 3xTgAD mice in Comprehensive Laboratory Animal 
Monitoring System (CLAMS) cages  
 
Between 4-8 weeks of age, cohorts of male triple transgenic 3xTgAD and Non-Tg control mice 
were fed a chow diet, then at 8 weeks the mice were either kept on chow or placed on an HF 
diet (n = 8 /group). At 7-8 months of age, body weight (A), caloric intake (B) and water intake 
(C) were monitored in individually housed mice over four days in CLAMS calorimetry cages. 
Data are 24 h means ± SEM. Two-way analysis of variance (ANOVA) with Tukey’s post-hoc 
analysis, #p<0.05, ##p < 0.01, ###p < 0.001 3xTgAD/HF versus 3xTgAD/chow or Non-Tg/HF 
versus Non-Tg/chow. 
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5.3.1.2.4. Effect of an HF diet on metabolic rate in 3xTgAD mice at 7-8 months of age 
 
At 7-8 months of age, indirect calorimetry to measure metabolic rate revealed that male 3xTgAD 
and Non-Tg mice fed a chow diet displayed similar 24 h rhythms in VO2 consumption (Figure 
5.5.A), VCO2 production (Figure 5.5.B) and RQ (Figure 5.5.C). VO2, VCO2 and RQ levels were 
lowest during the light, largely inactive phase, of the day and highest during the dark, active phase. 
On an HF diet, 3xTgAD and Non-Tg mice displayed similar 24 h rhythms in VO2 consumption 
(Figure 5.5.A), weak rhythms in VCO2 production (Figure 5.5.B) and no rhythm in RQ (Figure 5.5.C) 
when compared to their respective controls on a chow diet. 
 
Two-way ANOVA examining light phase VO2 (Figure 5.5.D) revealed that there was an effect of 
diet (F3,28 = 13.05, p < 0.01) but no effect of genotype (F3,28 = 0.2, p > 0.05) nor any interaction 
(F3,28 = 3.95, p > 0.05). Two-way ANOVA examining dark phase VO2 (Figure 5.5.G) revealed that 
there was an effect of diet (F3,28 = 15.01, p < 0.001) but no effect of genotype (F3,28 = 0.11, p > 
0.05) nor any interaction (F3,28 = 2.27, p > 0.05).Two-way ANOVA examining light phase VCO2 
(Figure 5.5.E) revealed that there was an effect of diet (F3,28 = 44.84, p < 0.001) but no effect of 
genotype (F3,28 = 0.81, p > 0.05) nor any interaction (F3,28 = 4.83, p > 0.05). Two-way ANOVA 
examining dark phase VCO2 (Figure 5.5.H) revealed that there was an effect of diet (F3,28 = 70.35, 
p < 0.001) but no effect of genotype (F3,28 = 0.71, p > 0.05) yet there was an interaction between 
diet and genotype (F3,28 = 4.69, p < 0.05). Two-way ANOVA examining light phase RQ (Figure 
5.5.F) revealed that there was an effect of diet (F3,28 = 128.3, p < 0.001) but no effect of genotype 
(F3,28 = 0.24, p > 0.05) nor any interaction (F3,28 = 0.69, p > 0.05). Two-way ANOVA examining dark 
phase RQ (Figure 5.5.I) revealed that there was an effect of diet (F3,28 = 253.8, p < 0.001) but no 
effect of genotype (F3,28 = 1.18, p > 0.05) nor any interaction (F3,28 = 0.63, p > 0.05). 
 
Posthoc analysis revealed that there was no difference in mean 12 h light or dark VO2, VCO2 and 
RQ between the Non-Tg and the 3xTgAD mice on a chow diet (Figure 5.5.D-I). Compared to a 
chow diet, 3xTgAD mice fed an HF diet displayed lower mean 12 h VCO2  (18% and 23%; p < 0.01 
and p < 0.001, Figure 5.5.E & H) and RQ (16% and 19%; p < 0.001, Figure 5.5. F & I) during the 
light and dark phases. However, in addition to a reduction in 12 h VCO2  (32% and 36%; p < 0.001, 
Figure 5.3.E-H) and RQ (14% and 21%; p < 0.001, Figure 5.3.F-I), the Non-Tg mice fed an HF diet 
also had lower VO2  (19% and 7%; p < 0.01, Figure 5.5.D & G) compared to chow-fed Non-Tg 
mice. During the metabolic monitoring period, all cohorts of mice exhibited a similar degree of 
positive energy balance (Non-Tg chow, 6.5 ± 1.3 kcal/day, Non-Tg HF, 12.4 ± 2.3 kcal/day, 
3xTgAD chow, 10.0 ± 1.6 kcal/day and 3xTgAD HF, 15.9 ± 1.5 kcal/day, p > 0.05). 
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Figure 5.5.  Effect of a high fat (HF) diet on metabolic rate in 7-8-month-old 3xTgAD mice 
 
Between 4-8 weeks of age cohorts of male triple transgenic 3xTgAD and Non-Tg control mice 
were fed a chow diet, then at 8 weeks the mice were either kept on chow or placed on an HF 
diet. At 7-8 months of age cohorts (n = 8 /group) were placed in Comprehensive Lab Animal 
Monitoring System (CLAMS) calorimetry cages to examine metabolic rate. Rhythms in VO2 (A) 
and VCO2 (B) and RQ (C), mean 12 h light phase VO2 (D), VCO2 (E) and RQ (F) and 12 h 
mean dark phase VO2 (G), VCO2 (H) and RQ (I) were assessed.  Data are 12 h means ± SEM. 
Two-way analysis of variance (ANOVA) with Tukey’s post-hoc analysis, ##p < 0.01 and ###p < 
0.001 3xTgAD/HF versus 3xTgAD/chow or Non-Tg/HF versus Non-Tg/chow. (A, B, C), white 
bars represent the light, inactive phase of the day, and black bars represent the dark active 
phase.  
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5.3.1.2.5. Effect of an HF diet on body weight, caloric intake and water intake of 11-12-
month-old 3xTgAD mice individually housed in CLAMS metabolic cages 
 
Two-way ANOVA examining body weight (Figure 5.6.A) revealed that there was no effect of 
genotype (F3,28 = 1.68, p > 0.05), an effect of diet (F3,28 = 123.7, p < 0.001) but no interaction (F3,28 
= 0.04, p > 0.05). Two-way ANOVA examining caloric intake (Figure 5.6.B) revealed that there was 
no effect of genotype (F3,28 = 0.42, p > 0.05), an effect of diet (F3,28 = 10.26, p < 0.001) but no 
interaction (F3,28 = 0.15, p > 0.05).Two-way ANOVA examining water intake (Figure 5.6.C) revealed 
that there was an effect of genotype (F3,28 = 9.02, p < 0.01) and diet (F3,28 = 16.31, p < 0.001) but 
no interaction (F3,28 = 1.39, p > 0.05).  
 
Posthoc analysis revealed when housed individually in CLAMS calorimetry cages at 11-12 months 
the 3xTgAD mice on a chow diet drank more (31%; p < 0.05 Figure 5.6.C) than the Non-Tg on a 
chow diet, but no difference in body weight and caloric intake were observed. On an HF diet, both 
the Non-Tg and 3xTgAD weighed more (74% and 72%; p < 0.001, Figure 5.6.A) yet displayed no 
difference in caloric intake (Figure 5.6.B) than their respective controls on a chow diet. The 3xTgAD 
mice on an HF drank less than the 3xTgAD mice on a chow diet (40%; p < 0.01 Figure 5.6.C).  
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Figure 5.6. Effect of a high fat (HF) diet on body weight, caloric intake and water intake in 
11-12-month-old 3xTgAD mice individually housed in CLAMS metabolic cages 
 
Between 4-8 weeks of age, cohorts of male triple transgenic 3xTgAD and Non-Tg mice were 
fed a chow diet, then at 8 weeks the mice were either kept on chow or placed on an HF diet (n 
= 8 /group). At 11-12 months of age, body weight (A), caloric intake (B) and water intake (C) 
were monitored in individually housed mice over four days in Comprehensive Laboratory 
Animal Monitoring System (CLAMS) calorimetry cages.  Data are 24 h means ± SEM. Two-way 
analysis of variance (ANOVA) with Tukey’s post-hoc analysis, *p < 0.05 3xTgAD/chow versus 
Non-Tg/chow, ##p < 0.01, ###p < 0.001 3xTgAD/HF versus 3xTgAD/chow or Non-Tg/HF 
versus Non-Tg/chow.  
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5.3.1.2.6. Effect of an HF diet on metabolic rate in 3xTgAD mice at 11-12 months of age 
 
At 11-12 months of age, indirect calorimetry to measure metabolic rate revealed that both the male 
3xTgAD and Non-Tg mice fed a chow diet displayed similar 24 h rhythms in VO2 consumption 
(Figure 5.7.A), VCO2 production (Figure 5.7.B) and RQ (Figure 5.7.C). VO2, VCO2 and RQ levels 
were lowest during the light, largely inactive phase of the day and highest during the dark, active 
phase. On an HF diet, both the 3xTgAD and Non-Tg mice displayed vey similar 24 h rhythms in 
VO2 consumption (Figure 5.7.A), weak rhythms in VCO2 production (Figure 5.7.B) and no rhythm in 
RQ (Figure 5.7.C) when compared to their respective chow-fed controls. 
 
Two-way ANOVA examining light phase VO2 (Figure 5.7.D) revealed that there was an effect of 
diet (F3,28 = 89.69, p < 0.001) but no effect of genotype (F3,28 = 0.05, p > 0.05) nor any interaction 
(F3,28 = 0.89, p > 0.05). Two-way ANOVA examining dark phase VO2 (Figure 5.7.G) revealed that 
there was an effect of diet (F3,28 = 94.79, p < 0.001) but no effect of genotype (F3,28 = 0.5, p > 0.05) 
nor any interaction (F3,28 = 0.37, p > 0.05).Two-way ANOVA examining light phase VCO2 (Figure 
5.7.E) revealed that there was an effect of diet (F3,28 = 125.05, p < 0.001) but no effect of genotype 
(F3,28 = 2.15, p > 0.05) nor any interaction (F3,28 = 3.77, p > 0.05). Two-way ANOVA examining dark 
phase VCO2 (Figure 5.7.H) revealed that there was an effect of diet (F3,28 = 151.5, p < 0.001) but 
no effect of genotype (F3,28 = 0.003, p > 0.05) nor any interaction (F3,28 = 0.76, p > 0.05). Two-way 
ANOVA examining light phase RQ (Figure 5.7.F) revealed that there was an effect of diet (F3,28 = 
84.79, p < 0.001) and genotype (F3,28 = 8.73, p < 0.01) and a significant interaction (F3,28 = 7.34, p 
< 0.05). Two-way ANOVA examining dark phase RQ (Figure 5.7.I) revealed that there was an 
effect of diet (F3,28 = 250.85, p < 0.001) but no effect of genotype (F3,28 = 2.06, p > 0.05) nor any 
interaction (F3,28 = 1.65, p > 0.05). 
 
Posthoc analysis revealed that there was no difference in mean 12 h light or dark VO2, VCO2 and 
RQ between the Non-Tg and 3xTgAD mice on a chow diet (Figure 5.7.D-I). Mean 12 h VO2 (p < 
0.001, Figure 5.7.D & G), VCO2 (p < 0.001 Figure 5.7.E & H) and RQ (p < 0.001 Figure 5.7.F & I) 
were lower during the light and dark phases in both HF fed 3xTgAD and Non-Tg mice, when 
compared to respective controls on a chow diet. During the metabolic monitoring period, all cohorts 
of mice exhibited a similar degree of positive energy balance (Non-Tg chow, 6.4 ± 1.0 kcal/day, 
Non-Tg HF, 12.2 ± 2.8 kcal/day, 3xTgAD chow, 7.9 ± 0.8 kcal/day and 3xTgAD HF, 11.5 ± 2.8 
kcal/day, p > 0.05). 
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Figure 5.7.  Effect of a high fat (HF) diet on metabolic rate in 11-12-month-old 3xTgAD 
mice 
 
Between 4-8 weeks of age cohorts of male triple transgenic 3xTgAD and Non-Tg control mice 
were fed a chow diet, then at 8 weeks the mice were either kept on chow or placed on an HF 
diet. At 11-12 months of age cohorts (Non-Tg/chow; n = 8, Non-Tg/HF; n = 4, 3xTgAD/chow; n 
= 7 and 3xTgAD/HF; n = 8) were placed in Comprehensive Lab Animal Monitoring System 
(CLAMS) calorimetry cages for four days to examine metabolic rate. Rhythms in VO2 (A) and 
VCO2 (B) and RQ (C), mean 12 h light phase VO2 (D), VCO2 (E) and RQ (F) and 12 h mean 
dark phase VO2 (G), VCO2 (H) and RQ (I) were assessed.  Data are 12 h means ± SEM. Two-
way analysis of variance (ANOVA) with Tukey’s post-hoc analysis, ###p < 0.001 3xTgAD/HF 
versus 3xTgAD/chow or Non-Tg/HF versus Non-Tg/chow. (A, B, C), white bars represent the 
light, inactive phase of the day, and black bars represent the dark active phase.  
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5.3.1.2.7.  Effect of an HF diet on body weight, caloric intake and water intake in 15-16-
months-old 3xTgAD mice individually housed in CLAMS metabolic cages 
 
Two-way ANOVA examining body weight (Figure 5.8.A) revealed that there was no effect of 
genotype (F3,23 = 0.24, p > 0.05), an effect of diet (F3,23 = 72.87, p < 0.001) but no interaction (F3,23 
= 0.43, p > 0.05). Two-way ANOVA examining caloric intake (Figure 5.8.B) revealed that there was 
no effect of genotype (F3,23 = 1.61, p < 0.05), an effect on diet (F3,23 = 22.93, p < 0.001) but no 
interaction (F3,23 = 1.16, p > 0.05). Two-way ANOVA examining water intake was not significant 
(Figure 5.8.C).  
 
Posthoc analysis revealed that when housed individually in CLAMS calorimetry cages at 15-16 
months of age, Non-Tg control and 3xTgAD mice on an HF diet weighed more (53% and 63%; p < 
0.001, Figure 5.8.A), consumed more calories (70% and 34%; p < 0.001 and p > 0.05, Figure 
5.8.B) but showed no difference in water intake when compared to their respective controls on a 
chow diet (Figure 5.8.C). There was no difference in body weight, caloric intake or water intake 
between the 3xTgAD and Non-Tg mice on either diet. 
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Figure 5.8. Effect of a high fat (HF) diet on body weight, caloric intake and water intake in 
15-16-month-old 3xTgAD mice individually housed in CLAMS metabolic cages 
 
Between 4-8 weeks of age, cohorts of male triple transgenic 3xTgAD and Non-Tg mice were 
fed a chow diet, then at 8 weeks the mice were either kept on chow or placed on an HF diet. At 
15-16 months of age cohorts (Non-Tg/chow diet; n = 8, Non-Tg/HF; n = 4, 3xTgAD/chow; n = 7 
and 3xTgAD/HF; n = 8) had body weight (A), caloric intake (B) and water intake (C) monitored 
when individually housed over four days in Comprehensive Laboratory Animal Monitoring 
System (CLAMS) calorimetry cages. Two-way analysis of variance (ANOVA) with Tukey’s post-
hoc analysis, #p < 0.05, ###p < 0.001 3xTgAD/HF versus 3xTgAD/chow or Non-Tg/HF versus 
Non-Tg/chow. 
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5.3.1.2.8.  Effect of an HF diet on metabolic rate in 15-16-month-old 3xTgAD mice 
 
At 15-16 months of age, indirect calorimetry to measure metabolic rate revealed that both the male 
3xTgAD and Non-Tg mice on a chow diet displayed similar 24 h rhythms in VO2 consumption 
(Figure 5.9.A), VCO2 production (Figure 5.9.B) and RQ (Figure 5.9.C). VO2, VCO2 and RQ levels 
were lowest during the light, largely inactive phase of the day and highest during the dark, active 
phase. On an HF diet, both the 3xTgAD and Non-Tg mice had similar 24 h rhythms in VO2 
consumption (Figure 5.9.A), weak rhythms in VCO2 production (Figure 5.9.B) and no rhythm in RQ 
(Figure 5.9.C) compared to their respective controls on a chow diet. 
 
Two-way ANOVA examining light phase VO2 (Figure 5.9.D) revealed that there was an effect of 
diet (F3,23 = 13.69, p < 0.01) but no effect of genotype (F3,23 = 0.26, p > 0.05) nor any interaction 
(F3,23 = 0.05, p > 0.05). Two-way ANOVA examining dark phase VO2 (Figure 5.9.G) revealed that 
there was an effect of diet (F3,23 = 1.23, p < 0.001) but no effect of genotype (F3,23 = 21.31, p > 
0.05) nor any interaction (F3,23 = 0.5, p > 0.05). Two-way ANOVA examining light phase VCO2 
(Figure 5.9.E) revealed that there was an effect of diet (F3,23 = 104.3, p < 0.001), but no effect of 
genotype (F3,23 = 23.77, p > 0.05) nor any interaction (F3,23 = 2.53, p > 0.05). Two-way ANOVA 
examining dark phase VCO2 (Figure 5.9.H) revealed that there was an effect of diet (F3,23 = 186.88, 
p < 0.001), genotype (F3,23 = 9.74, p < 0.01) and a significant interaction (F3,23 = 5.04, p < 0.05). 
Two-way ANOVA examining light phase RQ (Figure 5.9.F) revealed that there was an effect of diet 
(F3,23 = 108.86, p < 0.001), genotype (F3,23 = 34.42, p < 0.001) and a significant interaction (F3,23 = 
18.44, p < 0.001). Two-way ANOVA examining dark phase RQ (Figure 5.9.I) revealed that there 
was an effect of diet (F3,23 = 460.2, p < 0.001) but no effect of genotype (F3,23 = 0.28, p > 0.05) nor 
any interaction (F3,23 = 1.26, p > 0.05). 
 
Posthoc analysis revealed that during the light phase, the mean 12 h RQ was reduced (13%; p < 
0.001, Figure 5.9.F) and during the dark phase VCO2 was significantly increased (14%; p < 0.01, 
Figure 5.9.H) in the 3xTgAD, compared to Non-Tg mice on a chow diet. The increase in VCO2 in 
chow fed 3xTgAD mice is suggestive of an increase in metabolic rate. No difference in light phase 
VO2 was observed (Figure 5.9.D), whereas dark phase VO2 was significantly lower in both the HF 
fed 3xTgAD and Non-Tg mice, compared to their respective chow fed controls (p< 0.05 - p < 0.01, 
Figure 5.3.G). In contrast, both mean 12 h VCO2 (p < 0.01 - p < 0.001, Figure 5.9.E & H) and RQ (p 
< 0.001, Figure 5.9.F & I) were lower during the light and dark phases in HF fed 3xTgAD and Non-
Tg mice when compared to respective controls on a chow diet. During the metabolic monitoring 
period, all cohorts of mice were in positive energy balance. All cohorts exhibited a similar degree of 
positive energy balance (3xTgAD chow, 6.7 ± 0.8 kcal/day, 3xTgAD HF, 10.4 ± 1.9 kcal/day) 
except that the Non-Tg mice on an HF diet were in more positive balance than on a chow diet 
(Non-Tg chow, 3.8 ± 0.7 kcal/day versus Non-Tg HF, 11.0 ± 2.8 kcal/day, p < 0.05). 
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Figure 5.9.  Effect of a high fat (HF) diet on metabolic rate in 15-16-month-old 3xTgAD 
mice 
 
Between 4-8 weeks of age cohorts of male triple transgenic 3xTgAD and Non-Tg control mice 
were fed a chow diet, then at 8 weeks the mice were either kept on chow or placed on an HF 
diet. At 15-16 months of age cohorts (Non-Tg/ chow; n = 8, Non-Tg/HF; n = 4, 3xTgAD/chow; n 
= 7 and 3xTgAD/HF; n = 8) were placed in Comprehensive Lab Animal Monitoring System 
(CLAMS) calorimetry cages to examine metabolic rate. Rhythms in VO2 (A) and VCO2 (B) and 
RQ (C), mean 12 h light phase VO2 (D), VCO2 (E) and RQ (F) and 12 h mean dark phase VO2 
(G), VCO2 (H) and RQ (I) were assessed.  Data are 12 h means ± SEM. Two-way analysis of 
variance (ANOVA) with Tukey’s post-hoc analysis, **p < 0.01, ***p < 0.001 3xTgAD/chow mice 
versus Non-Tg /chow, #p < 0.05, ##p < 0.01 and ###p < 0.001 3xTgAD/HF versus 
3xTgAD/chow or Non-Tg/HF versus Non-Tg/chow. (A, B, C), white bars represent the light, 
inactive phase of the day, and black bars represent the dark active phase.  
 
Chapter 5                                                                              Effect of a high fat diet on 3xTgAD mice  
 
110 
 
5.3.1.3. Effect of an HF diet on epididymal fat pad weight in 3xTgAD mice at 3-4, 7-8, 11-12 
and 15-16 months of age 
 
Two-way ANOVA examining epdidymal fat pad weight at 3-4 months of age (Figure 5.10.A), 
revealed that there was an effect of diet (F3,39 = 91.37, p < 0.001) and genotype (F3,39 = 12.22, p < 
0.01) but no interaction (F3,39 = 4.06, p > 0.05). Two-way ANOVA examining epdidymal fat pad 
weight at 7-8 months of age (Figure 5.10.B), revealed that there was an effect of diet (F3,38 = 72.09, 
p < 0.001), genotype (F3,38 = 5.33, p < 0.05) and a significant interaction (F3,38 = 6.85, p < 0.05). 
Two-way ANOVA examining epdidymal fat pad weight at 11-12 months of age (Figure 5.10.C), 
revealed that there was an effect of diet (F3,34 = 73.31, p < 0.001), genotype (F3,34 = 27.61, p < 
0.001) and a significant interaction (F3,34 = 34.98, p < 0.001). Two-way ANOVA examining 
epdidymal fat pad weight at 11-12 months of age (Figure 5.10.D), revealed that there was an effect 
of diet (F3,24 = 23.3, p < 0.001), genotype (F3,24 = 12.47, p < 0.01) and a significant interaction (F3,24 
= 20.87, p < 0.001). 
 
Posthoc analysis revealed that at 3-4, 7-8, 11-12 and 15-16 months of age the male 3xTgAD mice 
on a chow diet displayed no difference in epididymal fat pad weight compared to the chow fed Non-
Tg mice (Figure 5.10. A-D). However, HF feeding lead to an increase (168% - 407%; p < 0.001, 
Figure 5.10.A-B) in epididymal fat pad weight in both the 3xTgAD and Non-Tg mice at 3-4 and 7-8 
months of age compared to their respective controls on a chow diet. Epididymal fat pad weight was 
lower in the 3xTgAD than the Non-Tg mice on an HF diet at 3-4 months of age (31%; p < 0.01) and 
higher in 3xTgAD mice at 7-8 months of age (55%; p < 0.01).  At 11-12 and 15-16 months of age, 
epididymal fat pad weight was not different in Non-Tg mice on an HF diet, whereas it was higher in 
the 3xTgAD mice on an HF diet (725%-778%; p < 0.001, Figure 5.10.C-D) compared to their 
respective controls on a chow diet.   
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Figure 5.10. Effect of high fat (HF) diet on epididymal fat pad weight in 3xTgAD mice at 3-
4, 7-8, 11-12 and 15-16 months of age 
 
Between 4-8 weeks of age, cohorts of male 3xTgAD and age-matched Non-Tg mice were fed a 
chow diet, then at 8 weeks the mice were either kept on chow (Non-Tg; n = 8-12 and 3xTgAD; 
n = 10) or placed on an HF diet (Non-Tg; n =9-12 and 3xTgAD; n = 10-11). At 3-4 (A), 7-8 (B), 
11-12 (C) and 15-16 (D) months of age epididymal fat pad weight was measured. Data are 24 h 
means ± SEM. Two-way analysis of variance (ANOVA) with Tukey’s post-hoc analysis, **p < 
0.01, ***p < 0.001 3xTgAD/HF versus Non-Tg/HF, ###p < 0.001 3xTgAD/HF versus 
3xTgAD/chow or Non-Tg/HF versus Non-Tg/chow. 
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5.3.2. Effect of an HF diet on behaviour and memory in 3xTgAD mice at 3-4, 7-8, 11-12 and 
15-16 months of age 
5.3.2.1. Effect of an HF diet on open-field (OF) behaviour in 3xTgAD mice at 3-4, 7-8, 11-12 
and 15-16 months of age 
 
Two-way ANOVA examining the number of cell entries at 3-4 months of age (Figure 5.11.A), 
revealed an effect of genotype (F3,39 = 0.04, p < 0.001) but no effect of diet (F3,39 = 28.82, p > 0.05) 
nor any interaction (F3,39 = 0.08, p > 0.05). Two-way ANOVA examining the number of cell entries 
at 7-8 months of age (Figure 5.11.B), revealed an effect of genotype (F3,38 = 27.97, p < 0.001) but 
no effect of diet (F3,38 = 0.02, p > 0.05) nor any interaction (F3,38 = 0.05, p > 0.05). Two-way ANOVA 
examining the number of cell entries at 11-12 months (Figure 5.11.C) and 15-15 months of age 
(Figure 5.11.D) was not significant. Two-way ANOVA examining the number of rearings at 3-4 
months of age (Figure 5.11.E), revealed an effect of genotype (F3,39 = 93.67, p < 0.001), no effect 
of diet (F3,39 = 2.48, p > 0.05) yet there was a significant interaction (F3,39 = 4.21, p < 0.05). Two-
way ANOVA examining the number of rearings at 7-8 months of age (Figure 5.11.F), revealed an 
effect of genotype (F3,38 = 17.92, p < 0.001) but no effect of diet (F3,38 = 0.009, p > 0.05) nor any 
interaction (F3,38 = 0.61, p > 0.05). Two-way ANOVA examining the number of rearings at 11-12 
months and 15-15 months of age was not significant (Figure 5.11.G-H). Two-way ANOVA 
examining the number of defecations at all ages was not significant (Figure 5.11.I-L). 
 
Posthoc analysis revealed that when placed in an OF arena, 3-4-month-old 3xTgAD mice on a 
chow or HF diet performed fewer cell entries (38% and 44%; p < 0.01, Figure 5.11.A), and rearings 
(66% and 54%; p < 0.001, Figure 5.11.E) but no difference in the number of defecations (Figure 
5.11.I) was observed when compared to their respective Non-Tg controls on the chow or HF diet. 
However, HF feeding had no effect on the behaviour of the Non-Tg or 3xTgAD mice at 3-4 months 
of age. At 7-8 months of age, 3xTgAD mice on a chow diet performed less cell entries (66%; p < 
0.001, Figure 5.11.B) and number of rearings (61%; p < 0.01, Figure 5.11.F), yet no difference in 
the number of defecations (Figure 5.11.J) was detected when compared to chow-fed Non-Tg mice.  
Diet had no effect on behaviour in 7-8-month-old Non-Tg mice, whereas HF feeding reversed the 
reduction in cell entries observed in chow fed 3xTgAD mice (122%; p < 0.05). At 11-12 and 15-16 
months of age, there was no effect of genotype or diet on the number of cell entries (Figure 5.11.C-
D), rearings (Figure 5.11.G-H) or defecations (Figure 5.11.K-L).   
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Figure 5.11. Effect of high fat (HF) diet on open-field (OF) behaviour in 3xTgAD mice at 3-
4, 7-8, 11-12 and 15-16 months of age 
 
Between 4-8 weeks of age cohorts of male triple transgenic 3xTgAD and age-matched Non-Tg 
mice were fed a chow diet, then at 8 weeks the mice were either kept on chow or placed on an 
HF diet.  At 3-4, 7-8, 11-12 and 15-16 months of age cohorts (Non-Tg/chow, n= 8-11, Non-
Tg/HF; n =6-12, 3xTgAD/chow; n = 8-10 and 3xTgAD/HF; n = 10) were placed in an OF arena 
and allowed to explore for 5 min. Cell entries (A-D), rearings (E-H) and number of defecations 
(I-L) were measured. Data are 24 h means ± SEM. Two-way analysis of variance (ANOVA) with 
Tukey’s post-hoc analysis, **p < 0.01,***p < 0.001 3xTgAD/chow versus Non-Tg/chow, and 
3xTgAD/HF versus Non-Tg/HF #p<0.05, 3xTgAD/chow verus 3xTgAD/HF 
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5.3.2.2. Effect of an HF diet on Y-maze spontaneous alternation (SA) in 3xTgAD mice at 3-4, 
7-8, 11-12 and 15-16 months of age 
 
Two-way ANOVA examining percentage alternation at 3-4 months of age was not significant 
(Figure 5.12.A). Two-way ANOVA examining percentage alternation at 7-8 months of age (Figure 
5.12.B), revealed an effect of diet (F3,38 = 0.03, p < 0.01) but no effect of genotype (F3,38 = 12.46, p 
> 0.05) nor any interaction (F3,38 = 42.76, p > 0.05). Two-way ANOVA percentage alternation at 11-
12 months of age (Figure 5.12.C), revealed an effect of diet (F3,35 = 13.82, p < 0.001), genotype 
(F3,35 = 4.34, p < 0.05) and a significant interaction (F3,35 = 4.14, p < 0.05). Two-way ANOVA 
examining percentage alternation at 15-16 months of age (Figure 5.12.D), revealed an effect of diet 
(F3,27 = 32.71, p < 0.001), genotype (F3,27 = 14.59, p < 0.001) but no interaction (F3,27 = 1.91, p > 
0.05). Two-way ANOVA examining the total number of moves at 3-4 months of age (Figure 
5.12.E), revealed an effect of genotype (F3,39 = 24.72, p < 0.001) but no effect of diet (F3,39 = 0.38, p 
> 0.05) nor any interaction (F3,39 = 0.22, p > 0.05). Two-way ANOVA examining the total number of 
moves at 7-8 months of age (Figure 5.12.F), revealed no effect of diet (F3,38 = 0.005, p > 0.05) nor 
genotype (F3,38 = 2.29, p > 0.05) yet a significant interaction (F3,38 = 8.92, p < 0.01). Two-way 
ANOVA examining the total number of moves at 11-12 and 15-16 months of age was not 
significant (Figure 5.12.G-H). 
 
Posthoc analysis revealed that when placed in a Y-maze at 3-4 months of age, there was no effect 
of diet or genotype on percentage alternations (Figure 5.12.A), but the 3xTgAD mice fed either a 
chow or HF diet showed a reduction in the total number of moves compared to their respective 
controls (31% and 35%; p < 0.05 and p < 0.01, Figure 5.12.E). At 7-8 months of age, the 3xTgAD 
mice on a chow diet displayed no difference in percentage alternation (Figure 5.12.B) yet they 
performed fewer moves than Non-Tg mice on a chow diet (32%; p < 0.05, Figure 5.12. F). 
However, there was no significant difference in percentage alternation or number of moves in 
3xTgAD mice fed an HF diet compared to Non-Tg controls. In addition, HF feeding had no effect on 
the percentage alternation or number of moves in Non-Tg or 3xTgAD mice. At 11-12 months of 
age, the 3xTgAD mice on a chow diet exhibited fewer percentage alternations (19% p < 0.05; 
Figure 5.12.C) than the Non-Tg control mice on a chow diet. In addition, an HF diet also impaired 
memory as the number of percentage alternations was reduced in 11-12-month-old the Non-Tg 
compared to chow fed controls (26%; p < 0.01). However, at 11-12 months of age, an HF diet did 
not appear to affect memory in 3xTgAD mice as there was no difference in the percentage 
alternations in HF fed 3xTgAD mice when compared to 3xTgAD mice on chow. Furthermore, no 
difference in the total number of moves was observed in any groups regardless of genotype or diet 
at 11-12 months of age (Figure 5.12.G). At 15-16 months of age 3xTgAD mice on a chow diet 
performed fewer percentage alternations (19% p < 0.05; Figure 5.12.D) than the Non-Tg mice on a 
chow diet. HF affected memory in 15-16-month-old 3xTgAD and Non-Tg mice as these mice 
performed lower percentage alternations (19%; p < 0.05 and p < 0.01) than their respective 
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controls on a chow diet. However, genotype or diet had no affect on the number of moves in 15-16-
month-old mice (Figure 5.12.H). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.12. Effect of a high fat (HF) diet on Y-maze spontaneous alternation (SA) 
performance in 3xTgAD mice at 3-4, 7-8, 11-12 and 15-16 months of age 
  
Between 4-8 weeks of age, cohorts of male triple transgenic 3xTgAD and age-matched Non-Tg 
mice were fed a chow diet, then at 8 weeks the mice were either kept on chow or placed on an 
HF diet. At 3-4, 7-8, 11-12 and 15-16 months of age, cohorts (Non-Tg/chow; n= 8-11, Non-
Tg/HF; n= 6-12, 3xTgAD/chow; n = 8-10 and 3xTgAD/HF; n=10) were individually placed in a 
Y-maze and allowed to explore for 8 min. Percentage of alternations (A-D) and total number of 
moves (E-H) were measured. Data are 24 h means ± SEM. Two-way analysis of variance 
(ANOVA) with Tukey’s post-hoc analysis, *p < 0.05, **p < 0.01 3xTgAD/chow versus Non-
Tg/chow or 3xTgAD/HF versus Non-Tg/HF, #p < 0.05, ##p < 0.01, 3xTgAD/chow versus 
3xTgAD/HF or Non-Tg/chow versus Non-Tg/HF. 
Chapter 5                                                                              Effect of a high fat diet on 3xTgAD mice  
 
116 
 
5.3.2.3. Effect of an HF diet on the Morris water maze (MWM) task in 3xTgAD mice at 3-4, 7-8, 
11-12 and 15-16 months of age 
 
Training 
 
By the second day of flagged training in the MWM there was no significant difference in escape 
latency or swim speed between any group at 3-4, 7-8, 11-12 or 15-16 months of age (data not 
shown).  
 
During submerged platform training, the Non-Tg mice on a chow diet showed significantly 
decreasing escape latency over training days at all ages tested (days 4-8 versus day 1; p < 0.05 - p 
< 0.001, Figure 5.13. A-D), whereas the 3xTgAD mice showed no evidence of learning. On an HF 
diet, the Non-Tg mice got quicker over training days at 3-4, 7-8, 11-12 and 15-16 months of age 
(days 2-8 versus day 1; p < 0.05 - p < 0.001), whereas the 3xTgAD mice on an HF diet, only got 
quicker at 3-4 months of age (days 7-8 versus day 1; p < 0.05) yet were unable to learn at 7-8, 11-
12 and 15-16 months of age. On individual training days there was no significant difference in 
escape latency between the cohorts.  
 
Probe test 
 
Two-way ANOVA examining the percentage time in the target quadrant at 3-4 months of age 
(Figure 5.13.E), revealed an effect of genotype (F3,39 = 29.33, p < 0.001) but no effect of diet (F3,39 
= 0.04, p > 0.05) nor any interaction (F3,39 = 0.09, p > 0.05). Two-way ANOVA examining the 
percentage time in the target quadrant at 7-8 months of age (Figure 5.13.F), revealed an effect of 
genotype (F3,38 = 23.18, p < 0.001), diet (F3,38 = 13.2, p < 0.001) but no interaction (F3,38 = 0.54, p > 
0.05). Two-way ANOVA examining the percentage time in the target quadrant at 11-12 months of 
age (Figure 5.13.G), revealed an effect of genotype (F3,34 = 18.38, p < 0.001) but no effect of diet 
(F3,34 = 0.59, p > 0.05) nor any interaction (F3,34 = 0.50, p > 0.05). Two-way ANOVA examining the 
percentage time in the target quadrant at 15-16 months of age (Figure 5.13.H), revealed an effect 
of genotype (F3,39 = 14.1, p < 0.001) but no effect of diet (F3,39 = 0.05, p > 0.05) nor any interaction 
(F3,39 = 0.24, p > 0.05). 
 
Posthoc analysis revealed that during the probe test on a chow diet, the 3xTgAD mice displayed 
deficits in the percentage time in the target quadrant at 3-4, 7-8 and 15-16 months of age when 
compared to Non-Tg control mice on a chow diet (38% - 54%; p < 0.05 - p < 0.001, Figure 5.13. E-
H). An HF diet worsened memory in the probe test in both the Non-Tg mice and 3xTgAD mice at 7-
8 months of age when compared to their respective controls on a chow diet (30% and 32%; p < 
0.05, Figure 5.13.F). Similarly, the 3xTgAD mice on an HF diet performed significantly worse than 
the Non-Tg mice on an HF diet (43%; p < 0.01) at 11-12 months of age, at an age when the 
3xTgAD mice on a chow diet did not show a significant memory deficit.  
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 Figure 5.13. Effect of a high fat (HF) diet on the Morris water maze (MWM) task in 3xTgAD 
mice at 3-4, 7-8, 11-12 and 15-16 months of age 
  
Between 4-8 weeks of age cohorts of male 3xTgAD and Non-Tg mice were fed a chow diet, 
and then at 8 weeks the mice were either kept on chow or placed on an HF diet. At 3-4, 7-8, 11-
12 and 15-16 months of age cohorts (Non-Tg/chow; n= 8-11, Non-Tg/HF; n = 6-12, 
3xTgAD/chow; n = 8-10 and 3xTgAD/HF; n = 10) were given four trials a day for 8 d of 
submerged platform training in the MWM (A-D). Twenty-four hours after the final trial the mice 
were given a probe test with no platform (E-H). Data are mean +/- SEM. For escape latency, 
three-way repeated measures analysis of variance (ANOVA) with Scheffe post-hoc analysis.  *p 
< 0.05, **p < 0.01, ***p < 0.001; Non-Tg/chow day 1 versus days 2-8 of training, #p < 0.05, ##p 
< 0.01, ###p < 0.001; Non-Tg/HF day 1 versus days 2-8 of training, $p < 0.05 3xTgAD/HF day 
1 versus days 2-8 of training. For percentage time in target, two-way analysis of variance 
(ANOVA) with Tukey’s post-hoc analysis, *p <0.05, **p < 0.01 3xTgAD/chow versus Non-
Tg/chow or 3xTgAD/HF versus Non-Tg/HF, # p < 0.05 3xTgAD/chow versus 3xTgAD/HF or 
Non-Tg/chow versus Non-Tg/HF. 
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5.3.2.4. Effect of an HF diet on memory in the novel object recognition (NOR) test in 3xTgAD 
mice at 3-4, 7-8, 11-12 and 15-16 months of age 
 
Overall at 3-4, 7-8, 11-12 and 15-16 months of age there was no difference in exploration of 
identical objects during phase 1 of the test (data not shown). At 3-4 and 7-8 months of age, during 
phase 2 after an interval of 1h, the Non-Tg mice on a chow or HF diet spent significantly more time 
exploring the novel versus the familiar object (chow; 42% and 15%; p < 0.001 and p < 0.05, HF; 
92% and 53%; p < 0.001, Figure 5.14.A-B). At 11-12 and 15-16 months of age, the Non-Tg mice 
on a chow diet also spent significantly more time exploring the novel versus the familiar object 
(95% and 62%; p < 0.01, Figure 5.14.C-D), whereas an HF diet impaired memory at these ages as 
HF fed Non-Tg mice spent a similar amount of time exploring both objects. In the 3xTgAD mice, 
memory was impaired at all ages, as mice on either a chow or HF diet explored both novel and 
familiar objects to a similar degree. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.14. Effect of a high fat (HF) diet on memory in novel object recognition (NOR) 
test in 3xTgAD mice in 3-4, 7-8, 11-12 and 15-16 months of age 
  
Between 4-8 weeks of age cohorts of male triple transgenic 3xTgAD and age-matched Non-Tg 
mice were fed a chow diet, then at 8 weeks the mice were either kept on chow or placed on an 
HF diet. At 3-4, 7-8, 11-12 and 15-16 months of age cohorts (Non-Tg/chow; n= 8-11, Non-
Tg/HF; n = 6-12, 3xTgAD/chow; n = 8-10 and 3xTgAD/HF; n = 10) underwent the NOR test. 
During phase 1 mice were placed in a NOR arena for 10 min with two identical novel objects 
(Data not shown). During phase 2 (A-D) after an interval of 1h the mice were placed back into 
the arena with one familiar object (presented in phase 1) and one novel object. Percentage time 
exploring objects were compared using Student’s t-tests (*p < 0.05, **p<0.01, ***p < 0.001).  
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5.3.2.5. Effect of an HF diet on memory in the odour recognition (OR) test in 3xTgAD mice at 
3-4, 7-8, 11-12 and 15-16 months of age 
 
Overall at 3-4, 7-8, 11-12 and 15-16 months of age there was no difference in exploration of 
identical scented balls during phase 1 (data not shown). During phase 2, after a delay of 3min, the 
Non-Tg mice at all ages on a chow diet spent a significantly higher percentage of time exploring the 
novel scented ball than the familiar scented ball previously presented in phase 1 indicating memory 
formation (21% - 56%, p < 0.05, Figure 5.15. A-D). Memory was unimpaired in the 3xTgAD mice 
on a chow diet at earlier time points, as mice spent more time exploring the novel scented ball at 3-
4 months of age (108%; p < 0.01, Figure 5.15. A) and more time exploring the familiar scented ball 
at 7-8 months of age (118%; p < 0.05, Figure 5.15. B). However, memory was impaired in chow fed 
3xTgAD mice at 11-12 and 15-16 months of age, as no difference in exploration between the novel 
and familiar smell was observed (Figure 5.15. C-D). HF feeding transiently impaired memory in the 
Non-Tg mice, as no preference for the exploring of the novel or familiar scented ball was detected 
at 3-4 and 7-8 months of age (Figure 5.15. A-B), but by 11-12 and 15-16 months of age HF fed 
Non-Tg mice spent more time exploring the novel scented ball (40% and 35%, p < 0.05, Figure 
5.15. C-D). In contrast, the 3xTgAD mice on an HF diet showed impaired memory at all ages, as 
they did not distinguish between the novel and familiar smell. 
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Figure 5.15. Effect of a high fat (HF) diet on memory deficits in odour recognition (OR) 
test in 3xTgAD mice at 3-4, 7-8, 11-12 and 15-16 months of age 
  
Between 4-8 weeks of age, cohorts of male triple transgenic 3xTgAD and age-matched Non-Tg 
mice were fed a chow diet, then at 8 weeks the mice were either kept on chow or placed on an 
HF diet. At 3-4, 7-8, 11-12 and 15-16 months of age cohorts (Non-Tg/chow; n = 8-11, Non-
Tg/HF; n = 6-12, 3xTgAD/chow; n = 8-10 and 3xTgAD/HF; n = 10) underwent the OR test. 
During phase 1, the mice were placed in a SR arena for 10 min with 2 identically scented balls 
(data not shown). During phase 2 (A-D) after an interval of 3 min the mice were placed back 
into the arena with one familiar scented ball (presented in phase 1) and one novel scented ball. 
Percentage time exploring balls were compared using Student’s t-tests (*p < 0.05).  
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5.4. Discussion 
 
Both consumption of an HF diet and obesity have been linked with increased incidence of AD. The 
final aim of this PhD, therefore, was to examine the effect of an HF diet on energy balance, as well 
as the onset and progression of behaviour and memory deficits in the 3xTgAD mice, compared to 
Non-Tg control mice. Non-Tg control and 3xTgAD mice displayed similar energy balance profiles in 
response to an HF diet. Furthermore, an HF diet induced memory impairments, in both Non-Tg and 
3xTgAD mice. 
 
5.4.1. Effect of an HF diet on energy balance in 3xTgAD mice 
5.4.1.1. Energy balance of control 3xTgAD mice on a chow diet 
 
On a chow diet, the body weight profiles of the Non-Tg control and 3xTgAD mice were similar 
between cohorts examined during this part of the study and to those seen during the 
characterisation study (chapter 3), except that aged 3xTgAD mice did not show decreased body 
weight, when compared to the Non-Tg control mice. However, the overall shape of the body weight 
profile, in each cohort on a chow diet in this study was the same as that seen in the 
characterisation study; if the animals would have been monitored for longer in the 15-16 month 
cohort, then it is possible that the 3xTgAD mice may have started to weigh less than the Non-Tg 
control mice. Similarly, the increase in metabolic rate was not seen as early as in characterisation 
study (chapter 3), but body weight was not less at this time point (12 months of age). Furthermore, 
in the 3xTgAD mice food intake was not significantly increased in this study at any age, when 
tested using 2-way ANOVA, whereas it was significantly increased at all ages when tested using a 
Student’s t-test. This discrepancy could be due to the more stringent nature of these analyses, and 
so future studies may require larger numbers of mice.  
 
No difference in epididymal fat deposition was observed between the 3xTgAD and Non-Tg control 
mice on chow at all ages. This is of interest, as it suggests that the increase in body weight seen in 
the 3xTgAD mice at 3-4 months of age is unlikely to be due to an increase in epididymal fat 
deposition, although it is possible that an increase in subcutaneous and other visceral fat deposits 
may be responsible. Future studies would need to be done (i.e. DEXA) to evaluate whole body 
adiposity in more detail. Overall, these results on energy balance are similar to those seen during 
the characterisation study and previous studies in 3xTgAD mice (Gimenez-Llort et al 2007; 
Halagappa et al 2007). As these studies were discussed earlier (chapter 3) they will not be 
mentioned here. 
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5.4.1.2. Effect of an HF diet on energy balance in 3xTgAD mice 
 
Both Non-Tg and 3xTgAD mice put on more weight in response to an HF diet than respective 
controls on a chow diet, although initially the 3xTgAD mice were slower to start gaining weight, 
possibly due to an increased caloric intake that was observed in the Non-Tg mice in the CLAMS 
calorimetry cages, which was not seen in the 3xTgAD mice. It must also be noted that the 3xTgAD 
mice started off heavier than the Non-Tg mice, which may have affected their initial response to 
being on an HF diet. The overall body weight and caloric profiles of Non-Tg and 3xTgAD mice were 
similar in response to an HF diet, with both the Non-Tg and 3xTgAD mice consuming significantly 
more calories on an HF diet than on a chow diet during the period in the CLAMS calorimetry cages, 
leading to an increased body weight. An HF diet reduced the RQ, as expected for fat oxidation, and 
appeared to lower the metabolic rate, in both Non-Tg mice and 3xTgAD mice. However, 
examination of metabolic rate in obese versus lean animals requires the measurement of lean 
mass (mass excluding fat), as lean tissue mass is the most metabolically active part of the body 
(Muller et al 2002). The decrease in metabolic rate observed here in HF fed mice, may be due to 
the fact that body weight, instead of lean mass, is being used in the calculation of VO2 and VCO2. 
Future studies would be required to measure lean and fat free mass (using DEXA, for example) in 
order to fully examine metabolic rate in response to an HF diet.  
 
Epididymal fat deposition was increased in the Non-Tg mice on an HF diet, at 3-4 and 7-8 months, 
which is expected, as they had increased body weight at these ages. However, at 11-12 and 15-16 
months of age they no longer had an increased epididymal fat pad weight, despite their increased 
body weight. The epididymal fat pad is just one fat depot that is normally representative of adipose 
tissue throughout the body. However, it is possible that there are differences in other fat depots that 
were not analysed, such as other visceral fat pads or subcutaneous fat, therefore future studies 
would need to analyse whole body fat. Epididymal fat was increased in the 3xTgAD mice on HF, 
compared to 3xTgAD mice on a chow diet at all ages, even at 3-4 months of age, when these mice 
showed no increase in body weight in response to an HF diet. The 3xTgAD mice had lower 
epididymal fat weight than the Non-Tg control mice on an HF diet at 3-4 months, which was 
expected, as they were slower to put on weight on the HF diet. At 7-8, 11-12 and 15-16 months of 
age, the 3xTgAD mice deposited more fat in their epididymal fat pads than the Non-Tg mice on an 
HF diet, which is of interest, as there was no difference in body weight between groups at these 
time points.  As stated above, epididymal fat is only one fat depot and future studies would need to 
analyse whole body fat and also assess lean tissue mass. Detailed examination of adiposity in 
response to an HF diet remains to be done in any model of AD.  
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5.4.1.3. Previous HF studies in mouse models of AD 
 
To date, no studies have examined in detail the effect of HF feeding on energy balance in AD 
mouse models. The majority of studies that report an effect on an HF diet on body weight and 
energy intake in AD mice focus on pathology and none have examined energy expenditure 
 
Only one study has examined the effect of an HF diet on energy balance in the 3xTgAD model of 
AD. When fed a 60% HF diet between 4-13 months of age, Non-Tg mice gained more weight 
compared to respective controls on a chow diet, whereas the body weight of 3xTgAD mice was not 
affected by the HF diet (Julien et al 2008). The difference in weight gain between the Non-Tg and 
3xTgAD on an HF diet appeared to be due to a low animal number and large variability in weight 
gain in the HF fed 3xTgAD mice.  Furthermore, 3xTgAD mice on a chow diet were heavier than 
Non-Tg mice on a chow diet, yet on an HF diet no difference in 3xTgAD and Non-Tg mice was 
observed. This is interesting, as we observed that 3xTgAD mice were slower to gain weight in the 
present study. The authors also noted that on an HF diet, 3xTgAD mice had higher levels of 
cortical A! and tau (Julien et al 2008). In contrast, when 3xTgAD mice were put on a 40% calorie 
restricted diet at 3 months of age for 11 months, the mice lost weight and A! and phosphorylated 
tau levels were reduced (Halagappa et al 2007). Pathology in the mice from the current study in 
response to an HF diet is yet to be completed. 
 
Studies in other mouse models of AD demonstrate that when fed an HF or high cholesterol diet AD 
mice gain weight compared to controls on a chow diet and show increased pathology (George et al 
2004; Ho et al 2004; Kohjima et al 2010; Levin-Allerhand et al 2002; Pedrini et al 2009; Refolo et al 
2000; Shie et al 2002). AD mouse models fed an HF diet also show higher cholesterol levels 
(Levin-Allerhand et al 2002; Shie et al 2002) and develop insulin resistance (Ho et al 2004; Kohjima 
et al 2010). Kohjima et al (2010) examined female APP mice on an HF diet, finding higher body 
weight, total body fat and insulin resistance after 3 months, when compared to APP mice on a 
chow diet (Kohjima et al 2010). The HF-fed APP mice had similar caloric intake to APP mice on a 
chow diet between 1 and 2 months, yet showed higher appetite at 3 months of age, which 
increased even further at 4 months of age, mirroring the increase in A! deposition in response to 
the HF diet. Kohijima and colleagues also found that levels of brain-derived neurotrophic factor 
(BDNF), known to play a role in feeding behaviour and satiety, were lower in APP mice on an HF 
diet. The authors suggest that increased pathology seen in APP mice on an HF diet could be a 
consequence of the down-regulated expression of BDNF, which in turn could have caused higher 
caloric intake and insulin resistance (Kohjima et al 2010). The authors also suggest that decreased 
BDNF levels, which are observed in AD patients (Phillips et al 1991) could be involved in the 
increased appetite seen in these patients. A full evaluation of neuropeptides involved in feeding 
behaviour remains to be examined in 3xTgAD mice and could be the focus of future studies. 
Kohijima and colleagues also reported that calorie restricting HF-fed APP mice (by pair-feeding to 
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the calorie intake of chow fed APP mice) prevented weight gain and insulin resistance. These 
findings suggest that increased caloric intake due to an HF diet rather than the diet composition 
itself is responsible for both the obesity and insulin resistance seen in APP mice.  
 
5.4.1.4. Effect of an HF diet on energy balance summary 
 
This is the first study examining longitudinal analysis of energy balance in response to an HF diet in 
3xTgAD mice. The main finding is that overall the metabolic response of 3xTgAD mice to an HF 
diet is not different to Non-Tg control mice—apart from 3xTgAD mice gain weight and deposit fat 
slightly slower, but then deposit fat to a greater extent at later time points, despite body weight 
being no different than Non-Tg mice on an HF diet. Overall, the results observed in this study 
mirror the few studies that have been done examining the effect of an HF diet in models of AD. The 
pathology of the mice in this study in response to an HF diet remains to be examined. !
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5.4.2. Effect of an HF diet on behaviour and memory in 3xTgAD mice 
 
An HF diet was shown to induce further memory deficits in 3xTgAD mice, but HF feeding also 
affected memory in Non-Tg control mice. 
 
 
5.4.2.1. Behaviour and memory in control 3xTgAD mice on a chow diet 
 
On a chow diet, the 3xTgAD mice had deficits in the OF at 3-4 and 7-8 months of age, 
characterised by a reduction in activity, which was no longer seen at 11-12 and 15-16 months of 
age. The 3xTgAD mice showed memory deficits in the NOR test and MWM probe from 3-4 months 
of age and in the SA and OR tests from 11-12 months of age. Overall, the 3xTgAD mice showed 
age-dependent deficits in behaviour and memory, consistent with our characterisation study apart 
from minor differences in onset of impairments, which may be expected between studies performed 
at different times using different cohorts of mice. The behaviour and memory of 3xTgAD mice on a 
chow diet was compared to previous studies in 3xTgAD mice and other models of AD in chapter 4, 
therefore this will not be discussed here. 
 
5.4.2.2. An HF diet induced memory deficits in both Non-Tg control and 3xTgAD mice 
 
Activity 
 
An HF diet partially inhibited the decrease in activity observed in the 3xTgAD mice in the OF 
activity/anxiety task and Y-maze SA test, whereas an HF diet had no effect on activity in Non-Tg 
control mice. As a diet-induced increase in activity and exploration in the OF was only seen in 
3xTgAD at one time point, it requires future investigation to determine if it is a real effect and its 
significance.  
 
Memory 
 
An HF diet affected memory, but the way in which it did this was different depending on the task 
used. 
  
Y-maze SA test  
 
An HF diet enhanced memory deficits in both the Non-Tg control and 3xTgAD mice, however, it 
took slightly longer for a significant diet-induced deficit to be seen in the Y-maze SA test in 3xTgAD 
mice. 
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MWM task 
 
An HF diet transiently increased memory deficits in both Non-Tg control and 3xTgAD mice. How 
and why only transient deficits were observed is unknown, although it could be due to variation 
between cohorts. Future studies need to be completed with the same groups of animals to monitor 
the full progression of diet-induced memory deficits. 
 
NOR test 
 
No effect of an HF diet could be observed in 3xTgAD mice, as a memory deficit was already 
present at an early time point. However, an age-dependent memory deficit was observed in Non-
Tg mice fed an HF diet.  
 
OR test 
 
An HF diet decreased the onset of memory deficit in 3xTgAD mice and affected memory in early 
ages in Non-Tg mice. As with the MWM task, how and why only transient deficits were seen in 
Non-Tg mice is unknown and requires further investigation. 
 
Overall, an HF diet made memory worse in both Non-Tg and 3xTgAD mice, however in some tasks 
it was not possible for the HF diet to have an effect in 3xTgAD mice, as they already had a deficit 
and further changes would not be possible to detect experimentally. Both hippocampally-
dependent (Y-maze, SA and MWM tests) and hippocampally-independent tasks (OR and NOR 
tests) were worsened by an HF diet. Interestingly though, diet-induced deficits in the MWM 
occurred much earlier than in the Y-maze SA test for both the 3xTgAD and Non-Tg mice. The 
reason for this is unknown, but could be due to motivational or anxiety issues related to the MWM 
making it more sensitive at picking up deficits earlier. Similarly, deficits in the OR test in Non-Tg 
mice were seen earlier than in the NOR test, even though the delay between trials is much shorter 
in the OR task than the NOR test. The reason for this is also unknown and would require more 
investigation in future studies, specifically examining pathology within the brain for any potential 
diet-related changes. 
 
5.4.2.3. The effect of an HF diet on behaviour and memory in models of AD 
 
Very few studies have investigated the effect of an HF diet on behaviour and memory in models of 
AD.  HF feeding increases A! and tau levels within the brain of 3xTgAD mice (Julien et al 2008), 
however the authors did not examine behaviour and memory. Pathology is yet to be examined and 
correlated to behaviour and memory in our study. More recently, 5-month-old 3xTgAD mice were 
put on an HF diet for 4 months, showing increased A! and tau deposition (Ma et al 2009). 3xTgAD 
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mice on a HF diet also displayed reduced performace in the Y-maze SA test after 1 and 2 months 
of HF diet, when compared to Non-Tg control mice on an HF diet. 3xTgAD mice in the study by Ma 
and colleagues 3xTgAD mice were put on the diet much later than in the present study which may 
affect onset of cognitive deficits. In the present study deficits on an HF were observed much later, 
the reasons for this may be due to the extra cholesterol added into this HF diet (1500 ppm versus 
269 ppm in the present study).  Body weight and energy balance was not described in this study, 
furthermore, no chow-fed mice were used in this study, however the authors noted that no 
deterioration in performance was observed between 1 and 2 months of HF diet in Non-Tg mice (Ma 
et al 2009). It was also not clear what gender the mice were used in this study.  In contrast to the 
effects of excess calorie intake induced by an HF diet, a 40% calorie restricted diet for 7 or 14 
months attenuated the reduction in rearing activity within an OF and improved performance in the 
MWM in 3xTgAD mice (Halagappa et al 2007). These beneficial effects of a calorie restriction on 
AD-related behavioural deficits in 3xTgAD mice are also associated with a reduction in A! and tau 
levels (Halagappa et al 2007). To date, no studies have investigated the effect of an HF diet on 
both longitudinal energy balance and a battery of behaviour and memory tasks in 3xTgAD mice.  
Studies in other models of AD demonstrate that an HF diet can induce memory deficits. After 5 
months of HF feeding, female APP mice at 9 months of age show impairments in the submerged 
platform learning and memory retention in the probe test compared to APP mice on a chow diet 
(Ho et al 2004). However, no Non-Tg control mice were used in this study. As HF feeding in this 
PhD caused memory deficits in both 3xTgAD and Non-Tg control mice, the diet-induced deficits 
seen in models of AD may therefore not be specific to AD, but rather to cognition in general.  
 
5.4.2.4. An HF diet affects memory in cognitively normal rodents and humans 
 
There are a multitude of studies demonstrating that an HF diet worsens memory in cognitively 
normal rodents (Granholm et al 2008; Greenwood & Winocur 1990; Kanoski & Davidson 2010; 
McNeilly et al 2010; Murray et al 2009; Valladolid-Acebes et al 2010; Winocur & Greenwood 2005). 
However, most studies have only assessed spatial memory and have not evaluated the response 
to an HF diet in a battery of different tests. In the present study, we found that both spatial and non-
spatial memory are impaired by an HF diet, in both Non-Tg control and 3xTgAD mice. Interestingly, 
a recent study showed that spatial reference memory in the radial arm maze is impaired in rats 
following only 72 h of a 40% HF diet, whereas non-spatial reference memory is only affected after 
30 days of HF diet (Kanoski & Davidson 2010). These data suggest that spatial memory is more 
sensitive to disruption than non-spatial memory. The authors also noted that once a diet-induced 
deficit was observed, it was stable over time. Similarly, we noted in this study that diet-induced 
deficits appeared in Non-Tg mice in the Y-maze SA and the NOR test, however we saw transient 
diet-induced deficits in Non-Tg mice in the MWM probe test and the OR test. However, each time 
point in the present study was a different cohort of mice and it is possible that the onset of diet-
induced deficits could vary between cohorts. In addition to the detrimental effects of HF diets on 
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cognition in rodents, evidence also suggests that obesity and a poor diet have detrimental effects 
on cognition in humans (Elias et al 2003; Jeong et al 2005). The Framingham heart study reported 
impaired cognitive function in obese individuals versus those that were not obese (Elias et al 2003). 
Similarly, a study of healthy adults (20-82 years) revealed that BMI was inversely related to 
cognition, with obese participants (BMI > 30) performing poorer than those with a normal weight 
(BMI = 18.5-24.9) (Gunstad et al 2007).  
 
5.4.2.5. Potential mechanisms underlying diet-induced memory deficits 
 
The mechanism underlying HF diet induced memory deficits are unknown, but studies in obese 
humans and animal models suggest that insulin resistance may play an important role. Insulin is 
thought to play a part in modulating synaptic plasticity and memory, as insulin receptors and 
insulin-sensitive glucose transporters are expressed in the medial temporal lobe, which is 
associated with memory (Naderali et al 2009). Therefore, problems with insulin signalling in the 
brain could contribute to impaired memory function, as obesity is linked with insulin resistance 
(Fatani et al 2007; Lloyd et al 2009; Naderali & Fatani 2005; Whitaker et al 1997), and studies have 
shown that people with insulin resistance have worse cognition (Elias et al 2003; Gunstad et al 
2007). Studies evaluating HF diet-induced cognitive deficits have demonstrated that rodents fed a 
HF diet show increased levels of cholesterol, leptin, triglycerides and exhibit insulin resistance 
(Granholm et al 2008; McNay et al 2010; Murray et al 2009; Valladolid-Acebes et al 2010; Winocur 
& Greenwood 2005). HF diet-induced deficits in Y-maze SA are seen in rats that are 
hyperglycaemic and hyperinsulinemic after 20 weeks of HF diet (McNay et al 2010). Rats also 
show a dose-response improvement in spatial working memory following intrahippocampal 
administration of insulin. Furthermore, blocking endogenous intrahippocampal insulin signalling 
impaired spatial memory in rats (McNay et al 2010). It has been hypothesised that insulin 
resistance and decreased glucose uptake are involved in cognitive deficits on an HF diet (Winocur 
& Greenwood 2005). Studies have shown that glucose treatment can temporarily improve memory 
in aged rats, potentially by aiding glucose metabolism within the brain. It is possible that the 
hippocampus is sensitive to insulin resistance, causing impaired glucose regulation and reduced 
glucose uptake within the hippocampus, which may explain memory deficits observed on an HF 
diet (Winocur & Greenwood 2005). Furthermore, obesity and HF feeding is associated with 
changes in many systems such as the upregulation of pro-inflammatory cytokines, which may also 
be linked to decreased cognition (Bellinger et al 1995; Gemma & Bickford 2007; Jankowsky & 
Patterson 1999; Viljoen & Koorts 2004). Studies in rodents have shown that memory deficits in 
response to an HF diet are associated with brain inflammation (Pistell et al 2009). 
 
The mechanisms underlying any association between increased adiposity on memory deficits in 
AD are unknown, although increased body fat (both BMI and fat mass) has been correlated with 
decreased neuronal viability in areas of the brain associated with learning and memory (Gazdzinski 
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et al 2008) and increased plasma and brain A! levels (Balakrishnan et al 2005). As previously 
described, obesity itself is associated with insulin resistance and upregulation of proinflammatory 
cytokines, which may explain the cognitive decline observed in obese humans (Viljoen & Koorts 
2004), all of which have been seen in AD (Benveniste et al 2001; Combs 2009; Craft 2005).  
Increasingly evidence suggests that type II diabetes is associated with higher risk in AD (Ott et al 
1999; Schrijvers et al 2010). For this reason, a potential molecular pathway has been proposed to 
explain the potential increased risk of AD associated with obesity (see Figure 5.16.). This model is 
based on the role of insulin resistance and hyperinsulinemia on the pathophysiology of AD and 
neuroinflammation, leading to increased neurodegeneration and cognitive decline (Craft 2005; 
Neumann et al 2008). 
Figure 5.16. Schematic representation of potential molecular pathways linking obesity 
and cognitive decline 
 
Obesity leads to peripheral insulin resistance (a) and hyperinsulinemia (b) which together 
with a potential contribution of central insulin resistance, leads to increased levels of insulin 
in the central nervous system (CNS), which reduces the insulin degrading enzyme and thus 
result in reduced degradation of Alzheimer’s disease (AD), hence upregulating cyclin 
dependent kinase 5  (Cdk5) leading to tau hyperphosphorylation. Peripheral insulin 
resistance (c), associated with decreased neuronal insulin signalling, together with 
decreased phosphoidylinositol 3,4,5 triphosphase (PI3K) and protein kinase B (PKB), leading 
to increased glycogen synthase kinase 3 (GSK3!), which is linked to increased tau 
hyperphosphorylation.  A! oligomers (d) are thought to activate an innate immune response 
in glia and lead to neuroinflammation (e), which in turn is associated with neurodegeneration 
and cognitive decline. PKB downregulation and high GSK3! are associated with pro-
apoptotic pathways leading to neurodegeneration (f). Chronic hyperinsulinemia is associated 
with down-regulation of insulin receptors in the blood brain barrier leading to decreased 
insulin levels in the CNS (g). Figure redrawn and adapted from (Neumann et al 2008). 
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Studies in mouse models of AD have demonstrated that consumption of an HF diet is associated 
with diet-induced memory deficits and/or increased pathology within the brain (George et al 2004; 
Ho et al 2004; Julien et al 2008; Kohjima et al 2010; Levin-Allerhand et al 2002; Ma et al 2009; 
Pedrini et al 2009; Refolo et al 2000; Shie et al 2002). In the present study, however, behaviour 
remains to be correlated to pathology. Studies in single and double transgenic models of AD have 
shown that an HF diet is associated with insulin resistance (Ho et al 2004; Kohjima et al 2010). 
Very recently, a study found that 3xTgAD mice with streptozocin-induced diabetes display 
increased A! pathology and that treatment with exendin-4 improved the amyloidogenic effect of 
diabetes and reduced hyperglycemia. In contrast, no effect on tau was observed (Li et al 2010). 
After 4 months of an HF diet, 3xTgAD mice displayed increased active c-jun N-terminal kinase 
(JNK) and phosphorylated insulin receptor substrate-1 (IRS-1) and tau and increased memory 
deficits (Ma et al 2009). The limited studies in 3xTgAD mice fit in with the proposed model of 
cognitive decline associated with obesity in AD. The mechanisms underlying memory deficits in 
Non-Tg control and 3xTgAD mice on a high fat diet in the present study diet are unknown, 
therefore future studies could assess metabolic parameters, insulin sensitivity and levels of 
proinflammatory cytokines in response to an HF diet. It remains to be determined if an HF diet 
causes memory deficits via the same or different mechanisms in both Non-Tg control and 3xTgAD 
mice, therefore, this is an area of research requiring more investigation. Understanding the 
mechanism of how an HF diet affects cognition in both the Non-Tg control and 3xTgAD mice may 
provide therapeutic targets for AD.  
 
5.4.2.6. Effect of an HF diet on energy balance and behaviour and memory summary 
 
AD is a progressive neurodegenerative disorder, characterised by deficits in language, behaviour 
and memory. Increasing evidence suggests that consuming an HF diet and obesity are risk factors 
for AD. The data presented in this PhD provide the first longitudinal study to investigate the effect 
of an HF diet on energy balance and behaviour and memory using a battery of tests, in Non-Tg 
control and 3xTgAD mice.  Non-Tg control and 3xTgAD mice displayed similar energy balance 
profiles in response to an HF diet. Furthermore, a HF diet induced memory impairments, in both 
Non-Tg and 3xTgAD mice. As HF feeding also caused memory deficits in Non-Tg mice, the diet-
induced impairment may therefore not be specific to AD, but rather to memory overall. These 
results stress the need for control groups of Non-Tg mice fed HF diets, to determine whether any 
effects of diet observed in AD mice are specific to the disease itself or cognition in general. The 
mechanisms involved in the dietary effect on memory remain poorly understood. 
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6.1 Final discussion 
 
AD is a progressive neurodegenerative disorder, characterised by deficits in language, behaviour 
and memory. Increasing evidence suggests that mid-life obesity and a diet high in fat are risk 
factors for AD (Fitzpatrick et al 2009; Rosengren et al 2005; Whitmer et al 2005; Whitmer et al 
2008). In contrast, life-threatening weight loss occurs and worsens as the disease progresses 
(Gillette Guyonnet et al 2007; Gillette-Guyonnet et al 2000; Guerin et al 2005; White et al 1996), 
despite adequate or increased food intake (Burns et al 1989; Keene & Hope 1997a; b; Niskanen et 
al 1993; Singh et al 1988; Smith et al 1999; Spindler et al 1996). A greater understanding of energy 
balance in AD may, therefore, uncover novel targets for therapy. The aim of my PhD was to further 
study how energy balance might be involved in AD, using an experimental model of the disease. 
Specific objectives were to: 
 
- characterise the energy balance profile of 3xTgAD mice 
- characterise behaviour and memory in a battery of tests in 3xTgAD mice 
- evaluate the effect of an HF diet on cognition in 3xTgAD mice 
 
 
Firstly, energy balance was characterised in Non-Tg control and 3xTgAD mice (see summary 
Table 6.1.), demonstrating altered body weight, food intake and metabolic rate in 3xTgAD mice. At 
2-month of age male 3xTgAD mice displayed greater food intake and body weight, but no 
difference in metabolic rate, whereas from 12 months of age 3xTgAD mice weighed less, despite 
eating more, and had a higher metabolic rate than Non-Tg control mice. This provides evidence 
that there is a shift towards a hypermetabolic state from 12 months of age in 3xTgAD mice, which 
may represent a key stage in advancement of the disease process. This work is completely novel, 
as it is the first longitudinal evaluation of energy balance including assessment of metabolic rate 
reported in any model of AD. As changes in energy balance are reported throughout the 
progression of AD, the 3xTgAD model represents a useful tool to better understand changes in 
energy balance and underlying mechanisms. 
 
 
Table 6.1. Summary of the characterisation of energy balance in 3xTgAD mice versus Non-
Tg control mice increase (! , increase; " , decrease and & , no difference) 
 
Age Body weight Food intake Metabolic rate 
2 months ! ! & 
12 months " ! ! 
18 months " ! ! 
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Secondly, behaviour and memory were characterised in Non-Tg control and 3xTgAD mice in a 
battery of tests at different ages (see summary Table 6.2.). 3xTgAD mice showed changes in OF 
activity/anxiety from 3 months of age. Memory impairments were first detected in 3xTgAD mice at 3 
months of age as deficits in OR, mirroring early impairments in odour memory seen in AD patients. 
Deficits in spatial memory were then observed in both the Y-maze SA and MWM tasks from 5 
months of age. Finally, deficits in non-spatial visual object memory were observed in 3xTgAD mice 
in the NOR at 8 months of age. Overall, 3xTgAD mice displayed age-dependent memory deficits 
consistent with previous studies. 
 
 
Table 6.2. Summary of the characterisation of behaviour and memory in 3xTgAD mice 
versus Non-Tg control mice (m, months; x, no difference; # change in OF behaviour or 
memory deficit in all other tests; -, not tested at this age; OR, odour recognition; OF, open-
field; SA, spontaneous alternation; MWM, Morris water maze and NOR, novel object 
recognition) 
 
 
 
 
 
 
 
 
 
The final part of the thesis went on to assess energy balance by disrupting it experimentally. This 
was done by putting Non-Tg control and 3xTgAD mice on a chow or HF diet and assessing energy 
balance, behaviour and memory at 3-4, 7-8, 11-12 or 15-16 months of age (see summary Table 
6.3.).  
 
Table 6.3. Summary of the effect of a high fat (HF) diet on a battery of cognitive tests in 
3xTgAD and Non-Tg control mice versus respective controls on a chow diet (m, months; x, 
no difference; # , change in OF behaviour or memory deficit in all other tests; OR, odour 
recognition; MWM, Morris water maze; OF, open-field; SA, spontaneous alternation and 
NOR, novel object recognition)  
 
Non-Tg 3xTgAD  
Age  Age  
Test 3-4 m 7-8m 11-12m 15-16m 3-4m 7-8m 11-12m 15-16m 
OR # # x x # # x x 
MWM x # x x x # # x 
OF x x x x x # x x 
SA x x # # x x x # 
NOR x x # # x x x x 
 
 
 Age  
Test 3 months 5 months 8 months 12 months 
OR # - - - 
OF # # - # 
SA x # - # 
MWM x # - # 
NOR x - # - 
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Non-Tg control and 3xTgAD mice displayed similar energy balance profiles in response to an HF 
diet. The HF diet was found to worsen memory in Non-Tg mice in OR at 3-4 and 7-8 months of 
age, in the MWM at 7-8 months of age and in NOR and SA at 11-12 and 15-16 months of age. 
Similarly, the HF diet worsened memory in 3xTgAD mice in OR at 3-4 and 7-8 months of age, the 
MWM at 7-8 and 11-12 months of age, and in SA at 15-16 months of age. As an HF diet induced 
memory impairments, in both Non-Tg control and 3xTgAD mice, it suggests that diet-induced 
deficits may therefore, not be specific to AD, but rather to cognition in general. These data support 
an important role for energy balance in the progression of AD as well as normal ageing. This work 
is completely novel as this is the first HF study in both Non-Tg control and 3xTgAD mice with 
longitudinal evaluation of energy balance with a battery of different behavioural tests.  
 
In AD, much remains unknown in the area of energy balance, as we do not know exactly when, 
how or why changes in energy balance occur. For this reason, energy balance needs to be 
examined in more detail, assesing caloric intake, adiposity and metabolic rate longitudinally in a 
more homogenous AD population than used to date, together with appropriate age-matched non-
demented controls. However, as previously described, changes in energy balance may occur years 
before patients go to a clinic. Ideally, it would be great to assess energy balance throughout life in a 
cohort of humans and see what diseases they get along the way. However, realistically this is 
almost impossible, even more so if investigating risk factors, such as diet. Unlike humans, mice 
have a shorter life span, are kept in a controlled environment and can be fed identical diets. This 
makes understanding diseases, such as AD, and associated risk factors much easier, as you have 
a homogenous cohort of animals, which you can study in great detail. As 3xTgAD mice display 
alterations in energy balance throughout life and display cognitive deficits in response to an HF 
diet, they represent an appropriate model. 
 
Future studies need to determine the exact timing of changes in body weight and metabolic rate on 
a chow diet in more detail and correlate them with both behaviour and pathology. It would also be 
interesting to try and prevent the lower body weight seen in aged male 3xTgAD mice on a chow 
diet, compared to Non-Tg control mice and see how that affects their energy balance as well as 
progression of pathology and cognitive decline. Feeding the 3xTgAD mice a higher calorific diet 
would be one way to do this. However, this would be difficult as would need to measure intake very 
carefully to prevent them weighing more than the Non-Tg control mice. A better way would be to 
fully understand why the 3xTgAD mice weigh less and an intervention study based on this.  
 
How an HF diet affects cognition in 3xTgAD mice also requires further work as differerent tasks 
were affected at different time points. However, it is difficult to compare time points in the present 
study, as they are in different cohorts of mice. Ultimately, cohorts of 3xTgAD and Non-Tg controls 
on a chow or HF diets would have cognition assessed at different time points throughout their lives 
with pathology being assessed with fMRI imaging techniques. In the present study, the effect of 
diet on pathology remains to be completed in 3xTgAD and correlated with cognition. Interestingly, it 
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also appears that HF diets can induce cognitive decline independently of AD phenotype, stressing 
the need for control groups of HF-fed Non-Tg mice in HF studies in trangsgenic models. The 
mechanisms underlying HF diet-induced deficits in both Non-Tg control and 3xTgAD mice require 
further examination. This could be done by putting cohorts of Non-Tg and 3xTgAD mice on the 
same HF diet used, during this thesis, and comparing their cognition with other cohorts on the 
same HF diet, but varying in one component such as increasing the level of cholesterol or changing 
the fatty acid ratio within the diet. It would also be interesting to put 3xTgAD mice on a HF diet and 
then try various intervention studies (low fat diet/caloric restriction, exercise sessions) to see how 
they affect progression of cognitive decline and pathology. As insulin resistance may be implicated 
in the effect of obesity on cognition, insulin resistance should be assessed in Non-Tg control and 
3xTgAD mice, used in this thesis. In future studies it would then be interesting to try anti-diabetes 
treatments, such as Metformin, and see how cognition and pathology are affected. 
 
Overall, there is an urgent need to identify disease-modifying treatments for AD, and data 
presented here indicate that energy balance could represent an attractive target. However, further 
clinical studies are needed to fully establish the profile of body weight and metabolic changes in 
patients at various stages of the disease. Experimental studies also need to better define the timing 
of body weight and metabolic changes, and how these correlate with both behaviour and 
pathology. More detailed analyses of risk factors, such as an HF diet is also required in both clinical 
and experimental studies to fully understand how they affect AD. Only once this work has been 
done can targeted interventions be used to determine if they modify progression or severity of the 
AD-like changes in models of AD, and whether these might be translatable to the clinic. 
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Appendix A: Nutritional profiles of chow and HF diets 
 
Chow diet 
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60% HF diet 
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Appendix B: Genotyping of 3xTgAD and Non-Tg control mice 
 
To verify the genotype of 3xTgAD and Non-Tg mice tail snips were genotyped.  
 
To obtain DNA, 0.5 cm of tail was placed in 500 #l of lysis buffer (stock prepared as follows; 2.5 ml 
of 100 mM Tri-HCL pH 8.5, 250 #l of 5 mM EDTA pH 8, 500 #l of 0.2% SDS, 1 ml of 200 mM NaCl 
and 250 #l of 100 #g/ml Proteinase K And 20.5 ml sterile water) and placed on a rotor (Labnet, 
Problot hybridization oven, Edison, NJ, USA) overnight at 55
0
C. Samples were then spun at 10,000 
rpm for 10 min at room temperature (Mikro 200R Hettich zentrifugen, Wolf Laboratories, UK). The 
tissue lysate was then collected and diluted (20 #l lysate and 90 #l ultra-sterile H2O) and 3 #l DNA 
lysate added to 47 #l PCR reaction (37 #l sterile water, 5 #l 10x PCR buffer, 3 #l MgCl2, 0.5 #l 
dNTP, 1 #l primer mix, 0.5 #l Tag DNA polymerase). PS-1 PCR product was digested for 1 h at 
60
o
C with BstE II (Lambda DNA/BstE II digest, Sigma-Aldrich, MO, USA). Negative controls were 
also prepared by adding distilled water to the PCR reaction instead of DNA lysate). The PCR 
reaction was then run (Gene AMP 9700 PE Applied Biosystems, Warrington, Cheshire, UK)  
 
PCR programs and primers:  
 
PS-1 PCR 
 
5’- CAC ACG CAA CTC TGA CAT GCA CAG GC -3’ 
5’- AGG CAG GAA GAT CAC GTG TTC AAG TAC-3’ 
 
 
 
Conditions 
 
Initial denaturation 2.5 min at 94
o
C 
----- 
Denaturation 40 s at 94
o
C 
Annealing 40 s at 62
o
C 
Extension 1 min at 72
o
C 
(35 cycles) 
----- 
Final extension 2 min at 72
o
C 
Hold at 4
o
C 
 
 
APP PCR 
 
5’- GGT GAG TTT GTA AGT GAT GCC -3’ 
5’- TCT TCT TCT TCC ACC TCA GC -3’ 
 
5’– CAA ATG TTG CTT GTC TGG TG – 3’ 
5’- GTC AGT CGA GTG CAC AGT TT -3’ 
 
 
 
 
 
 
Control primer pair 
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Conditions  
 
Initial denaturation 1.5 min at 94
o
C  
---- 
Denaturation 30 s at 94
o
C 
Annealing 45 s at 60
o
C 
Extension 45 s at 72
o
C  
(35cycles) 
---- 
Final extension 2 min at 72
o
C  
Hold at 4
o
C 
 
 
TAU PCR 
 
5’– TGA ACC AGG ATG GCT GAG -3’ 
5’- TTG TCA TCG CTT CCA GTC C -3’ 
 
5’- CAA ATG TTG CTT GTC TGG TG -3’ 
5’- GTC AGT CGA GTG CAC AGT TT -3’ 
 
 
Conditions  
 
Initial denaturation 5 min at 94
o
C  
---- 
Denaturation 30 s at 94
o
C 
Annealing 30 s at 60
o
C touching down by -0.5
o
C each cycle) 
Extension 45 s at 72
0
C  
(22 cycles) 
---- 
Denaturation 30 s at 94
o
C 
Annealing 30 s at 50
o
C  
Extension 45 s at 72
o
C  
(13 cycles) 
--- 
Final extension 10 mins at 72
o
C  
Hold at 4
o
C 
 
 
 
PCR products were kept at 4
o
C until the PCR gel was run. 1.3% agarose in 1xTAE (tris acetic acid 
EDTA) was made by adding 1.3 g agarose to 100 ml TAE. The solution was then gently 
microwaved for 3 min and left to cool. Ethidium bromide (5 #l in 100 #l) was then added and the gel 
was poured and left to set. 15 #l of sample or control and 3 #l DNA loading buffer (5x) were then 
pipetted on nescofilm. The first lane was loaded with 8 #l of DNA marker (Hyperladder 4, Bioline, 
London, UK) and 8 #l of the tail snip PCR sample or control and loading buffer were loaded into the 
other lanes. The gel was run a 100 v for 1 h (Hybaid Electrophoresis tank, Thermoscientific). 
 
All mice used during this PhD were genotyped. For example results see Figure B1. 
Control primer pair 
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Figure B1. Genotyping 3xTgAD and Non-Tg control mice   
 
All mice used throughout this PhD were genotyped, A. APP (control primer; mouse DNA is an 
internal control), B. PS-1 and C. Tau (control primer; mouse DNA as an internal control).  
 
                                                                                                                                           Appendices          
 
142 
 
Appendix C: Published manuscript 
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